Pending

Delayed-Release Dimethyl Fumarate Safety and Efficacy in Pediatric Patients With Relapsing-Remitting Multiple Sclerosis.
Improvement of Remyelination in Demyelinated Corpus Callosum Using Human Adipose-Derived Stem Cells (hADSCs) and Pregnenolone in the Cuprizone Rat Model of Multiple Sclerosis.
Ofatumumab (Kesimpta) for multiple sclerosis.
LUNA-EMG to Enhance Motor Functions in Multiple Sclerosis
Efficacy and tolerability of folate-aminopterin therapy in a rat focal model of multiple sclerosis.
Dynamic Balance Training in Multiple Sclerosis
Long-Term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.
Heparanome-mediated rescue of oligodendrocyte progenitor quiescence following inflammatory demyelination.
Discontinuation and dose reduction of rituximab in relapsing-remitting multiple sclerosis.
The Core of Gut Life: Firmicutes Profile in Patients with Relapsing-Remitting Multiple Sclerosis.
Endogenous Retroviruses in Nervous System Disorders.
Women’s and Fetal Issues in Neurotoxicology.
Effect of applying inclusion and exclusion criteria of phase III clinical trials to multiple sclerosis patients in routine clinical care.
Reduced Fragmentation of IGFBP-2 and IGFBP-3 as a Potential Mechanism for Decreased Ratio of IGF-II to IGFBPs in Cerebrospinal Fluid in Response to Repeated Intrathecal Administration of Triamcinolone Acetonide in Patients With Multiple Sclerosis.
Two-year follow-up during fingolimod treatment in a pediatric multiple sclerosis patient still active on first-line treatment.
Designed PKC-targeting bryostatin analogs modulate innate immunity and neuroinflammation.
Clinical feasibility of longitudinal lateral ventricular volume measurements on T2-FLAIR across MRI scanner changes.
Is baseline routine renal ultrasound indicated for all MS patients?
Cortical M1 plasticity and metaplasticity in patients with multiple sclerosis.
Factors associated with health care utilization in pediatric multiple sclerosis.
Cognitive performance and cognitive workload in multiple sclerosis: Two different constructs of cognitive functioning?
Environmental risk factors for multiple sclerosis in Japanese people.
Unmet needs influence health-related quality of life in people with multiple sclerosis.
Pain-related illness intrusiveness is associated with lower activity engagement among persons with multiple sclerosis.
Cesarean section in women with MS: A choice or a need?
Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada.
Paricalcitol improves experimental autoimmune encephalomyelitis (EAE) by suppressing inflammation via NF-κB signaling.
The multifaceted role of kinases in amyotrophic lateral sclerosis: genetic, pathological and therapeutic implications.
Necrotizing Fasciitis in a Patient on Long-Term Intramuscular Interferon-Beta for Multiple Sclerosis: A Case Report.
Achillea spp.: A comprehensive review on its ethnobotany, phytochemistry, phytopharmacology and industrial applications.
[Multiple sclerosis].
[Therapeutic attitudes towards multiple sclerosis in Central America and the Caribbean facing the SARS-CoV-2 pandemia].
Remote testing of vitamin D levels across the UK MS population-A case control study.
Societal costs of primary progressive multiple sclerosis in Australia and the economic impact of a hypothetical disease-modifying treatment that could delay disease progression.
Quantification of biotin in plasma samples by column switching liquid chromatography – tandem mass spectrometry.
Comparison of Expression Levels of miR-29b-3p and miR-326 in T Helper-1 and T Helper-17 Cells Isolated from Responsive and Non-responsive Relapsing-remitting Multiple Sclerosis Patients Treated with Interferon-beta.
Is Easier Better Than Harder? An Experiment on Choice Experiments for Benefit-Risk Tradeoff Preferences.
In vivo detection of teriflunomide-derived fluorine signal during neuroinflammation using fluorine MR spectroscopy.
Teriflunomide-associated urolithiasis: a new adverse reaction explained by its uricosuric effect.
Isolated neurosarcoidosis mimicking multiple sclerosis.
Response to ibudilast treatment according to progressive multiple sclerosis disease phenotype.
Intravitreal Interleukin-2 modifies retinal excitatory circuits and retinocollicular innervation.
Novel compounds with dual S1P receptor agonist and histamine H3 receptor antagonist activities act protective in a mouse model of multiple sclerosis.
Autonomic nervous system abnormalities predict cardiovascular changes after initiation of siponimod in secondary progressive multiple sclerosis.
Predicting long walking capacity from the timed 25-foot walk test in persons with multiple sclerosis – a potential simple aid to assist ambulation scoring?
Effect of Ozanimod on Symbol Digit Modalities Test Performance in Relapsing MS.
What percentage of AQP4-ab-negative NMOSD patients are MOG-ab positive? A study from the Argentinean multiple sclerosis registry (RelevarEM).
The Wnt effector TCF7l2 promotes oligodendroglial differentiation by repressing autocrine BMP4-mediated signaling.
Quantitative MRI phenotypes capture biological heterogeneity in multiple sclerosis patients.
Cyclophosphamide treatment in active multiple sclerosis.
Cognitive assessment in patients with multiple sclerosis: From neuropsychological batteries to ecological tools.
Cognitive rehabilitation in multiple sclerosis: An overview of clinical tools.
Interest of self-management education for mental fatigue in multiple sclerosis: Preliminary results.
Autobiographical memory and future thinking impairments in multiple sclerosis: Cognitive and neural mechanisms, functional impact and rehabilitation.
Effect of a strong desire to void on walking speed in individuals with multiple sclerosis and urinary disorders.
Characterization of BAY 1905254, an Immune Checkpoint Inhibitor Targeting the Immunoglobulin-Like Domain Containing Receptor 2 (ILDR2).
Multiple sclerosis: A special issue in the Annals of Physical and Rehabilitation Medicine.
Reliability of Outcome Measures in Clinical Trials in Secondary Progressive Multiple Sclerosis.
When tumefactive demyelination is truly a tumor: case report of a radiographic misdiagnosis.
Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives.
Measuring quality of life and identifying what is important to Jordanian living with multiple sclerosis using the Arabic version of the patient-generated index.
Pathological cerebrospinal fluid protein concentration and albumin quotient at relapse predicts short-term disability progression in multiple sclerosis: a retrospective single center observational study.
EMDR treatment for anxiety in MS patients: A pilot study.
An emerging potential of metabolomics in multiple sclerosis: a comprehensive overview.
Brain lipidomics as a rising field in neurodegenerative contexts: Perspectives with Machine Learning approaches.
Bilirubin nanomedicine ameliorates the progression of experimental autoimmune encephalomyelitis by modulating dendritic cells.
Seasonal patterns of relapse and disability in Danish MS patients: A population-based cohort study.
Babesia microti infection in a patient with Multiple Sclerosis treated with Ocrelizumab.
QALY league table of Iran: a practical method for better resource allocation.
A Phase 2 Study of Orelabrutinib in Patients With Relapsing-Remitting Multiple Sclerosis
A ToM Training for People With Multiple Sclerosis: an Efficacy Study.
Changing Behaviour towards Aerobic and Strength Exercise (BASE): Design of a randomised, phase I study determining the safety, feasibility and consumer-evaluation of a remotely-delivered exercise programme in persons with multiple sclerosis.
Natalizumab-associated progressive multifocal leukoencephalopathy (PML) in multiple sclerosis (MS): “a case report from Ireland with review of literature, clinical pitfalls and future direction”.
Vision Problems in Multiple Sclerosis.
Study protocol: randomised controlled trial evaluating exercise therapy as a supplemental treatment strategy in early multiple sclerosis: the Early Multiple Sclerosis Exercise Study (EMSES).
Effect of lateral therapy switches to oral moderate-efficacy drugs in multiple sclerosis: a nationwide cohort study.
HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data.
Myelin-specific T cells in animals with Japanese macaque encephalomyelitis.
Comparing Transanal Irrigation With Navina Smart vs. Standard Bowel Care in Patients With Multiple Sclerosis
[Robotic assistance in activities of daily living exemplified by food intake].
Microvascular Transposition Without Teflon: A Single Institution’s 17-Year Experience Treating Trigeminal Neuralgia.
The Effect of Cognitive Rehabilitation on Balance Skills of Individuals with Multiple Sclerosis.
Successful use of tofacitinib in the treatment of diffuse systemic sclerosis and axial spondyloarthritis: a case-based review.
Two-armed active comparator trials are unethical in paediatric multiple sclerosis – Commentary.
Determinants of therapeutic lag in multiple sclerosis.
Primary Progressive Multiple Sclerosis Under Anti-TNFα Treatment: A Case Report.
Psychobehavioral Treatment Options for Sexual Dysfunction in Multiple Sclerosis: A Systematic Review.
“I Will Respect the Autonomy of My Patient”: A Scoping Review of Shared Decision Making in Multiple Sclerosis.
Mobilized Multipotent Hematopoietic Progenitors Stabilize and Expand Regulatory T Cells to Protect Against Autoimmune Encephalomyelitis.
A Case of Atypical Multiple Sclerosis Mimicking Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Syndrome.
Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein IgG associated disorder: A comprehensive neuro-ophthalmic review.
Importance of incorporating quantitative imaging biomarker technical performance characteristics when estimating treatment effects.
Urinary incontinence and impaired physical function are associated with expiratory muscle weakness in patients with multiple sclerosis.
Social Cognition in Multiple Sclerosis, From a Study of Eye Movement and Gaze Strategies Using Video-oculography
COVID-19 in teriflunomide-treated patients with multiple sclerosis: A case report and literature review.
Brain ultrashort T2 component imaging using a short TR adiabatic inversion recovery prepared dual-echo ultrashort TE sequence with complex echo subtraction (STAIR-dUTE-ES).
Prevalence of adverse pregnancy outcomes after exposure to interferon beta prior to or during pregnancy in women with MS: Stratification by maternal and newborn characteristics in a register-based cohort study in Finland and Sweden.
Therapeutic potential of cannabinoids in combination cancer therapy.
GABAB-Receptor Agonist-Based Immunotherapy for Type 1 Diabetes in NOD Mice.
Current and Long-Term Physical Activity Among Adults with Multiple Sclerosis in the United States: COM-B Variables as Explanatory Factors.

Acute teriflunomide overdose with relatively mild symptoms: A case report.
The TGF-β superfamily cytokine Activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation.
Are the protective benefits of vitamin D in neurodegenerative disease dependent on route of administration? A systematic review.
Assessment of Adaptive Engagement and Support Model for People With Chronic Health Conditions in Online Health Communities: Combined Content Analysis.
Rituximab for the treatment of multiple sclerosis: a review.
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis.
A Prospective Observational Registry of Repository Corticotropin Injection (Acthar® Gel) for the Treatment of Multiple Sclerosis Relapse.
Effects of dietary restriction on neuroinflammation in neurodegenerative diseases.
Cardiovascular safety of mirabegron in individuals treated for spinal cord injury- or multiple sclerosis-induced neurogenic detrusor overactivity.
Immune phenotyping study revealing caveats regarding a switch from fingolimod to cladribine.
Restless legs syndrome and health-related quality of life in adults with multiple sclerosis.
Health Care Professionals’ Views on Using Remote Measurement Technology in Managing Central Nervous System Disorders: Qualitative Interview Study.
New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab.
Experimental autoimmune encephalomyelitis is associated with changes of the microbiota composition in the gastrointestinal tract.
Cost per response analysis of repository corticotropin injection versus other alternative treatments for acute exacerbations of multiple sclerosis.
Immune responses to azacytidine in animal models of inflammatory disorders: a systematic review.
Reproductive history and progressive multiple sclerosis risk in women.
Combination of Hydroxychloroquine and Indapamide Attenuates Neurodegeneration in Models Relevant to Multiple Sclerosis.
The Roles of Orphan G Protein-Coupled Receptors in Autoimmune Diseases.
A STAT3 inhibitor ameliorates CNS autoimmunity by restoring Teff:Treg Balance.
Neuro-ophthalmologic manifestations of multiple sclerosis other than acute optic neuritis.
The effects of chronic Δ-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) use on cerebral glucose metabolism in multiple sclerosis: a pilot study.
Long-Term Respiratory and Neurological Sequelae of COVID-19.
Frontiers in the Clinical Applications of Botulinum Toxin A as Treatment for Neurogenic Lower Urinary Tract Dysfunction.
Macrophage Migration Inhibitory Factor (MIF) and Its Homologue d-Dopachrome Tautomerase (DDT) Inversely Correlate with Inflammation in Discoid Lupus Erythematosus.
Shared development of targeted therapies among autoimmune and inflammatory diseases: a systematic repurposing analysis.
Anti-inflammatory Activity of Caspian Cobra (Naja naja oxiana) Snake Venom on the Serum Level of Interleukin-27 and Histopathological Changes in Myelin Oligodendrocyte Glycoprotein-experimental Autoimmune Encephalomyelitisinduced Mice.
Cumulative effects of therapies on disability in relapsing multiple sclerosis.
Neuroprotection mediated by ST266 requires full complement of proteins secreted by amnion-derived multipotent progenitor cells.
Differentiating axonal loss and demyelination in chronic MS lesions: A novel approach using single streamline diffusivity analysis.
The Added Value of Cognition-targeted Exercise Versus Symptom-targeted Exercise for Multiple Sclerosis Fatigue
Investigating the Utility of Demyelination Tracer [18F]3F4AP in Controls and Multiple Sclerosis Subjects
IL-2 Signaling and Polarization of Regulatory LBs: Involvement in Multiple Sclerosis
Peripheral Blood NRF2 Expression as a Biomarker in Human Health and Disease.
Comparing the effects of multi-session anodal trans-cranial direct current stimulation of primary motor and dorsolateral prefrontal cortices on fatigue and quality of life in patients with multiple sclerosis: a double-blind, randomized, sham-controlled trial.
MS Spasticity: Take Control (STC) for ambulatory adults: protocol for a randomized controlled trial.
Progressive multifocal leukoencephalopathy lesion and brain parenchymal segmentation from MRI using serial deep convolutional neural networks.
Bee Venom in Wound Healing.
Early-life-trauma triggers interferon-β resistance and neurodegeneration in a multiple sclerosis model via downregulated β1-adrenergic signaling.
A cell-based drug delivery platform for treating central nervous system inflammation.
[Current aspects of neurogenic dysfunctions of the lower urinary tract in multiple sclerosis].
Administration of CD4+CD25highCD127-FoxP3+ Regulatory T Cells for Relapsing-Remitting Multiple Sclerosis: A Phase 1 Study.
Respiratory repercussions of neurological diseases and how best to manage them.
Tumefactive demyelinating lesions after initiating fingolimod in patient with multiple sclerosis: A case report.
B7-H3: A promising therapeutic target for autoimmune diseases.
The clinical correlates of participation levels in people with multiple sclerosis.
Prospective Memory Deficits in Multiple Sclerosis: Voxel-based Morphometry and Double Inversion Recovery Analysis.
The Levels of Depression, Anxiety, Acceptance of Illness, and Medication Adherence in Patients with Multiple Sclerosis – Descriptive and Correlational Study.
Moringa oleifera Lam and its Therapeutic Effects in Immune Disorders.
Epstein-Barr Virus and Multiple Sclerosis.
Deletion of Protocadherin Gamma C3 Induces Phenotypic and Functional Changes in Brain Microvascular Endothelial Cells In Vitro.
Eomesodermin in CD4+T cells is essential for Ginkgolide K ameliorating disease progression in experimental autoimmune encephalomyelitis.
Management of Self-Injurious Behavior, Aggression, and Psychogenic Non-Epileptic Seizures in Patients With Tuberous Sclerosis: A Case Report With a Review of Literature.
Alterations of the Fecal Microbiota in Chinese Patients With Multiple Sclerosis.
IL-37 exerts therapeutic effects in experimental autoimmune encephalomyelitis through the receptor complex IL-1R5/IL-1R8.
Brain-derived neurotrophic factor precursor in the immune system is a novel target for treating multiple sclerosis.
Social support is linked to mental health, quality of life, and motor function in multiple sclerosis.
Remediation Program Via a “Serious Game” for the Cognitive Functions of Multiple Sclerosis Patients
ChariotMS – Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis
Internet-based technology in multiple sclerosis: Exploring perceived use and skills and actual performance.
Identifying the Distinct Cognitive Phenotypes in Multiple Sclerosis.
MRI Characteristics of NMO, MOG and MS Related Optic Neuritis.
SARS-CoV-2/COVID-19 in multiple sclerosis patients receiving disease-modifying therapy.
Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis?
The changing landscape of optic neuritis: a narrative review.
The Potential for Immunospecific Therapy in Multiple Sclerosis Based on Identification of Driver Clones of the Disease.
EEG Biofeedback for Treatment of Psychogenic Non-Epileptic Seizures (PNES) in Multiple Sclerosis: A Case Report.
Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options.
Adaptive changes in muscle activity after cryotherapy treatment: Potential mechanism for improvement the functional state in patients with multiple sclerosis.
B3 agonists or anticholinergics in the treatment of the lower urinary tract dysfunction in patients with multiple sclerosis?-A randomized study.
Subtyping relapsing-remitting multiple sclerosis using structural MRI.
Safinamide in neurological disorders and beyond: evidence from preclinical and clinical studies.
Delayed onset hypophysitis after therapy with daclizumab for multiple sclerosis – A report of two cases.
How may patients with MS benefit from using music assisted therapy? A case-control feasability study investigating motor outcomes and beyond.
Safety and efficacy of low-dose medical cannabis oils in multiple sclerosis.
Differentiating societal costs of disability worsening in multiple sclerosis.
Quantity and quality of gait and turning in people with multiple sclerosis, Parkinson’s disease and matched controls during daily living.
Among Persons With Multiple Sclerosis (MS), Objective Sleep, Psychological Functioning, and Higher Physical Activity Scores Remained Stable Over 2 Years-Results From a Small Study Under Naturalistic Conditions.
Metabolomic Biomarkers of Multiple Sclerosis: A Systematic Review.
The Effectiveness of Group-based Cognitive Hypnotherapy on the Psychological Well-being of Patients with Multiple Sclerosis: A Randomized Clinical Trial.
Quality of life in patients with multiple sclerosis and their caregivers in Colombia: One-year follow-up.
Do disease-modifying drugs (DMD) have a positive impact on the occurrence of secondary progressive multiple sclerosis? No.
Therapeutic Effect of Ginsenoside Rd on Experimental Autoimmune Encephalomyelitis Model Mice: Regulation of Inflammation and Treg/Th17 Cell Balance.
Case Report: A Spinal Ischemic Lesion in a 24-Year-Old Patient With Fabry Disease.
Mesenchymal stem cells instruct a beneficial phenotype in reactive astrocytes.
Pomegranate peel extract ameliorates the severity of experimental autoimmune encephalomyelitis via modulation of gut microbiota.
Impact of psychiatric distress and physical disability on quality of life in neuromyelitis optica spectrum disorder and chronic autoimmune demyelinating polyneuropathies.
Andrographolide, an Anti-Inflammatory Multitarget Drug: All Roads Lead to Cellular Metabolism.
Calming the (Cytokine) Storm: Dimethyl Fumarate as a Therapeutic Candidate for COVID-19.
Safety of Newer Disease Modifying Therapies in Multiple Sclerosis.
Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity.
[Argentinean consensus guidelines on the identification and clinical care of secondary progressive multiple sclerosis].
Predicting Multiple Sclerosis from Gait Dynamics Using an Instrumented Treadmill – A Machine Learning Approach.
Evaluation of the rate of COVID-19 infection, hospitalization and death among Iranian patients with multiple sclerosis.
Favorable outcomes after COVID-19 infection in multiple sclerosis patients treated with cladribine tablets.
Are multiple sclerosis patients and their caregivers more anxious and more committed to following the basic preventive measures during the COVID-19 pandemic?
Poly(d,l-lactide-co-glycolide) (PLGA) Nanoparticles Loaded with Proteolipid Protein (PLP)-Exploring a New Administration Route.
Effect of Disease Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years.
Systematic review and meta-analysis of the development of multiple sclerosis in clinically isolated syndrome.
Cognitive Processing Speed Impairment Does Not Influence the Construct Validity of Six-Spot Step Test Performance in People With Multiple Sclerosis.

Tumefactive multiple sclerosis (TMS): A case series of this challenging variant of MS.
Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis
Use of Audio Recordings of Self-Hypnosis and Meditation for Fatigue Management in Multiple Sclerosis
Cell type-specific transcriptomics identifies neddylation as a novel therapeutic target in multiple sclerosis.
Effects of Comorbid Fibromyalgia Syndrome on activities of daily living in multiple sclerosis patients.
Changes in mental health symptoms from pre-COVID-19 to COVID-19 among participants with systemic sclerosis from four countries: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study.
Spinal cord involvement by atrophy and associations with disability are different between multiple sclerosis and neuromyelitis optica spectrum disorder.
Exercise Effects on Multiple Sclerosis Quality of Life and Clinical-Motor Symptoms.
Role of Vitamin D in Preventing and Treating Selected Extraskeletal Diseases-An Umbrella Review.
Paula Method (Circular Muscle Exercise) for Urinary Incontinence Symptoms of Women with Multiple Sclerosis: A Pilot Study.
Ozanimod (Zeposia) for multiple sclerosis.
Encephalopathy associated with COVID-19 in a patient with multiple sclerosis.
Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis.
Delayed diagnosis of multiple sclerosis in a low prevalence country.
Critically appraised paper: A home-based standing frame program may improve motor function in people with progressive multiple sclerosis [synopsis].
Toll-like receptor 2 and 4 antagonism for the treatment of experimental autoimmune encephalitis (EAE)-related pain.
PROGRESS IN PROGESTIN-BASED THERAPIES FOR NEUROLOGICAL DISORDERS.
Comorbidity in multiple sclerosis patients from Nordland County, Norway – validated data from the Norwegian Patient Registry.
Interleukin-6 inhibition with tocilizumab for relapsing MOG-IgG associated disorder (MOGAD): A case-series and review.
Cladribine inhibits secretion of pro-inflammatory cytokines and phagocytosis in human monocyte-derived M1 macrophages in-vitro.
Suppression of Experimental Autoimmune Encephalomyelitis by ILT3.Fc.
Prognostication and contemporary management of clinically isolated syndrome.
Blocking PDGF-CC signaling ameliorates multiple sclerosis-like neuroinflammation by inhibiting disruption of the blood-brain barrier.
Tuberous sclerosis patient with neuroendocrine carcinoma of the esophagogastric junction: A case report.
Central Nervous System Demyelination Associated With Immune Checkpoint Inhibitors: Review of the Literature.
Rehabilitation Before and After Autologous Haematopoietic Stem Cell Transplantation (AHSCT) for Patients With Multiple Sclerosis (MS): Consensus Guidelines and Recommendations for Best Clinical Practice on Behalf of the Autoimmune Diseases Working Party, Nurses Group, and Patient Advocacy Committee of the European Society for Blood and Marrow Transplantation (EBMT).
Human Commensal Prevotella histicola Ameliorates Disease as Effectively as Interferon-Beta in the Experimental Autoimmune Encephalomyelitis.
Bixin Attenuates Experimental Autoimmune Encephalomyelitis by Suppressing TXNIP/NLRP3 Inflammasome Activity and Activating NRF2 Signaling.
Severe Acute Respiratory Syndrome Coronavirus 2-Induced Neurological Complications.
A new era for monoclonal antibodies with applications in neurology (Review).
SARS-CoV-2, multiple sclerosis, and focal deficit in a postpartum woman: A case report.
Alemtuzumab: A Review in Relapsing Remitting Multiple Sclerosis.
Molecular hydrogen (H2 ) as a potential treatment for acute and chronic fatigue.
Alleviation of extensive visual pathway dysfunction by a remyelinating drug in a chronic mouse model of multiple sclerosis.
Real-world experience of ocrelizumab in multiple sclerosis in a Spanish population.
Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: the VIAADISC score.
Thymoquinone in autoimmune diseases: Therapeutic potential and molecular mechanisms.
Physiotherapy use and access-barriers in persons with multiple sclerosis: A cross-sectional analysis.
Influence of delaying ocrelizumab dosing in multiple sclerosis due to COVID-19 pandemics on clinical and laboratory effectiveness.
Serum amyloid A level correlates with T2 lesion volume and cortical volume in patients with multiple sclerosis.
IA or PE – What is the Best Treatment Option of Steroid Refractory Neurological Autoimmune Diseases
Ocrelizumab-Induced Severe Colitis.
Brief Report Treatment of infertility and menopause in a patient with multiple sclerosis affecting the pituitary stalk: a case report.
No evidence of associations among body composition and symptoms in persons with multiple sclerosis.
Clinical High-Resolution 3D-MR Spectroscopic Imaging of the Human Brain at 7 T.
Bright Light Therapy as Possible Treatment Option for MS-Fatigue
HLA Class II Genotype Does Not Affect the Myelin Responsiveness of Multiple Sclerosis Patients.
Anti-Kir4.1 Antibodies in Multiple Sclerosis: Specificity and Pathogenicity.
Increased Radiosurgery Toxicity Associated With Treatment of Vestibular Schwannoma in Multiple Sclerosis.
Blood-flow Restriction Training for a Person With Primary Progressive Multiple Sclerosis: A Case Report.
Human gut microbiota and its association with pathogenesis and treatments of neurodegenerative diseases.
Risk factors for infusion-related reactions following Ocrelizumab infusion in a community setting: Development of an electronic medical record-based explanatory model.
Fingolimod treatment reverses signs of diffuse white matter damage in multiple sclerosis: A pilot study.
Establishment of a safety protocol for the administration of treatments in multiple sclerosis during the SARS-CoV-2 pandemic.
COVID-19 prevention and multiple sclerosis management: The SAFE pathway for the post-peak.
Mild COVID-19 infection in a patient with multiple sclerosis and severe depletion of T-lymphocyte subsets due to alemtuzumab.
Radiologically Isolated Syndrome: A Review for Neuroradiologists.
Manganese-Enhanced MRI in Patients with Multiple Sclerosis.
Development and Validation of a Five-Gene Signature to Predict Relapse-Free Survival in Multiple Sclerosis.
Patterning Chronic Active Demyelination in Slowly Expanding/Evolving White Matter MS Lesions.
Effect of Short-term Integrated Palliative Care on Patient-Reported Outcomes Among Patients Severely Affected With Long-term Neurological Conditions: A Randomized Clinical Trial.
Vitamin D and IFN-β Modulate the Inflammatory Gene Expression Program of Primary Human T Lymphocytes.
Reactive Astrocytes as Therapeutic Targets for Brain Degenerative Diseases: Roles Played by Metabotropic Glutamate Receptors.
Chitinase 3-like 1 is neurotoxic in primary cultured neurons.
Phytocannabinoid-dependent mTORC1 regulation is dependent upon IPMK activity.
Etiological spectrum, clinico-radiological profile and treatment outcomes of longitudinally extensive transverse myelitis – A prospective study from Northwest India.
Pitavastatin ameliorates autoimmune neuroinflammation by regulating the Treg/Th17 cell balance through inhibition of mevalonate metabolism.
Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg.
Experience in Multiple Sclerosis Patients with COVID-19 and Disease-Modifying Therapies: A Review of 873 Published Cases.
Inertial sensor-based gait parameters reflect patient-reported fatigue in multiple sclerosis.
COVID-19 in MS patients: susceptibility, severity risk factors and serological response.
[Direct and indirect neurological manifestations of COVID-19].
[Efficacy and safety of Kinezia (fampridine) in the complex therapy of multiple sclerosis].
First line treatment failure: Predictive factors in a cohort of 863 Relapsing Remitting MS patients.
Expression Profile of ERK5 and PKM2 Kinases in Neuroinflammatory Diseases.
Involvement of Genetic Factors in Multiple Sclerosis.
Factors influencing daily treatment choices in multiple sclerosis: practice guidelines, biomarkers and burden of disease.
Early focality and spread of cortical dysfunction in amyotrophic lateral sclerosis: A regional study across the motor cortices.
Selenization of S. cerevisiae increases its protective potential in experimental autoimmune encephalomyelitis by triggering an intestinal immunomodulatory loop.
Umbilical Cord Mesenchymal Stem Cells as well as their Released Exosomes Suppress Proliferation of Activated PBMCs in Multiple Sclerosis.
Pegylated Interferon Alfa 2a Therapy in Patients with Myeloproliferative Disorders: A Review of Clinical Effectiveness and Cost-Effectiveness
Melatonin: A review of its potential functions and effects on neurological diseases.
The Roles of the NLRP3 Inflammasome in Neurodegenerative and Metabolic Diseases and in Relevant Advanced Therapeutic Interventions.
Are multiple sclerosis therapies safe in severe acute respiratory syndrome coronavirus 2 times?
Prevalence of bipolar disorder in multiple sclerosis: a systematic review and meta-analysis.
Siponimod and cognition in secondary progressive multiple sclerosis: EXPAND secondary analyses.
[A patient with relapsing-remitting multiple sclerosis who relapsed frequently and developed primary biliary cholangitis after pregnancy and discontinuation of fingolimod].
Non-invasive Brain and Spinal Stimulation for Pain and Related Symptoms in Multiple Sclerosis: A Systematic Review.
Various Diseases and Clinical Heterogeneity Are Associated With “Hot Cross Bun”.
Rationale for COVID-19 Treatment by Nebulized Interferon-β-1b-Literature Review and Personal Preliminary Experience.
Extensive Healthy Donor Age/Gender Adjustments and Propensity Score Matching Reveal Physiology of Multiple Sclerosis Through Immunophenotyping.
Mapping the Progressive Treatment-Related Reduction of Active MRI Lesions in Multiple Sclerosis.
Rapamycin Alleviates the Symptoms of Multiple Sclerosis in Experimental Autoimmune Encephalomyelitis (EAE) Through Mediating the TAM-TLRs-SOCS Pathway.
Efficacy of cladribine tablets in high disease activity patients with relapsing multiple sclerosis: Post hoc analysis of subgroups with and without prior disease-modifying drug treatment.
Pharmacological treatment of central neuropathic pain: consensus of the Brazilian Academy of Neurology.
Cannabinoid-Based Medicines and Multiple Sclerosis.
Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosis.
Orem’s Self-Care Model with Multiple Sclerosis Patients’ Balance and Motor Function.
Seroconversion and indolent course of COVID-19 in patients with multiple sclerosis treated with fingolimod and teriflunomide.
Interferon Beta Activity Is Modulated via Binding of Specific S100 Proteins.

The Relationship of the Mechanisms of the Pathogenesis of Multiple Sclerosis and the Expression of Endogenous Retroviruses.
Severe pneumonia with formation of a pulmonary cavity associated with long-term rituximab therapy in multiple sclerosis.
Effect of an Educational Intervention on Therapeutic Inertia in Neurologists With Expertise in Multiple Sclerosis: A Randomized Clinical Trial.
Signatures of immune reprogramming in anti-CD52 therapy of MS: markers for risk stratification and treatment response.
Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disorder-optic neuritis: a comprehensive review of diagnosis and treatment.
Epileptic seizures in multiple sclerosis: prevalence, competing causes and diagnostic accuracy.
A case report of late-onset atypical Hemolytic Uremic Syndrome during interferon beta in multiple sclerosis: Open issues in literature review.
Insights into multiple sclerosis-associated uveitis: a scoping review.
A literature review of biosensors for multiple sclerosis: Towards personalized medicine and point-of-care testing.
Study of Efficacy and Safety of Fingolimod (Gilenya) 0.5 mg in Chinese Patients With Relapsing Multiple Sclerosis (RMS) Patients
Marine n-3 polyunsaturated fatty acids: Efficacy on inflammatory-based disorders.
A cross-sectional comparison of performance, neurophysiological and MRI outcomes of responders and non-responders to fampridine treatment in multiple sclerosis – An explorative study.
High serum neurofilament levels among Chinese patients with aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorders.
The place of sphingosine-1-phosphate modulators in the therapy of inflammatory bowel diseases
Retinal cotton wool spot associated with cladribine therapy for multiple sclerosis.
Fast and safe: Optimising multiple sclerosis infusions during COVID-19 pandemic.
False hepatitis B and C viral serologies in patients with multiple sclerosis receiving high-dose biotin.
Lower total cerebral arterial flow contributes to cognitive performance in multiple sclerosis patients.
Therapeutic Plasma Exchange in Tehran Between 2011 and 2014.
Plasma levels of protein C pathway proteins and brain magnetic resonance imaging volumes in multiple sclerosis.
The caring experience in multiple sclerosis: Caregiving tasks, coping strategies and psychological well-being.
Failed B cell survival factor trials support the importance of memory B cells in multiple sclerosis.
The hidden information in patient-reported outcomes and clinician-assessed outcomes: multiple sclerosis as a proof of concept of a machine learning approach.
A high yielding IFNAR1 ECD mammalian expression process for use in autoimmune disease drug development.
Noninvasive Brain Delivery and Efficacy of BDNF to Stimulate Neuroregeneration and Suppression of Disease Relapse in EAE Mice.
2D linear measures of ventricular enlargement may be relevant markers of brain atrophy and long-term disability progression in multiple sclerosis.
Importance of Patient-Centered Outcomes When Evaluating Treatments for Secondary Progressive Multiple Sclerosis.
Substrate Specific Inhibitor Designed against the Immunomodulator GMF-beta Reversed the Experimental Autoimmune Encephalomyelitis.
A clinically feasible 7-Tesla protocol for the identification of cortical lesions in Multiple Sclerosis.
Standardized, comprehensive, hospital-based circuit training in people with multiple sclerosis: results on feasibility, adherence and satisfaction of the training intervention.
Molecular mechanisms of necroptosis and relevance for neurodegenerative diseases.
Stability and Activity of the Hyperglycosylated Human Interferon-β R27T Variant.
A Precision Medicine Tool for Patients With Multiple Sclerosis (the Open MS BioScreen): Human-Centered Design and Development.
Recombinant antibodies derived from laser captured single plasma cells of multiple sclerosis brain identified phage peptides which may be used as tools for characterizing intrathecal IgG response.
Location matters: highly divergent protein levels in samples from different CNS compartments in a clinical trial of rituximab for progressive MS.
Detrended fluctuation analysis of gait dynamics when entraining to music and metronomes at different tempi in persons with multiple sclerosis.
Effect of a Combined Program of Strength and Dual Cognitive-Motor Tasks in Multiple Sclerosis Subjects.
Long-term ocrelizumab in progressive multiple sclerosis.
High-dose biotin in multiple sclerosis: the end of the road.
Temporal profile of serum neurofilament light in multiple sclerosis: Implications for patient monitoring.
Computational modeling of the immune response in multiple sclerosis using epimod framework.
Short-term reproducibility of cystometry in multiple sclerosis patients.
Efficacy and safety of oral prednisolone tapering following intravenous methyl prednisolone in patients with multiple sclerosis relapses: A randomized, double-blind, placebo-controlled trial.
Understanding the impact of cognitive impairment and disease severity on activities of daily living in MS patients with different disability levels.
Effect of everolimus on multifocal micronodular pneumocyte hyperplasia in tuberous sclerosis complex.
Neuregulin-1 beta 1 is implicated in pathogenesis of multiple sclerosis.
Concentration-QTc Modeling of Ozanimod’s Major Active Metabolites in Adult Healthy Subjects.
Biomarkers of treatment response in patients with progressive multiple sclerosis treated with high-dose pharmaceutical-grade biotin (MD1003).
The Effect of Combined Therapy on the Support and Development of Social Skills of people with Multiple Sclerosis in Senior Age.
Synthesis and analysis of 4-(3-fluoropropyl)-glutamic acid stereoisomers to determine the stereochemical purity of (4S)-4-(3-[18F]fluoropropyl)-L-glutamic acid ([18F]FSPG) for clinical use.
Preventive Program in Multiple Sclerosis
A Multicenter Study to Assess Response to Influenza Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab
Cognitive Improvement Through tDCS for Patients With Multiple Sclerosis
Naive B cells in neuromyelitis optica spectrum disorders: impact of steroid use and relapses.
Searching for Peripheral Biomarkers in Neurodegenerative Diseases: The Tryptophan-Kynurenine Metabolic Pathway.
Rare case of Marchiafava-Bignami disease due to thiamine deficiency and malnutrition.
Defining the course of tumefactive multiple sclerosis: a large retrospective multicentre study.
Comparing the effects of vestibular rehabilitation with and without lavender oil scents as an olfactory stimulus on balance, fear of falling down and activities of daily living of people with multiple sclerosis: a randomized clinical trial.
Alemtuzumab mediates the CD39+ T-regulatory response via CD23+ macrophages.
Brainstem trigeminal fiber microstructural abnormalities are associated with treatment response across subtypes of trigeminal neuralgia.
Live birth rates, infertility diagnosis, and infertility treatment in women with and without multiple sclerosis: Data from an administrative claims database.
Neuromyelitis optica spectrum disorder in China: Quality of life and medical care experience.
Long-term effectiveness of natalizumab on MRI outcomes and no evidence of disease activity in relapsing-remitting multiple sclerosis patients treated in a Czech Republic real-world setting: A longitudinal, retrospective study.
CNS demyelination during tofacitinib therapy: First report.
Long-term safety data from the cladribine tablets clinical development program in multiple sclerosis.
Does oral salbutamol improve fatigue in multiple sclerosis? A pilot placebo-controlled study.
Late onset multiple sclerosis is associated with more severe ventricle expansion.
Systemic erythematous lupus after treatment of multiple sclerosis with alemtuzumab.
Comorbidity effect on processing speed test and MRI measures in multiple sclerosis patients.
Identifying disability level in multiple sclerosis patients in a U.S.-based health plan claims database.
Immunotherapy Use in Patients With Lung Cancer and Comorbidities.
Comparison of Cognitive Rehabilitation versus Donepezil Therapy on Memory Performance, Attention, Quality of Life, and Depression among Multiple Sclerosis Patients.
IFN-β signaling dampens microglia reactivity but does not prevent from light-induced retinal degeneration.
Beneficial contribution of induced pluripotent stem cell-progeny to Connexin 47 dynamics during demyelination-remyelination.
The epidemiology of multiple sclerosis in the Scottish Highlands: Prevalence, incidence and time to confirmed diagnosis and treatment initiation.
Tumefactive demyelinating lesions spectrum disorders and the potential role of contemporary disease modifying treatments: a case report.
Offering Support and Electronic Resources for Care Partners of Those With Multiple Sclerosis
The epidemiology of primary headaches in patients with multiple sclerosis.
Telemedicine in neurology: current evidence.
Preventive neurology concepts for training the next-generation and closing gaps in real-world Multiple Sclerosis Care.
Exercise Training in Pediatric-Onset Multiple Sclerosis Patients
Ozanimod to Treat Relapsing Forms of Multiple Sclerosis: A Comprehensive Review of Disease, Drug Efficacy and Side Effects.
MicroRNA-219c-5p regulates bladder fibrosis by targeting FN1.
Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects.
Nicotinamide adenine dinucleotide treatment alleviates the symptoms of experimental autoimmune encephalomyelitis by activating autophagy and inhibiting the NLRP3 inflammasome.
Intranasal administration of small extracellular vesicles derived from mesenchymal stem cells ameliorated the experimental autoimmune encephalomyelitis.
Fatigue in teriflunomide-treated patients with relapsing remitting multiple sclerosis in the real-world Teri-FAST study.
Usage trend of oral drugs for multiple sclerosis patients in Argentina.
Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Patients With Multiple Sclerosis
Effects of Massage Therapy on Multiple Sclerosis: a Case Report.
Bruton’s Tyrosine Kinase Inhibition Promotes Myelin Repair.
Statin therapy and risk of Alzheimer’s and age-related neurodegenerative diseases.
Perspective of an International Online Patient and Caregiver Community on the Burden of Spasticity and Impact of Botulinum Neurotoxin Therapy: Survey Study.
Continuous and interval training attenuate encephalomyelitis by separate immunomodulatory mechanisms.
The Intellicage system provides a reproducible and standardized method to assess behavioral changes in cuprizone-induced demyelination mouse model.
A novel decision tree approach to predict the probability of conversion to multiple sclerosis in Iranian patients with optic neuritis.
Selective cognitive dysfunction and physical disability improvement after autologous hematopoietic stem cell transplantation in highly active multiple sclerosis.
Advances in ophthalmic structural and functional measures in multiple sclerosis: do the potential ocular biomarkers meet the unmet needs?
Multiple Sclerosis Data Alliance – A global multi-stakeholder collaboration to scale-up real world data research.
Quality of life among injectable and oral disease-modifying therapy users in the Pacific Northwest Multiple Sclerosis Registry.

Treatment of pseudobulbar affect (PBA) in a patient with a history of traumatic brain injury, partial brain resection, and brainstem stroke: a case report.
Retrospective evaluation of regional telemedicine team meetings for multiple sclerosis (MS) patients: Experience from the Caen MS expert center in Normandy, France.
Curcumol and FTY720 synergistically induce apoptosis and differentiation in chronic myelomonocytic leukemia via multiple signaling pathways.
Motivations towards exercise participation: Active persons with multiple sclerosis have greater self-directed and self-capable motivations.
A Delphi panel on treatment of high disease activity relapsing remitting multiple sclerosis in the Netherlands.
Metal Imbalance in Neurodegenerative Diseases with a Specific Concern to the Brain of Multiple Sclerosis Patients.
Patient autonomy in dentistry: demonstrating the role for shared decision making.
Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A new Route to Fight against COVID-19?
Effects of ibudilast on MRI measures in the phase 2 SPRINT-MS study.
TRAILR1 (rs20576) and GRIA3 (rs12557782) are not associated with interferon-β response in multiple sclerosis patients.
Detecting and Targeting Neurodegenerative Disorders using Electrospun Nanofibrous Matrices: Current Status and Applications.
Oral nomegestrol acetate and transdermal 17-beta-estradiol for preventing post-partum relapses in multiple sclerosis: The POPARTMUS study.
The efficiency of mirror therapy on drop foot in Multiple Sclerosis Patients.
Molecular imaging of microbiota-gut-brain axis: searching for the right targeted probe for the right target and disease.
JC Virus Seroprevalence and JCVAb Index in Polish Multiple Sclerosis Treatment-Naïve Patients.
Efficacy of high-intensity aerobic exercise on brain MRI measures in multiple sclerosis.
Antigen-specific therapy for multiple sclerosis.
Effectiveness of Hippotherapy Simulator in PwMS
Characteristics of pediatric multiple sclerosis: A tertiary referral center study.
Exercise-Induced Brain Excitability Changes in Progressive Multiple Sclerosis: A Pilot Study.
Anti-Inflammatory Treatment with FTY720 Starting after Onset of Symptoms Reverses Synaptic Deficits in an AD Mouse Model.
Oligodendrocyte myelin glycoprotein as a novel target for pathogenic autoimmunity in the CNS.
Multiple Sclerosis in a Multi-Ethnic Population in Houston, Texas: A Retrospective Analysis.
Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic.
Home Based Infusions for Ocrelizumab
Sphingosine 1-phosphate Receptor Modulator ONO-4641 Regulates Trafficking of T Lymphocytes and Hematopoietic Stem Cells and Alleviates Immune-Mediated Aplastic Anemia in a Mouse Model.
Quality of life in adults with multiple sclerosis: a systematic review.
IL-10 based immunomodulation initiated at birth extends lifespan in a familial mouse model of amyotrophic lateral sclerosis.
Differential Effects of Fingolimod and Natalizumab on B Cell Repertoires in Multiple Sclerosis Patients.
Current and emerging disease modulatory therapies and treatment targets for multiple sclerosis.
Quantifying cognition and fatigue to enhance the sensitivity of the EDSS during relapses.
ROCK Inhibitors 4: Structure-Activity Relationship Studies of 7-Azaindole-Based Rho Kinase (ROCK) Inhibitors.
Measures of Thalamic Integrity are Associated with Cognitive Functioning in Fingolimod-treated Multiple Sclerosis Patients.
Different cortical excitability profiles in hereditary brain iron and copper accumulation.
[Multiple sclerosis and childbirth: Relapse frequency and pregnancy outcome. A hospital-based retrospective study].
Blood-brain barrier genetic disruption leads to protective barrier formation at the Glia Limitans.
Non-invasive quantification of inflammation, axonal and myelin injury in multiple sclerosis.
Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis.
Operative findings and outcome of microvascular decompression/adhesiolysis for trigeminal neuralgia in multiple sclerosis without demyelinating brain stem lesions.
[Clinical and demographic aspects of secondary progressive multiple sclerosis in Argentina].
Naringenin Attenuates Experimental Autoimmune Encephalomyelitis by Protecting the Intact of Blood-Brain Barrier and Controlling Inflammatory Cell Migration.
Diffuse alveolar hemorrhage as an early complication of alemtuzumab treatment: A case report of a multiple sclerosis patient and an overview of 14 cases.
Oleanolic acid ameliorates intestinal alterations associated with EAE.
The Development of Cladribine Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review.
The Impact of Coconut Oil and Epigallocatechin Gallate on the Levels of IL-6, Anxiety and Disability in Multiple Sclerosis Patients.
Vestibular rehabilitation in multiple sclerosis: study protocol for a randomised controlled trial and cost-effectiveness analysis comparing customised with booklet based vestibular rehabilitation for vestibulopathy and a 12 month observational cohort study of the symptom reduction and recurrence rate following treatment for benign paroxysmal positional vertigo.
Skin Histology in Systemic Sclerosis: a Relevant Clinical Biomarker.
Work Productivity Outcomes Associated with Ocrelizumab Compared with Other Disease-Modifying Therapies for Multiple Sclerosis.
[Clinical observation experience of a pediatric patient with primary progressive multiple sclerosis in the Moscow office for the treatment of children and adolescents with multiple sclerosis].
Response to Letter to the Editor Regarding the Article Entitled “Treatment Effects for Dysphagia in Adults with Multiple Sclerosis: A Systematic Review”.
Coenzyme Q10 enhances remyelination and regulate inflammation effects of cuprizone in corpus callosum of chronic model of multiple sclerosis.
Annual Cost Burden by Level of Relapse Severity in Patients with Multiple Sclerosis.
Cuprizone-induced demyelination triggers a CD8-pronounced T cell recruitment.
Youth with multiple sclerosis have low levels of fitness.
Effect of etazolate upon cuprizone induced demyelination in vivo: Behavioral and myelin gene analysis.
Comparison between cerebrospinal fluid and serum levels of myelin-associated glycoprotein, total antioxidant capacity, and 8-hydroxy-2′-deoxyguanosine in patients with multiple sclerosis.
Physical activity behavior in people with multiple sclerosis during the COVID-19 pandemic in Israel: Results of an online survey.
Cyclophosphamide in treatment of tumefactive multiple sclerosis.
Pediatric onset multiple sclerosis.
Amelioration of experimental autoimmune encephalomyelitis by Rhodiola rosea, a natural adaptogen.
Multiple Sclerosis Disease-Modifying Therapies in the COVID-19 Era.
Feasibility and initial efficacy of a high-intensity interval training program using adaptive equipment in persons with multiple sclerosis who have walking disability: study protocol for a single-group, feasibility trial.
Tolerogenic nanoparticles suppress central nervous system inflammation.
X-ray Phase Contrast Tomography Serves Preclinical Investigation of Neurodegenerative Diseases.
Impact of an Existential-Spiritual Intervention Compared with a Cognitive-Behavioral Therapy on Quality of Life and Meaning in Life among Women with Multiple Sclerosis.
A Case of Central Diabetes Insipidus Secondary to Neurosarcoidosis.
Severe Bilateral Optic Neuritis: A Rare Presentation of Clinically Isolated Syndrome.
BAFF 60-mer, and Differential BAFF 60-mer Dissociating Activities in Human Serum, Cord Blood and Cerebrospinal Fluid.
Superoxide dismutase (SOD), advanced oxidation protein products (AOPP), and disease-modifying treatment are related to better relapse recovery after corticosteroid treatment in multiple sclerosis.
Inflammatory Activity and Treatment Response in Pediatric Compared to Adult Multiple Sclerosis: A Pilot, Retrospective and Observational Study of the First Year After Diagnosis.
Informing the Development of a Digital Health Platform Through Universal Points of Care: Qualitative Survey Study.
Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial.
Screening of FDA-Approved Drugs Using a 384-Well Plate-Based Biofilm Platform: The Case of Fingolimod.
Oleacein Attenuates the Pathogenesis of Experimental Autoimmune Encephalomyelitis through Both Antioxidant and Anti-Inflammatory Effects.
Continuous Immune-Modulatory Effects of Human Olig2+ Precursor Cells Attenuating a Chronic-Active Model of Multiple Sclerosis.
Intranasal Delivery: Effects on the Neuroimmune Axes and Treatment of Neuroinflammation.
Strategies for Neuroprotection in Multiple Sclerosis and the Role of Calcium.
Human Pluripotent Stem Cells-Based Therapies for Neurodegenerative Diseases: Current Status and Challenges.
Living with secondary progressive multiple sclerosis in Europe: perspectives of multiple stakeholders.
Latency of Multifocal Visual Evoked Potential in Multiple Sclerosis: A Visual Pathway Biomarker for Clinical Trials of Remyelinating Therapies.
Cross-cultural adaptation and psychometric properties of the Turkish version of the Manual Ability Measure-36 (MAM-36) in people with multiple sclerosis.
Letter to Editor Regarding the Article Entitled “Treatment Effects for Dysphagia in Adults with Multiple Sclerosis: A Systematic Review”.
Adding brain volume measures into response criteria in multiple sclerosis: the Río-4 score.
Brain Barriers and Multiple Sclerosis: Novel Treatment Approaches from a Brain Barriers Perspective.
Fluid Intake and Urinary Symptoms in Patients with Multiple Sclerosis.
Pharmacovigilance during treatment of multiple sclerosis: early recognition of CNS complications.
Efficacy of high-intensity aerobic exercise on cognitive performance in people with multiple sclerosis: A randomized controlled trial.
The protective effect of extra-virgin olive oil in the experimental model of multiple sclerosis in the rat.
Patterns of regional brain volume loss in multiple sclerosis: a cluster analysis.
Secukinumab for patients with plaque psoriasis affected by multiple sclerosis: a mini-review with a representative case report.
Signaling molecules targeting cannabinoid receptors: Hemopressin and related peptides.
The Role of Th17-Related Cytokines in Atopic Dermatitis.
Rodent Models of Optic Neuritis.
Effects of aging on finger movements in multiple sclerosis.
CCN3 is dynamically regulated by treatment and disease state in multiple sclerosis.
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Corneal epithelial dendritic cells in patients with multiple sclerosis: An in vivo confocal microscopy study.
Advances in the Treatment of Multiple Sclerosis.
A new convenient methodology based on dihydropyridine derivative for selective fluorimetric analysis of baclofen: Application to spiked urine and content uniformity evaluation.
Effectiveness of Dimethyl Fumarate in Patients With Relapsing Multiple Sclerosis Switching After Suboptimal Response to Glatiramer Acetate, Including Patients With Early Multiple Sclerosis: Subgroup Analysis of RESPOND.

The reliability and validity of the Turkish version of the Multiple Sclerosis Questionnaire for physiotherapists.
Reliability and Validity of the Lower-Extremity Motor Activity Log (LE-MAL) for Measuring Real-world Leg-Use in Adults with Multiple Sclerosis.
A psychoeducation program for stress management and psychosocial problems in multiple sclerosis.
Treating brain diseases using systemic parenterally-administered protein therapeutics: Dysfunction of the brain barriers and potential strategies.
Photobiomodulation on trigeminal neuralgia: systematic review.
Intranasal delivery of interferon-β-loaded nanoparticles induces control of neuroinflammation in a preclinical model of multiple sclerosis: A promising simple, effective, non-invasive, and low-cost therapy.
Digesting science: Developing educational activities about multiple sclerosis, prevention and treatment to increase the confidence of affected families.
Low serum Α-SYNUCLEIN and oligomer Α-SYNUCLEIN levels in multiple sclerosis patients.
Mesenchymal Stem Cells in Multiple Sclerosis: Recent Evidence from Pre-Clinical to Clinical Studies.
Increased C-X-C Motif Chemokine Ligand 12 Levels in Cerebrospinal Fluid as a Candidate Biomarker in Sporadic Amyotrophic Lateral Sclerosis.
Ellagic acid ameliorates neuroinflammation and demyelination in experimental autoimmune encephalomyelitis: Involvement of NLRP3 and pyroptosis.
Acute effects of whole-body vibration training on neuromuscular performance and mobility in hypoxia and normoxia in persons with multiple sclerosis: A crossover study.
Independent outdoor mobility of persons with multiple sclerosis – A systematic review.
Conducting dietary intervention trials in people with multiple sclerosis: Lessons learned and a path forward.
Evaluating functional electrical stimulation (FES) cycling on cardiovascular, musculoskeletal and functional outcomes in adults with multiple sclerosis and mobility impairment: A systematic review.
Effects of inspiratory muscle training in advanced multiple sclerosis.
The effect of emerging nutraceutical interventions for clinical and biological outcomes in multiple sclerosis: A systematic review.
The frequency of longitudinally extensive transverse myelitis in MS: A population-based study.
Longitudinal analysis of cerebral aqueduct flow measures: multiple sclerosis flow changes driven by brain atrophy.
High association of MOG-IgG antibodies in children with bilateral optic neuritis.
Efficacy of Sulforaphane in Neurodegenerative Diseases.
Increasing Progenitor Cell Proliferation in the Sub-Ventricular Zone: A Therapeutic Treatment for Progressive Multiple Sclerosis?
Recent Insights on the Role of PPAR-β/δ in Neuroinflammation and Neurodegeneration, and Its Potential Target for Therapy.
Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factors.
The metabolic cost of exercising with a robotic exoskeleton: a comparison of healthy and neurologically impaired people.
Upper limb rehabilitation interventions using virtual reality for people with multiple sclerosis: A systematic review.
Quality of Life and Mental Health in Multiple Sclerorsis Patients in Bosnia and Herzegovina Measured by Generc and Disease-Specific Questionaire.
Auditory-motor Coupling in Multiple Sclerosis With Cerebellar Lesions
Lower Urinary Tract Symptoms and Depression in Patients with Multiple Sclerosis.
Analysis of Postural Control in Sitting by Pressure Mapping in Patients with Multiple Sclerosis, Spinal Cord Injury and Friedreich’s Ataxia: A Case Series Study.
Natalizumab is associated with early improvement of working ability in relapsing-remitting multiple sclerosis patients: WANT observational study results.
Chronic Toxoplasma gondii Infection Alleviates Experimental Autoimmune Encephalomyelitis by the Immune Regulation Inducing Reduction in IL-17A/Th17 Via Upregulation of SOCS3.
Siponimod: Disentangling disability and relapses in secondary progressive multiple sclerosis.
Effect of Behavioral Therapy Versus Interferential Current on Bladder Dysfunction in Patients With Multiple Sclerosis
Fatigue at enrollment predicts EDSS worsening in the New York State Multiple Sclerosis Consortium.
Allergic diseases and long-term risk of autoimmune disorders: longitudinal cohort study and cluster analysis.
Automated Assessment of Oral Diadochokinesis in Multiple Sclerosis Using a Neural Network Approach: Effect of Different Syllable Repetition Paradigms.
Using Acute Optic Neuritis Trials to Assess Neuroprotective and Remyelinating Therapies in Multiple Sclerosis.
Parvovirus B19 infection in a patient with multiple sclerosis treated with ocrelizumab.
Cortical Excitability through Anodal Transcranial Direct Current Stimulation: a Computational Approach.
Epilepsy and autoimmune diseases: Comorbidity in a national patient cohort.
Imagiologically aggressive presentation of paediatric multiple sclerosis.
Novel Assessment of Synaptic Density in Progressive MS
Low Load Resistance Training Using Blood Flow Restriction for People With Multiple Sclerosis
Inducible expression of antigens in plants: a study focused on peptides related to multiple sclerosis immunotherapy.
IL-12 p40 monomer is different from other IL-12 family members to selectively inhibit IL-12Rβ1 internalization and suppress EAE.
Targeting the RNA-Binding Protein HuR Alleviates Neuroinflammation in Experimental Autoimmune Encephalomyelitis: Potential Therapy for Multiple Sclerosis.
The impact of lymphocytosis and CD4/CD8 ratio on the anti-JCV antibody index and clinical data in patients treated with natalizumab.
Optic Neuritis During Lactation: A Case Series.
Ocrelizumab in relapsing and primary progressive multiple sclerosis: pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO.
[Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis: Diagnosis and Treatment].
ASPIRE trial: study protocol for a double-blind randomised controlled trial of aspirin for overheating during exercise in multiple sclerosis.
Monomethylfumarate Ameliorates Murine Macrophage Activation Syndrome in Both Heme Oxygenase 1-dependent and -independent Manners.
Influences of Dual-Task Training on Walking and Cognitive Performance of People With Relapsing Remitting Multiple Sclerosis: Randomized Controlled Trial.
The Dresden Protocol for Multidimensional Walking Assessment (DMWA) in Clinical Practice.
Pre-clinical and Clinical Implications of “Inside-Out” vs. “Outside-In” Paradigms in Multiple Sclerosis Etiopathogenesis.
The Role of Antibodies in the Pathogenesis of Multiple Sclerosis.
Analysis of Polymorphisms rs7093069-IL-2RA, rs7138803-FAIM2, and rs1748033-PADI4 in the Group of Adolescents With Autoimmune Thyroid Diseases.
Organic Selenium Reaches the Central Nervous System and Downmodulates Local Inflammation: A Complementary Therapy for Multiple Sclerosis?
Intestinal Dysbiosis in, and Enteral Bacterial Therapies for, Systemic Autoimmune Diseases.
Interferon-γ/Interleukin-27 Axis Induces Programmed Death Ligand 1 Expression in Monocyte-Derived Dendritic Cells and Restores Immune Tolerance in Central Nervous System Autoimmunity.
The Crotoxin:SBA-15 Complex Down-Regulates the Incidence and Intensity of Experimental Autoimmune Encephalomyelitis Through Peripheral and Central Actions.
Dimethyl fumarate transfer into human milk.
The impact of the face-to-face consultation on decisional conflict in complex decision-making in multiple sclerosis: A pilot study.
Gut microbiome and multiple sclerosis: New insights and perspective.
Amifostine ameliorates induction of experimental autoimmune encephalomyelitis: Effect on reactive oxygen species/NLRP3 pathway.
Progress in the Management of Paediatric-Onset Multiple Sclerosis.
Anti-Inflammatory Effects of Amantadine and Memantine: Possible Therapeutics for the Treatment of Covid-19?
Biomarkers in Rare Demyelinating Disease of the Central Nervous System.
Cognitive Fatigue Is Associated with Altered Functional Connectivity in Interoceptive and Reward Pathways in Multiple Sclerosis.
Occurrence and microstructural features of slowly expanding lesions on fingolimod or natalizumab treatment in multiple sclerosis.
Stiff-Person Syndrome and Psychiatric Comorbidities: A Systematic Review.
Systematic approach to selecting licensed drugs for repurposing in the treatment of progressive multiple sclerosis.
[Socio-economic aspects of neurogenic dysfunctions in urology].
Inhibition of Chondroitin Sulfate Proteoglycans by APRIL.
The metabolic, neuroprotective cardioprotective and antitumor effects of the Klotho protein.
The role of Nrf2 in Neural stem/Progenitors cells: from maintaining stemness and self-renewal to promoting differentiation capability and facilitating therapeutic application in neurodegenerative disease.
Are falls in people with multiple sclerosis related to the severity of urinary disorders?
A real-world cohort analysis of alemtuzumab outcomes in relapsing multiple sclerosis.
Fear of falling and falls in people with multiple sclerosis: A literature review.
Correlation between IL-31 and sCD40L plasma levels in Fingolimod-treated patients with Relapsing-Remitting Multiple Sclerosis (RRMS).
Myelin quantification with MRI: A systematic review of accuracy and reproducibility.
Comparative Adherence Trajectories of Oral Fingolimod and Injectable Disease Modifying Agents in Multiple Sclerosis.
Exploring Adherence to First-Line and Second-Line Immunotherapies in Multiple Sclerosis: An Interview Study.
An International Standardized Magnetic Resonance Imaging Protocol for Diagnosis and Follow-up of Patients with Multiple Sclerosis: Advocacy, Dissemination, and Implementation Strategies.
Inhibiting Epileptiform Activity in Cognitive Disorders: Possibilities for a Novel Therapeutic Approach.
Combined upper limb and breathing exercise programme for pain management in ambulatory and non-ambulatory multiple sclerosis individuals: part II analyses from feasibility study.
DNL104, a Centrally Penetrant RIPK1 Inhibitor, Inhibits RIP1 Kinase Phosphorylation in a Randomized Phase I Ascending Dose Study in Healthy Volunteers.
A Patient With Multiple Sclerosis and Coexisting Moyamoya Disease: Why and How.
Pelvic floor dysfunction negatively impacts general functional performance in patients with multiple sclerosis.
Autoencoder as a New Method for Maintaining Data Privacy While Analyzing Videos of Patients With Motor Dysfunction: Proof-of-Concept Study.
Memory improvement in multiple sclerosis after an extensive cognitive rehabilitation program in groups with a multicenter double-blind randomized trial.
A Qualitative Exploration of Occupational Adaptation in Caregivers of People with Multiple Sclerosis.
Identification of a de novo TSC2 variant in a Han-Chinese family with tuberous sclerosis complex.
Long-Term Consequences of High Titer Neutralizing Antibodies to Interferon-β in Multiple Sclerosis.
The effect of tonsillectomy on John Cunningham virus serological status in multiple sclerosis patients: A retrospective case-control study.
Effectiveness of percutaneous posterior tibial nerve stimulation for the management of bowel dysfunction in multiple sclerosis patients.
A Multi-Center, Open-Label Long-Term Extension Study of CNM-Au8 In Patients With Stable Relapsing Multiple Sclerosis
Assessment of delayed diagnosis and treatment in multiple sclerosis patients during 1990-2016.
Isolated cortical tuber in an infant with genetically confirmed tuberous sclerosis complex 1 presenting with symptomatic West syndrome.

New Strategies for Rehabilitation and Pharmacological Treatment of Fatigue Syndrome in Multiple Sclerosis.
Associations between cognitive impairment at onset and disability accrual in young people with multiple sclerosis.
The Rise and Fall of High-Dose Biotin to Treat Progressive Multiple Sclerosis.
Combining Magnetization Transfer Ratio MRI and Quantitative Measures of Walking Improves the Identification of Fallers in MS.
The Presence of Human Herpesvirus 6 in the Brain in Health and Disease.
An immunocompromised woman in her twenties with abdominal pain and vaginal discharge.
Patterns and Outcomes of Complementary and Alternative Medicine Use Among Adult Patients With Multiple Sclerosis.
Apamin administration impact on miR-219 and miR-155-3p expression in cuprizone induced multiple sclerosis model.
Exploring the Cost Effectiveness of Shared Decision Making for Choosing between Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis in the Netherlands: A State Transition Model.
The effect of counseling based on the PLISSIT model on sexual quality of life of married women with multiple sclerosis referring to MS center in 2019: a randomized, controlled trial.
The combined treatment of NAD+ and atorvastatin ameliorates the development of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Alterations in peripheral blood monocyte and dendritic cell subset homeostasis in relapsing-remitting multiple sclerosis patients.
RC18 in Patients With Relapsing Remitting Multiple Sclerosis：a Phase II Trial
Immunomodulatory Effects of Vitamin D in Pregnancy and Beyond.
The dentato-rubro-thalamic tract as the potential common deep brain stimulation target for tremor of various origin: an observational case series.
Behavioral practices of patients with multiple sclerosis during Covid-19 pandemic.
[Neurological complications of JC virus infection: A review].
Consequences of Insurance Denials Among U.S. Patients Prescribed Repository Corticotropin Injection for Acute Exacerbations of Multiple Sclerosis.
Pilot Study of Videos to Deliver Mindfulness-Based Art Therapy for Adults With Multiple Sclerosis.
Therapeutic Role of Inflammasome Inhibitors in Neurodegenerative Disorders.
Therapeutic potential of Fingolimod in triple negative breast cancer preclinical models.
Air pollution as a contributor to the inflammatory activity of multiple sclerosis.
E.U. paediatric MOG consortium consensus: Part 2 – Neuroimaging features of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.
Cardiac sarcoidosis requiring ICD placement and immune thrombocytopenia following alemtuzumab treatment for multiple sclerosis.
Real-time assessment of daytime sleepiness in drivers with multiple sclerosis.
Treatment Patterns and Relapses Among Newly Treated Multiple Sclerosis Patients From a Retrospective Claims Analysis.
Expression analysis of PINK1 and PINK1-AS in multiple sclerosis patients versus healthy subjects.
Depression Comorbid With Stroke, Traumatic Brain Injury, Parkinson’s Disease, and Multiple Sclerosis: Diagnosis and Treatment.
A Pilot Study to Explore Patient Satisfaction With a Virtual Rehabilitation Program in Multiple Sclerosis: The RehabVR Study Protocol.
[Libman-Sacks endocarditis under apixaban in a patient with a high-risk profile venous antiphospholipid syndrome].
Symptom clusters and quality of life in persons with multiple sclerosis across the lifespan.
Anti-Inflammatory Effect of KW-2449 on Autoimmune Encephalomyelitis: An Experimental Study on Mice.
Severe lymphopenia after subcutaneous cladribine in a patient with multiple sclerosis: To vaccinate or not?
A case series and literature review of multiple sclerosis and COVID-19: Clinical characteristics, outcomes and a brief review of immunotherapies.
Pilot Study of the Safety and Tolerability of L-DLPFC iTBS rTMS for MDD in MS
Periodic Leg Movements’ Diagnosis in Spinal Cord Injury: Actigraphy as an Alternative for Polysomnography?
Cognitive-motor Dual Task Training in Patients With Multiple Sclerosis
Vaccination in multiple sclerosis – Challenging practices (Review).
Oligodendrocyte-derived extracellular vesicles as antigen-specific therapy for autoimmune neuroinflammation in mice.
Cohort profile: Design and implementation of the Danish Physiotherapy Research Database for patients receiving primary care with chronic disease.
EFFECTIVENESS OF PHYSICAL THERAPY IN MYOFASCIAL SYNDROME IN PATIENTS WITH MULTIPLE SCLEROSIS.
High anti-JCPyV serum titers coincide with high CSF cell counts in RRMS patients.
Long-Term Observational Results from the ASPIRE Study: OnabotulinumtoxinA Treatment for Adult Lower Limb Spasticity.
A mathematical model of the multiple sclerosis plaque.
Ambulatory Neuroproprioceptive Facilitation and Inhibition Physical Therapy Improves Clinical Outcomes in Multiple Sclerosis and Modulates Serum Level of Neuroactive Steroids: A Two-Arm Parallel-Group Exploratory Trial.
Clinical Immunological Correlations in Patients with Multiple Sclerosis Treated with Natalizumab.
Scoring disease in an animal model of multiple sclerosis using a novel infrared-based automated activity-monitoring system.
New insights in the mechanisms of impaired redox signaling and its interplay with inflammation and immunity in multiple sclerosis.
Asymptomatic SARS-CoV-2 infection in two patients with multiple sclerosis treated with fingolimod.
Association of social network structure and physical function in patients with multiple sclerosis.
Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS.
Rationale for the use of sphingosine analogues in COVID-19 patients.
Is it worth it?: The experiences of persons with multiple sclerosis as they access health care to manage their condition.
Blood neurofilament light: a critical review of its application to neurologic disease.
The cool things to know about TRPM8!
Advances in Multiple Sclerosis Research-Series I.
18F-FAC PET Visualizes Brain-Infiltrating Leukocytes in a Mouse Model of Multiple Sclerosis.
Role of Dietary Antioxidants in Neurodegenerative Diseases: Where are We Standing?
Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis.
Heterogeneity of Baló’s concentric sclerosis: a study of eight cases with different therapeutic concepts.
A new feasible approach based on utility of ninhydrin for selective fluorimetric analysis of baclofen. Application to content uniformity evaluation.
[Met5]-enkephalin preserves diffusion metrics in EAE mice.
Sustained disease remission after discontinuation of disease modifying treatments in relapsing-remitting multiple sclerosis.
Non-parametric combination analysis of multiple data types enables detection of novel regulatory mechanisms in T cells of multiple sclerosis patients.
Fall Risk Prediction in Multiple Sclerosis Using Postural Sway Measures: A Machine Learning Approach.
Correlation between spinal cord diffusion tensor imaging and postural response latencies in persons with multiple sclerosis: A pilot study.
Handedness and potential implications for neurorehabilitation in multiple sclerosis.
[Risk of SARS-CoV-2 infection and clinical outcomes in multiple sclerosis patients in La Rioja (Spain)].
Vaccination in B-cell-depleted patients with multiple sclerosis.
Fingolimod (FTY720) prevents chronic rejection of rodent cardiac allografts through inhibition of the RhoA pathway.
The Administrative Prevalence of Multiple Sclerosis in Greece on the Basis of a Nationwide Prescription Database.
Effects of Alemtuzumab on (Auto)antigen-Specific Immune Responses.
Caffeic Acid Phenethyl Ester Protects against Experimental Autoimmune Encephalomyelitis by Regulating T Cell Activities.
Autophagy in White Matter Disorders of the CNS: Mechanisms and Therapeutic Opportunities.
DIM mitigates the development of experimental autoimmune encephalomyelitis by maintaining the stability and suppressive function of regulatory T cells.
Atypical localization of colorectal cancer metastasis one case and literature review.
Transdiagnostic treatment of emotional disorders for women with multiple sclerosis: a randomized controlled trial.
Transdiagnostic treatment of emotional disorders in people with multiple sclerosis: randomized controlled trial.
The Danish Multiple Sclerosis Registry.
Progress in Multiple Sclerosis Research: An Example of Bedside to Bench.
Anti-Axl antibody treatment reduces the severity of experimental autoimmune encephalomyelitis.
Platelets as Mediators of Neuroinflammation and Thrombosis.
Autonomic dysfunctions in multiple sclerosis: Challenges of clinical practice (Review).
The ameliorative effects of capsidiol isolated from elicited Capsicum annuum on mouse splenocyte immune responses and neuroinflammation.
BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MS.
Dealing with Treatment-confounder Feedback and Sparse Follow-up in Longitudinal studies – Application of a Marginal Structural Model in a Multiple Sclerosis Cohort.
Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium.
The influence of glatiramer acetate on Th17-immune response in multiple sclerosis.
Precision Medicine in Neurology: The Inspirational Paradigm of Complement Therapeutics.
Gangliosides in the Brain: Physiology, Pathophysiology and Therapeutic Applications.
Effects of Retinal Transcription Regulation After GB20 Needling Treatment in Retina With Optic Neuritis.
Renal-Limited Antiglomerular Basement Membrane Disease Related To Alemtuzumab: A Case Report.
Transcutaneous tibial nerve stimulation for the treatment of bladder storage symptoms in people with multiple sclerosis: Protocol of a single-arm feasibility study.
Adherence to social distancing and use of personal protective equipment and the risk of SARS-CoV-2 infection in a cohort of patients with multiple sclerosis.
Mild or no COVID-19 symptoms in cladribine-treated multiple sclerosis: Two cases and implications for clinical practice.
A Critical Review of the Role of the Cannabinoid Compounds Δ9-Tetrahydrocannabinol (Δ9-THC) and Cannabidiol (CBD) and their Combination in Multiple Sclerosis Treatment.
Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database.
“I’m in a very good frame of mind”: a qualitative exploration of the experience of standing frame use in people with progressive multiple sclerosis.
The Helminth Parasite Heligmosomoides polygyrus Attenuates EAE in an IL-4Rα-Dependent Manner.
Brain energy metabolism and multiple sclerosis: progress and prospects.

Atypical Multiple Sclerosis with Antibody to MOG.
Importance of early treatment decisions on future income of multiple sclerosis patients.
Effect of tobacco use on disease activity and DMT discontinuation in multiple sclerosis patients treated with dimethyl fumarate or fingolimod.
A comparative study of tolerability and effects on immunoglobulin levels and CD19 cell counts with ocrelizumab vs low dose of rituximab in multiple sclerosis.
Toxic effects on astrocytes of extracellular vesicles from CSF of multiple sclerosis patients: a pilot in vitro study.
Selective serotonin reuptake inhibitor attenuates the hyperresponsivenss of TLR2+ and TLR4+ Th17/Tc17-like cells in multiple sclerosis patients with major depression.
Syncytin-1/HERV-W envelope is an early activation marker of leukocytes and is upregulated in multiple sclerosis patients.
Prevalence of Human Polyomavirus JC and BK in Normal Population.
Effect of visual biofeedback cycling training on gait in patients with multiple sclerosis.
Group sequential designs for negative binomial outcomes.
Beyond Randomized Clinical Trials: Use of External Controls.
Advances in neuroprosthetic management of foot drop: a review.
Probiotics in Treatment of Viral Respiratory Infections and Neuroinflammatory Disorders.
Hematopoietic Stem Cell Transplantation for Autoimmune Disease.
Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: an observational study.
Regulation of neuroinflammation by B cells and plasma cells.
The contribution of thymic tolerance to central nervous system autoimmunity.
Siponimod: A Review in Secondary Progressive Multiple Sclerosis.
Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite.
Conservative treatment of monolateral giant renal angiomyolipoma in a patient with Tuberous Sclerosis Complex (TSC): A case report.
No Impact of Long-Term Fingolimod Treatment on Fecal Secretory Immunoglobulin A Levels in Patients With Multiple Sclerosis.
Refractory hemorrhagic esophageal ulcers by Candida esophagitis with advanced systemic sclerosis.
The effect of cortical versus sacral repetitive magnetic stimulation on lower urinary tract dysfunction in patients with multiple sclerosis.
COVID-19: A Review for the Pediatric Neurologist.
Response heterogeneity in a randomized controlled trial of telerehabilitation interventions among adults with multiple sclerosis.
Matrine Inhibits CNS Autoimmunity Through an IFN-β-Dependent Mechanism.
Immunomodulatory Effects of Diterpenes and Their Derivatives Through NLRP3 Inflammasome Pathway: A Review.
Oligodendrocyte-specific deletion of FGFR2 ameliorates MOG35-55 -induced EAE through ERK and Akt signalling.
Cortical projection neurons as a therapeutic target in multiple sclerosis.
Optimizing treatment strategies in paediatric, adult and late-onset multiple sclerosis.
Long-term prognostic counselling in people with multiple sclerosis using an online analytical processing tool.
Autologous Hematopoietic Stem Cell Transplant in Multiple Sclerosis: Recommendations of the National Multiple Sclerosis Society.
Stem Cells Therapy for Multiple Sclerosis.
Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis
Fingolimod in multiple sclerosis: profile of use in habitual practice.
Chances and Challenges of Registry-Based Pharmacovigilance in Multiple Sclerosis: Lessons Learnt from the Implementation of the Multicenter REGIMS Registry.
Associations Between Self-Reported Symptoms and Gait Parameters Using In-Home Sensors in Persons With Multiple Sclerosis.
Impact of coronavirus disease (COVID-19) pandemic on multiple sclerosis care.
Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab.
Sphingosine-1-phosphate receptor subtype 1 activation in the central nervous system contributes to morphine withdrawal in rodents.
Immunomodulatory effects of cytokine-induced expansion of cytotoxic lymphocytes in a mouse model of lupus-like disease.
Androgen Therapy in Neurodegenerative Diseases.
Transcranial magnetic resonance-guided focused ultrasound thalamotomy as a safe treatment option in multiple sclerosis patients with essential tremor.
Methylprednisolone alleviates multiple sclerosis by expanding myeloid-derived suppressor cells via glucocorticoid receptor β and S100A8/9 up-regulation.
Primary Sjögren’s syndrome: central and peripheral nervous system involvements.
Association between serum paraoxonase 1 activity and its polymorphisms with multiple sclerosis: a systematic review.
StatPearls
Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid.
Clinical and MRI efficacy of sc IFN β-1a tiw in patients with relapsing MS appearing to transition to secondary progressive MS: post hoc analyses of PRISMS and SPECTRIMS.
Novel inhibitors of leukocyte transendothelial migration.
Risk factors for lymphopenia in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate.
Dimethyl fumarate reduces TNF and Plasmodium falciparum induced brain endothelium activation in vitro.
More time, more safety: is this the future optimal way for natalizumab treatment in multiple sclerosis?
Narrowband UVB phototherapy reduces TNF production by B-cell subsets stimulated via TLR7 from individuals with early multiple sclerosis.
Comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis.
The role of B cells in Multiple Sclerosis and related disorders.
The Framingham cardiovascular risk score and 5-year progression of multiple sclerosis.
Testosterone Treatment for Erectile Dysfunction and Multiple Sclerosis
HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis.
Dimethyl fumarate induced lymphopenia in multiple sclerosis: A review of the literature.
Cervical spondylosis is a risk factor for localized spinal cord lesions in multiple sclerosis.
Total flavonoids of astragalus attenuates experimental autoimmune encephalomyelitis by suppressing the activation and inflammatory responses of microglia via JNK/AKT/NFκB signaling pathway.
Multisite reliability and repeatability of an advanced brain MRI protocol.
Outcomes of ileal conduit urinary diversion in patients with multiple sclerosis.
Manic episode in patient with bipolar disorder and recent multiple sclerosis diagnosis: A case report.
Rehabilitation Improves Mitochondrial Energetics in Progressive Multiple Sclerosis: The Significant Role of Robot-Assisted Gait Training and of the Personalized Intensity.
Revisiting remyelination: Towards a consensus on the regeneration of CNS myelin.
Natalizumab versus fingolimod for patients with active relapsing-remitting multiple sclerosis: results from REVEAL, a prospective, randomised head-to-head study.
COS-7 cells are a cellular model to monitor polyomavirus JC miR-J1-5p expression.
Recommendations of the Polish Medical Society of Radiology and the Polish Society of Neurology for a protocol concerning routinely used magnetic resonance imaging in patients with multiple sclerosis.
A single, clinically relevant dose of the GABAB agonist baclofen impairs visuomotor learning.
Course of neuropsychological impairment during Natalizumab associated progressive multifocal leukoencephalopathy.
Short-term changes in frequencies of circulating leukocytes associated with narrowband UVB phototherapy in people with clinically isolated syndrome.
[The multiple sclerosis functional composite correlates with the sociomedical recommendation of earning capacity of rehabilitants with Multiple Sclerosis].
Contralateral Strength Training as Preparation for Direct Strength Training in a Patient With Unilateral Foot-Drop Because of Multiple Sclerosis: A Case Report.
A recursive framework for predicting the time-course of drug sensitivity.
Design, synthesis, molecular modeling, and biological evaluation of acrylamide derivatives as potent inhibitors of human dihydroorotate dehydrogenase for the treatment of rheumatoid arthritis.
Cost-effectiveness of fingolimod versus interferon-β1a for the treatment of pediatric-onset multiple sclerosis in Canada.
Walking in multiple sclerosis improves with tDCS: a randomized, double-blind, sham-controlled study.
Efficacy of non-invasive brain stimulation on cognitive functioning in brain disorders: a meta-analysis.
Magnetic resonance spectroscopy of the normal appearing grey matter in the posterior cingulate gyrus in the prognosis and monitoring of disease activity in MS patients treated with interferon-β in a 3-year follow-up.
Brain Atrophy Rates for Stable Multiple Sclerosis Patients on Long-Term Fingolimod versus Glatiramer Acetate.
Improved Glucocorticoid Receptor Ligands: Fantastic Beasts, but How to Find Them?
Natalizumab in Multiple Sclerosis Treatment: From Biological Effects to Immune Monitoring.
Multiple doses of cell therapy and neurorehabilitation in amyotrophic lateral sclerosis: A case report.
B cell targeting therapies in MS patients during the SARS-CoV-2 pandemic – when immunosuppression meets infection?
Artifactual hypoglycemia in a patient with systemic sclerosis.
Botulinum Toxin in Patients With Spastic Lower Limb Paresis Associated With Multiple Sclerosis
High dose of dexamethasone protects against EAE-induced motor deficits but impairs learning/memory in C57BL/6 mice.
The role of gut microbiota in shaping the relapse-remitting and chronic-progressive forms of multiple sclerosis in mouse models.
The effects of vitamin D supplementation on expanded disability status scale in people with multiple sclerosis: A critical, systematic review and metaanalysis of randomized controlled trials.
TNFR2 limits proinflammatory astrocyte functions during EAE induced by pathogenic DR2b-restricted T cells.
[Treatment of Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder and Myasthenia Gravis during the COVID-19 Pandemic].
Productivity Loss and Associated Costs Among Employed Patients Receiving Disease-Modifying Treatment for Multiple Sclerosis.
Overexpression of the ubiquitin-editing enzyme A20 in the brain lesions of Multiple Sclerosis patients: moving from systemic to central nervous system inflammation.
Engineered regulatory T cells expressing myelin-specific chimeric antigen receptors suppress EAE progression.
CSF enhancement on post-contrast fluid-attenuated inversion recovery images; a systematic review.
Monitoring the Redox Status in Multiple Sclerosis.
Optical coherence tomography outcomes from SPRINT-MS, a multicenter, randomized, double-blind trial of ibudilast in progressive multiple sclerosis.
Aminopiridines in the treatment of multiple sclerosis and other neurological disorders.

Vaccine-associated measles in a patient treated with natalizumab: a case report.
PET imaging of P2X7R in the experimental autoimmune encephalomyelitis model of multiple sclerosis using [11C]SMW139.
Comprehension of confidence intervals in audio-visual patient information materials for people with multiple sclerosis (COCO-MS): A web-based randomised controlled, parallel group trial.
Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis.
PSYCHIATRIC DISORDERS IN THE COURSE OF MULTIPLE SCLEROSIS.
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis.
Assessment of Pediatric Optic Neuritis Visual Acuity Outcomes at 6 Months.
Secondary progressive multiple sclerosis – from neuropathology to definition and effective treatment.
Fingolimod suppressed the chronic unpredictable mild stress-induced depressive-like behaviors via affecting microglial and NLRP3 inflammasome activation.
Effects of mesenchymal stem cells transplantation on multiple sclerosis patients.
Quantitative proteomic analysis of cerebrospinal fluid of women newly diagnosed with multiple sclerosis.
Minocycline for the Management of Multiple Sclerosis: Repositioning Potential, Opportunities, and Challenges.
Multiple sclerosis: NICE recommends treatment for secondary progressive MS.
Aging-Exacerbated Acute Axon and Myelin Injury Is Associated with Microglia-Derived Reactive Oxygen Species and Is Alleviated by the Generic Medication Indapamide.
Upfront Combination Therapy With Rituximab and Mycophenolate Mofetil for Progressive Systemic Sclerosis.
Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
Obtaining Patient Priorities in a Multiple Sclerosis Comprehensive Care Center: Beyond Patient-Reported Outcomes.
PDSS2-Del2, a new variant of PDSS2, promotes tumor cell metastasis and angiogenesis in hepatocellular carcinoma via activating NF-κB.
The Dichotomous Role of Inflammation in the CNS: A Mitochondrial Point of View.
Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?
Characterization of Asparagine Deamidation in Immunodominant Myelin Oligodendrocyte Glycoprotein Peptide Potential Immunotherapy for the Treatment of Multiple Sclerosis.
Re-Examining the Role of TNF in MS Pathogenesis and Therapy.
Raloxifene as Treatment for Various Types of Brain Injuries and Neurodegenerative Diseases: A Good Start.
Predicting Neuropsychological Impairment in Relapsing Remitting Multiple Sclerosis: The Role of Clinical Measures, Treatment, and Neuropsychiatry Symptoms.
Amnion-Derived Multipotent Progenitor Cells Suppress Experimental Optic Neuritis and Myelitis.
The expression analyses of RMRP, DDX5, and RORC in RRMS patients treated with different drugs versus naïve patients and healthy controls.
A review on preventive role of ketogenic diet (KD) in CNS disorders from the gut microbiota perspective.
A Study To Evaluate The Efficacy And Safety Of Fenebrutinib Compared With Teriflunomide In Relapsing Multiple Sclerosis (RMS)
Study To Evaluate The Efficacy And Safety Of Fenebrutinib Compared With Teriflunomide In Relapsing Multiple Sclerosis (RMS)
Novel CMKLR1 Inhibitors for Application in Demyelinating Disease.
The effect of exercise on high-level mobility in individuals with neurodegenerative disease: a systematic literature review.
Effectiveness of expiratory muscle strength training on expiratory strength, pulmonary function and cough in the adult population: a systematic review.
Delivering Transcranial Direct Current Stimulation Away From Clinic: Remotely Supervised tDCS.
A Descriptive Cross-Sectional Study of Manipulative Dexterity on Different Subtypes of Multiple Sclerosis.
Modulation of experimental autoimmune encephalomyelitis through colonisation of the gut with Escherichia coli.
Focus on neglected features of cognitive rehabilitation in MS: Setting and mode of the treatment.
Prolonged residence of an albumin-IL-4 fusion protein in secondary lymphoid organs ameliorates experimental autoimmune encephalomyelitis.
Polish validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS battery): correlation of cognitive impairment with mood disorders and fatigue.
Botulinum toxin type A for hand tremor: a meta-analysis of randomised controlled trials.
Tenofovir as a treatment option for multiple sclerosis.
Newly approved agents for relapsing remitting multiple sclerosis: how real-world evidence compares with randomized clinical trials?
Thalamic Nuclei Volumes and Their Relationships to Neuroperformance in Multiple Sclerosis: A Cross-Sectional Structural MRI Study.
Dyschromatopsia in multiple sclerosis reflects diffuse chronic neurodegeneration beyond anatomical landmarks.
Impact of disease-modifying drugs on severity of COVID-19 infection in multiple sclerosis patients.
Transcription cofactor GRIP1 differentially affects myeloid cell-driven neuroinflammation and response to IFN-β therapy.
Safety results of administering ocrelizumab per a shorter infusion protocol in patients with primary progressive and relapsing multiple sclerosis.
Qigong for Multiple Sclerosis: A Feasibility Study
Genomic, proteomic, and systems biology approaches in biomarker discovery for multiple sclerosis.
Involvement of Indoleamine-2,3-Dioxygenase and Kynurenine Pathway in Experimental Autoimmune Encephalomyelitis in Mice.
Neural implant for the treatment of multiple sclerosis.
The Effects of Omega-3 Supplementation on the Expanded Disability Status Scale and Inflammatory Cytokines in Multiple Sclerosis Patients: A Systematic Review and Meta-Analysis.
Effect of task-oriented circuit training on motor and cognitive performance in patients with multiple sclerosis: A single-blinded randomized controlled trial.
Comorbidity is associated with disease activity in MS: Findings from the CombiRx trial.
Inclusion of Carer Health-Related Quality of Life in National Institute for Health and Care Excellence Appraisals.
Two-year macular volume assessment in multiple sclerosis patients treated with fingolimod.
Peak width of skeletonized mean diffusivity (PSMD) and cognitive functions in relapsing-remitting multiple sclerosis.
Long non-coding RNAs as targets for immunosuppressive drug teriflunomide in anti-cancer potential for hepatocellular carcinoma.
Impact of intradetrusor botulinum toxin A injections on serum and urinary concentrations of nerve growth factor and brain-derived neurotrophic factor in patients with multiple sclerosis and neurogenic detrusor overactivity.
Recent developments in MOG-IgG associated neurological disorders.
Relapsing and progressive MS: the sex-specific perspective.
Paramagnetic Rims in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Quantitative Susceptibility Mapping Study with 3-T MRI.
Variation of the Penetration Effort in an Artificial Tissue by Hypodermic Needles.
How Much Vitamin D is Too Much? A Case Report and Review of the Literature.
RNA-Seq profiling of leukocytes reveals a sex-dependent global circular RNA upregulation in multiple sclerosis and 6 candidate biomarkers.
The effect of out-of-pocket costs on initiation of disease-modifying therapies among medicare beneficiaries with multiple sclerosis.
Evaluation of the impact of intrathecal baclofen on the walking ability of people with Multiple Sclerosis related spasticity.
The relationship between dimensions of mental health and alexithymia in multiple sclerosis patients.
Prior treatment status: impact on the efficacy and safety of teriflunomide in multiple sclerosis.
Treatment response score to glatiramer acetate or interferon beta-1a.
Successful treatment of PLA2R1-antibody positive membranous nephropathy with ocrelizumab.
Internuclear Ophthalmoplegia as the First Manifestation of Pediatric-Onset Multiple Sclerosis and Concurrent Lyme Disease.
A Canadian perspective on severe acute respiratory syndrome coronavirus 2 infection and treatment: how prevalent underlying inflammatory disease contributes to pathogenesis.
John Cunningham Virus Status, Seroconversion Rate, and the Risk of Progressive Multifocal Leukoencephalopathy in Polish John Cunningham Virus-Seronegative Patients with Relapsing-Remitting Multiple Sclerosis.
Ocrelizumab VErsus Rituximab Off-Label at the Onset of Relapsing MS Disease
Epley Manoeuvre in Participants With Multiple Sclerosis Diagnosed From Benign Paroxysmal Positional Vertigo
TRPMS to Improve Mobility and Depression in Multiple Sclerosis
Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental Tissue.
Mediating Role of Resilience on Quality of Life in Individuals With Multiple Sclerosis: A Structural Equation Modeling Approach.
Practical Sleep Information for People With Multiple Sclerosis.
Stem Cell Therapy for Neurogenic Bladder Dysfunction in Rodent Models: A Systematic Review.
Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis.
The right therapeutic method of ozone therapy used to treat multiple sclerosis patients.
Prevalence And Impact Of Myofascial Pain Syndrome In Relapsing-Remitting Multiple Sclerosis And The Effects Of Local Anesthetic Injections For Short-Term Treatment.
Human placental extract attenuates neurological symptoms in the experimental autoimmune encephalomyelitis model of multiple sclerosis-a putative approach in MS disease?
Oleanolic Acid Acetate Alleviates Symptoms of Experimental Autoimmune Encephalomyelitis in Mice by Regulating Toll-Like Receptor 2 Signaling.
CADASIL vs. Multiple Sclerosis: Is It Misdiagnosis or Concomitant? A Case Series.
IV/IT hUC-MSCs Infusion in RRMS and NMO: A 10-Year Follow-Up Study.
The DQB1*03:02 Genotype and Treatment for Pain in People With and Without Multiple Sclerosis.
Management of MS Patients Treated With Daclizumab – a Case Series of 267 Patients.
Comparative Analysis of Roseoloviruses in Humans, Pigs, Mice, and Other Species.
Acceptability and outcomes of an individualized exergaming telePT program for veterans with multiple sclerosis: a pilot study.
Multiple Sclerosis: Impact on Oral Hygiene, Dysphagia, and Quality of Life.
Efficacy of an Internet-Based Program to Promote Physical Activity and Exercise after Inpatient Rehabilitation in Persons with Multiple Sclerosis: A Randomized, Single-Blind, Controlled Study.
Gut microorganisms act together to exacerbate inflammation in spinal cords.
Efficacy and safety of amantadine for the treatment of fatigue in multiple sclerosis: a systematic review and meta-analysis.
Mechanisms of M2 Macrophage-Derived Exosomal Long Non-coding RNA PVT1 in Regulating Th17 Cell Response in Experimental Autoimmune Encephalomyelitisa.
Case Report: Adult Still’s Disease in an Alemtuzumab-Treated Multiple Sclerosis Patient.
A Scoring Algorithm for Deriving Utility Values from the Neuro-QoL for Patients with Multiple Sclerosis.
Smell as a clinical-marker for functional limitations in multiple sclerosis: A pilot study.
A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment.

Focus on Chinese herbal medicine therapy for multiple sclerosis by dialectical treatment.
Summary-data-based Mendelian randomization prioritizes potential druggable targets for multiple sclerosis.
Renal tumors in tuberous sclerosis complex.
MicroRNAs in amyotrophic lateral sclerosis: from pathogenetic involvement to diagnostic biomarker and therapeutic agent development.
Selective modulation of trans-endothelial migration of lymphocyte subsets in multiple sclerosis patients under fingolimod treatment.
A bibliometric evaluation of the top 100 cited natalizumab articles.
A self-management programme to reduce falls and improve safe mobility in people with secondary progressive MS: the BRiMS feasibility RCT.
Transcutaneous Tibial Neuro-stimulation to Improve Voiding Dysfunction in Multiple Sclerosis.
HFP (High-Fiber Supplement) in MS (Multiple Sclerosis)
Graph Theoretic Analysis of Brain Connectomics in Multiple Sclerosis: Reliability and Relationship with Cognition.
Application of Cannabinoids in Neurosciences: Considerations and Implications.
Fibroblast growth factor receptor 3 activates a network of profibrotic signaling pathways to promote fibrosis in systemic sclerosis.
B cells reappear less mature and more activated after their anti-CD20-mediated depletion in multiple sclerosis.
Long-term peripheral immune cell profiling reveals further targets of oral cladribine in MS.
Cataclysmically disseminating neurologic presentation in an immunosuppressed lupus patient: From the National Multiple Sclerosis Society Case Conference Proceedings.
Editorial: Expanding the indications for autologous stem cell transplantation: do we need a new approach to supportive care for patients with multiple sclerosis?
Occupational performance in multiple sclerosis and its relationship with quality of life and fatigue.
[Multiple sclerosis and immuno-modulators of sphingosine 1-phosphate receptors].
What is the role of axonal ion channels in multiple sclerosis?
Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues.
Clinical Applications of Bee Venom Acupoint Injection.
Chronic Facial Pain: Trigeminal Neuralgia, Persistent Idiopathic Facial Pain, and Myofascial Pain Syndrome-An Evidence-Based Narrative Review and Etiological Hypothesis.
Paroxysmal Symptoms in Multiple Sclerosis-A Review of the Literature.
Iron Metabolism in Oligodendrocytes and Astrocytes, Implications for Myelination and Remyelination.
SARS-CoV-2 (COVID-19) in Patients with some Degree of Immunosuppression.
Severe Necrosis and Cellulitis Complicating Treatment with Interferon β-1a.
The effect of microglial ablation and mesenchymal stem cell transplantation on a cuprizone-induced demyelination model.
Protective effect of tolvaptan against cyclophosphamide-induced nephrotoxicity in rat models.
The Effect of a Polysaccharide-Based Multinutrient Dietary Supplementation Regimen on Infections and Immune Functioning in Multiple Sclerosis.
Remaining At Home With Severe Disability.
REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal.
Efficacy and safety of long-term immunotherapy in adult patients with MOG antibody disease: a systematic analysis.
Targeting foam cell formation in inflammatory brain diseases by the histone modifier MS-275.
The role of microRNAs in multiple sclerosis.
Comparative Bioavailability of BAFIERTAM™ (Monomethyl Fumarate) and Tecfidera® (Dimethyl Fumarate) in Healthy Subjects
Mental and somatic comorbidity of depression: a comprehensive cross-sectional analysis of 202 diagnosis groups using German nationwide ambulatory claims data.
Multiple Sclerosis Attack Case Presenting with Pseudo-Vestibular Neuritis.
Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database.
Predictors of Health Utility in Relapsing-Remitting and Secondary-Progressive Multiple Sclerosis: Implications for Future Economic Models of Disease-Modifying Therapies.
A Systematic Review and Mixed Treatment Comparison of Pharmaceutical Interventions for Multiple Sclerosis.
Nursing interventions in autologous stem cell transplantation for autoimmune diseases.
Neuromyelitis optica spectrum disorder: an overview.
Subcutaneous anti-CD20 antibody treatment delays gray matter atrophy in human myelin oligodendrocyte glycoprotein-induced EAE mice.
Psychosocial adjustment to multiple sclerosis diagnosis: A meta-review of systematic reviews.
Intravascular iliac artery lithotripsy to enable transfemoral thoracic endovascular aortic repair.
Antigen-specific immune decoys intercept and exhaust autoimmunity to prevent disease.
Awareness of patients with multiple sclerosis in Saudi Arabia regarding the relationship between smoking and multiple sclerosis.
Biomarkers of inflammation and epithelial barrier function in multiple sclerosis.
COVID-19 in multiple sclerosis patients and risk factors for severe infection.
Blockade of Kv1.3 potassium channel inhibits CD8+ T cell-mediated neuroinflammation via PD-1/Blimp-1 signaling.
Histone deacetylases as targets in autoimmune and autoinflammatory diseases.
Clinical Parameters to Predict Future Clinical Disease Activity After Treatment Change to Higher-Dose Subcutaneous Interferon Beta-1a From Other Platform Injectables in Patients With Relapsing-Remitting Multiple Sclerosis.
Systemic Effects by Intrathecal Administration of Triamcinolone Acetonide in Patients With Multiple Sclerosis.
Fasciola hepatica-Derived Molecules as Regulators of the Host Immune Response.
Uncommon presentation of morphea related to interferon beta in a patient with concomitant multiple sclerosis and chronic hepatitis C: A case report.
Teriflunomide-exposed pregnancies in a French cohort of patients with multiple sclerosis.
Epilepsy in Children with Tuberous Sclerosis Complex: A Prospective Observational Study in Bangladesh.
[Mechanisms underlying remyelination with special focus on demyelination models of multiple sclerosis].
Validity and reliability of the Greek version of the neurogenic bladder symptom score (NBSS) questionnaire in a sample of Greek patients with multiple sclerosis.
Central pain syndromes.
Ketogenic diet and Neuroinflammation.
Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES)
Wireless, Implantable Tibial Nerve Stimulator System for the Treatment of Refractory Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis
c-Jun N-Terminal Kinase as a Therapeutic Target in Experimental Autoimmune Encephalomyelitis.
Overview of Differences and Similarities of Published Mixed Treatment Comparisons on Pharmaceutical Interventions for Multiple Sclerosis.
Multiple sclerosis and COVID-19: how many are at risk?
Genetic factors for susceptibility to and manifestations of neuromyelitis optica.
Patient perspective on decisions to switch disease-modifying treatments in relapsing-remitting multiple sclerosis.
COVID-19 in people with multiple sclerosis: A global data sharing initiative.
MS, pregnancy and COVID-19.
Exploring Multiple Sclerosis (MS) and Amyotrophic Lateral Sclerosis (ALS) as neurodegenerative diseases and their treatments: A review.
Retrospective unbiased plasma lipidomic of progressive multiple sclerosis patients-identifies lipids discriminating those with faster clinical deterioration.
Dynamic Responses of Microglia in Animal Models of Multiple Sclerosis.
Impaired Verb-Related Morphosyntactic Production in Multiple Sclerosis: Evidence From Greek.
Comorbidity in Multiple Sclerosis.
Cystic echinococcosis causing thrombosis of the inferior vena cava in a patient with multiple sclerosis treated with alemtuzumab.
TRPV4-Mediated Regulation of the Blood Brain Barrier Is Abolished During Inflammation.
Comparative analysis of dimethyl fumarate and fingolimod in relapsing-remitting multiple sclerosis.
In Vivo Proton Exchange Rate (kex ) MRI for the Characterization of Multiple Sclerosis Lesions in Patients.
Early evidence of disease activity during fingolimod predicts medium-term inefficacy in relapsing-remitting multiple sclerosis.
High-Efficacy Disease-Modifying Therapies in People with Relapsing-Remitting Multiple Sclerosis: The Role of Risk Attitude in Treatment Decisions.
The effect of yoga on the quality of life and fatigue in patients with multiple sclerosis: A systematic review and meta-analysis of randomized clinical trials.
Discontinuation of disease-modifying treatments in multiple sclerosis to plan a pregnancy: A retrospective registry study.
Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression.
Keeping standards of multiple sclerosis care through the COVID-19 pandemic.
Employment status of people with multiple sclerosis in relation to 10-year changes in functioning and perceived impact of the disease.
An analysis of first-line disease-modifying therapies in patients with relapsing-remitting multiple sclerosis using the French nationwide health claims database from 2014-2017.
Impact of Exercise on Immunometabolism in Multiple Sclerosis.
Home Based Tele-exercise for People With Chronic Neurological Impairments: COVID and Beyond
Asymptomatic optic nerve lesions: An underestimated cause of silent retinal atrophy in MS.
Alemtuzumab-associated diffuse alveolar damage – a case report.
Implications of Vitamin D in Multiple Sclerosis and Other Neurodegenerative Processes: Bibliometric Analysis and Systematic Review.
The current status and challenges in multiple sclerosis management in the Philippines.
High-intensity Resistance Training in People With Multiple Sclerosis Experiencing Fatigue
Self-administered Hyperinsufflation Chest Mobilization Randomized Study on the Risk of Low Respiratory Infection in Patients With Multiple Sclerosis With Sputum Capacity Deficit
Case of Susac’s syndrome initially diagnosed as multiple sclerosis.
Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis.
Development of robust targeted proteomics assays for cerebrospinal fluid biomarkers in multiple sclerosis.
Backward Walking and Dual-Task Assessment Improve Identification of Gait Impairments and Fall Risk in Individuals with MS.
The prevalence of comorbidities in patients with multiple sclerosis: population-based registry data.

Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis.
In vivo imaging of chronic active lesions in multiple sclerosis.
Analysis of defective pathways and drug repositioning in Multiple Sclerosis via machine learning approaches.
Recommendations on vitamin D needs in multiple sclerosis from the MS Society of Canada.
The use of mesenchymal stromal cells in the treatment of coronavirus disease 2019.
Case Report: Confirmation by Metagenomic Sequencing of Visceral Leishmaniasis in an Immunosuppressed Returned Traveler.
Renal Manifestations of Tuberous Sclerosis Complex.
Multiple Sclerosis Atlas: A Molecular Map of Brain Lesion Stages in Progressive Multiple Sclerosis.
Incidence of uveitis and macular edema among patients taking fingolimod 0.5 mg for multiple sclerosis.
Myelin Pathology Beyond White Matter in Tuberous Sclerosis Complex (TSC) Cortical Tubers.
αB-crystallin as a promising target in pathological conditions – A review.
Changes in structural and functional connectivity during two years of fingolimod therapy for multiple sclerosis.
Isolated opsoclonus heralding neuromyelitis optica spectrum disorder.
Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia.
Smartphone based behavioral therapy for pain in multiple sclerosis (MS) patients: A feasibility acceptability randomized controlled study for the treatment of comorbid migraine and ms pain.
Characterization of multiple sclerosis lesions with distinct clinical correlates through quantitative diffusion MRI.
Attenuated immune control of Epstein Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15.
Modeling the Efficacy of Natalizumab in Multiple Sclerosis Patients Who Switch From Every-4-Week Dosing to Extended-Interval Dosing.
Improving our understanding of the most important items of the Multiple Sclerosis Walking Scale-12 indicating mobility dysfunction: Secondary results from a RIMS multicenter study.
A systematic review of oral health in people with multiple sclerosis.
Economic costs incurred by the patients with multiple sclerosis at different levels of the disease: a cross-sectional study in Northwest Iran.
SARS-CoV-2 Infection: A Role for S1P/S1P Receptor Signaling in the Nervous System?
Assessment of the efficacy of a fatigue management therapy in schizophrenia: study protocol for a randomized, controlled multi-centered study (ENERGY).
The Relation of the Brain-Derived Neurotrophic Factor with MicroRNAs in Neurodegenerative Diseases and Ischemic Stroke.
High density lipoprotein cholesterol and apolipoprotein A-I are associated with greater cerebral perfusion in multiple sclerosis.
Lithium Use During Pregnancy in a Patient With Bipolar Disorder and Multiple Sclerosis.
Delay from treatment start to full effect of immunotherapies for multiple sclerosis.
haMSter: a Novel Smartphone Communication Tool for People With MS
Acquisition of Early Developmental Milestones and Need for Special Education Services in Pediatric Multiple Sclerosis.
Efficacy of andrographolide in not active progressive multiple sclerosis: a prospective exploratory double-blind, parallel-group, randomized, placebo-controlled trial.
Pharmacotherapeutic management of lower urinary tract symptoms in Multiple Sclerosis patients.
Efficacy and safety of rituximab in treating patients with multiple sclerosis (MS): A systematic review and meta-analysis.
Formal and informal care received by middle-aged and older adults with chronic conditions in Canada: CLSA data.
[Robotic mechanotherapy in patients with multiple sclerosis with impaired walking function].
Vaccinations in patients with multiple sclerosis: A Delphi consensus statement.
Pediatric multiple sclerosis – current status of epidemiology, diagnosis and treatment.
Physical activity, sitting time and exercise types, and associations with symptoms in Australian people with multiple sclerosis.
Feasibility of improving dietary quality using a telehealth lifestyle intervention for adults with multiple sclerosis.
Inflammatory colitis associated with Teriflunomide.
Physical activity, sedentary behavior, and restless legs syndrome in persons with multiple sclerosis.
My MS Toolkit + Coaching: A Guided Web-based Symptom Self-Management Program for People With MS
Benefits and harms of medical cannabis: a scoping review of systematic reviews.
Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis.
Interleukin-17 and ischemic stroke.
Brain activity changes following neuroproprioceptive “facilitation, inhibition” physiotherapy in multiple sclerosis: a parallel group randomized comparison of two approaches.
An adult case of parainfectious optic neuritis associated with genital herpes simplex virus type 2 infection.
Racial Disparities in Medicaid Home and Community-Based Service Utilization among White, Black, and Hispanic Adults with Multiple Sclerosis: Implications of State Policy.
Pharmacological Inhibition of Acid Sphingomyelinase Ameliorates Experimental Autoimmune Encephalomyelitis.
Objectively Monitoring Amyotrophic Lateral Sclerosis Patient Symptoms During Clinical Trials With Sensors: Observational Study.
[Comparison of the clinical benefits of second-line drugs modifying the course of multiple sclerosis].
[Neuropathic pain: Pharmacotherapy].
Dimethyl fumarate-induced lymphocyte count drop is related to clinical effectiveness in relapsing-remitting multiple sclerosis.
Enhancing quality of life in progressive multiple sclerosis with powered robotic exoskeleton.
Follow-up Study of the Effectiveness of Virtual Reality Therapy in MS Patients
A Prospective Biomarker Study in Active SPMS Subjects Treated With Cladribine Tablets
Hepatitis B vaccination and central demyelination – History, description and observed/expected analyses of 624 cases reported to the French pharmacovigilance over a 20-year period.
Motivational interviewing to promote health outcomes and behaviour change in multiple sclerosis: a systematic review.
[Updated recommendations of the Council of Experts on the use and safety of alemtuzumab (Lemtrada)].
Health service utilization in immigrants with multiple sclerosis.
Cuprizone-induced demyelination in mouse hippocampus is alleviated by ketogenic diet.
Probable Autoimmune Depression in a Patient With Multiple Sclerosis and Antineuronal Antibodies.
Supplementary medication in multiple sclerosis: Real-world experience and potential interference with neurofilament light chain measurement.
Ursolic acid treatment suppresses cuprizone-induced demyelination and motor dysfunction via upregulation of IGF-1.
Torsadogenic potential of a novel remyelinating drug clemastine for multiple sclerosis assessed in the rabbit proarrhythmia model.
Prevalence of mental disorders is higher in patients with multiple sclerosis than in the general population or in patients with rheumatoid arthritis in France.
Interleukin 6 (IL6) level is a biomarker for functional disease progression within IL6R358Ala variant groups in amyotrophic lateral sclerosis patients.
Inner nuclear layer and olfactory threshold are interlinked and reflect inflammatory activity in multiple sclerosis.
Sensor-based technology for upper limb rehabilitation in subjects with multiple sclerosis: A randomized controlled trial.
Interferon-β alleviates delayed tPA-induced adverse effects via modulation of MMP3/9 production in ischemic stroke.
Imaging Butyrylcholinesterase in Multiple Sclerosis.
12-months prospective Pentraxin-3 and metabolomic evaluation in multiple sclerosis patients treated with glatiramer acetate.
Intermittent caloric restriction with a modified fasting-mimicking diet ameliorates autoimmunity and promotes recovery in a mouse model of multiple sclerosis.
Ocrelizumab Treatment in Patients with Primary Progressive Multiple Sclerosis: Short-term Safety Results from a Compassionate Use Programme in Germany.
Dicrocoelium Ova Can Block the Induction Phase of Experimental Autoimmune Encephalomyelitis.
Proximal Resistance Training for People With Multiple Sclerosis
Effect of Pilates Training in Patients With Multiple Sclerosis
Tools for comprehensive evaluation of sexual function in patients with multiple sclerosis.
Creatine and multiple sclerosis.
CNS delivery of anti-CD52 antibodies modestly reduces disease severity in an animal model for multiple sclerosis.
Sphingosine 1-Phosphate Receptors in Cerebral Ischemia.
Effects of Lactobacillus casei Strain T2 (IBRC-M10783) on the Modulation of Th17/Treg and Evaluation of miR-155, miR-25, and IDO-1 Expression in a Cuprizone-Induced C57BL/6 Mouse Model of Demyelination.
[Engaging clinicians to identify and prioritize disinvestment opportunities in the treatment of neurodegenerative diseases: a qualitative study.]
The Changes in 1H-MRS Metabolites in Cuprizone-Induced Model of Multiple Sclerosis: Effects of Prior Psychological Stress.
Speech metrics, general disability, brain imaging and quality of life in MS.
Beyond COVID-19: DO MS/NMO-SD patients treated with anti-CD20 therapies develop SARS-CoV2 antibodies?
The Gut Microbiota in Multiple Sclerosis: An Overview of Clinical Trials.
Unraveling B-lymphocytes in CNS inflammatory diseases: Distinct mechanisms and treatment targets.
Lipid Nanoparticles Vectorized with NFL-TBS.40-63 Peptide Target Oligodendrocytes and Promote Neurotrophin-3 Effects After Demyelination In Vitro.
Bruton’s tyrosine kinase inhibitors: a promising emerging treatment option for multiple sclerosis.
Lymphomatosis cerebri masquerading as the Marburg variant of multiple sclerosis.
Long-term safety and efficacy of teriflunomide in patients with relapsing multiple sclerosis: Results from the TOWER extension study.
Aerobic Exercises for Multiple Sclerosis
The IL-12 cytokine family in cardiovascular diseases.
Lipoprotein(a) Levels Are Associated with the Size of Extracranial Arteries in Multiple Sclerosis.
Time-Based Prospective Memory Is Associated with Functional Performance in Persons with MS.
Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
Feasibility of Real Time Internet-Based Teleconsultation in Patients With Multiple Sclerosis: Interventional Pilot Study.
Safety and Tolerability of Plasma Exchange and Immunoadsorption in Neuroinflammatory Diseases.
Morpholino Analogues of Fingolimod as Novel and Selective S1P1 Ligands with In Vivo Efficacy in a Mouse Model of Experimental Antigen-Induced Encephalomyelitis.
The BAFF / APRIL system as therapeutic target in multiple sclerosis.

Urinary tract infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society.
Intrathecal treatment trial of rituximab in progressive MS: results after a 2-year extension.
Design, synthesis, and anti-neuroinflammatory activity of amidecontaining dithiolethiones.
SMILE: a predictive model for Scoring the severity of relapses in MultIple scLErosis.
Autoantigen Tetramer Silences Autoreactive B Cell Populations.
A Comprehensive Monitoring Study on Electrocardiographic Assessments and Cardiac Events After Fingolimod First Dose-Possible Predictors of Cardiac Outcomes.
Profile of MIF in Developing Hippocampus: Association With Cell Proliferation and Neurite Outgrowth.
Effect of Cervical Mobilization on Tonus and Plantar Pressure Distribution in Multiple Sclerosis
Clinical Use of Schistosoma mansoni Antigens as Novel Immunotherapies for Autoimmune Disorders.
A Study To Evaluate The Efficacy And Safety Of Fenebrutinib Compared With Ocrelizumab In Adult Participants With Primary Progressive Multiple Sclerosis
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis
Impact of Repetitive Transcranial Magnetic Stimulation on Neurocognition and Oxidative Stress in Relapsing-Remitting Multiple Sclerosis: A Case Report.
Multiple sclerosis, human herpesvirus 4 and thyroid collision tumor: A case report.
Immune reconstitution, glomerulonephritis, and successful treatment with rituximab.
Differential diagnosis in acute inflammatory myelitis.
A systematic review and meta-analysis of randomized controlled trials to evaluating the trend of cytokines to vitamin A supplementation in autoimmune diseases.
Disrupting Myelin-Specific Th17 Cell Gut Homing Confers Protection in an Adoptive Transfer Experimental Autoimmune Encephalomyelitis.
COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment.
Discerning novel drug targets for treating Mycobacterium avium ss. paratuberculosis-associated autoimmune disorders: an in silico approach.
Pharmacotherapy in multiple sclerosis-induced cognitive impairment: A systematic review and meta-analysis.
US Spending Associated With Transition From Daily to 3-Times-Weekly Glatiramer Acetate.
Rituximab and glatiramer-acetate in secondary-progressive multiple sclerosis: A randomized-clinical trial.
Varicella-zoster virus vasculopathy in a multiple sclerosis patient on fingolimod.
Immunohistochemical Analysis of Protective Effects of Maternal Fingolimod on the Placenta and Fetal Lung and Brain in Chorioamnionitis-Induced Preterm Birth Rat Model.
A novel fumarate, isosorbide di-(methyl fumarate) (IDMF), replicates astrocyte transcriptome responses to dimethyl fumarate (DMF) but specifically down-regulates genes linked to a reactive phenotype.
Effects of fingolimod, a sphingosine-1-phosphate (S1P) receptor agonist, on white matter microstructure, cognition and symptoms in schizophrenia.
Autologous Hematopoietic Stem Cell Transplantation in Neurological Disorders: Current Approach and Future Directions.
Mitoxantrone impairs proteasome activity and prompts early energetic and proteomic changes in HL-1 cardiomyocytes at clinically relevant concentrations.
Extrinsic immune cell-derived, but not intrinsic oligodendroglial factors contribute to oligodendroglial differentiation block in multiple sclerosis.
Introduction: Druggable Lipid Signaling Pathways.
A Phase 1 Single and Multiple Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Immunogenicity of HuL001 in Healthy Volunteers and Multiple Sclerosis Subjects
Shikonin ameliorates experimental autoimmune encephalomyelitis (EAE) via immunomodulatory, anti-apoptotic and antioxidative activity.
Changes of central noradrenaline transporter availability in immunotherapy-naïve multiple sclerosis patients.
CCL-11 or Eotaxin-1: An Immune Marker for Ageing and Accelerated Ageing in Neuro-Psychiatric Disorders.
Persons with Multiple Sclerosis Exhibit Strength Asymmetries in both Upper and Lower Extremities.
High effector-memory CD8+ T-cell levels correlate with high PML risk in natalizumab-treated patients.
Urinary tract infection in patients with multiple sclerosis: An overview.
Aerobic Exercise for Remyelination in Multiple Sclerosis
Learning Strategies for Improving Dual Task Performance in Multiple Sclerosis
Estimating the relative contribution of comorbidities in predicting health-related quality of life of people with multiple sclerosis.
An Absence of Epstein-Barr Virus Reactivation and Associations with Disease Activity in People with Multiple Sclerosis Undergoing Therapeutic Hookworm Vaccination.
An international discrete choice experiment assessing patients’ preferences for disease-modifying therapy attributes in multiple sclerosis.
Health Related Quality of Life in Patients with Onco-hematological Diseases.
The co-occurrence of multiple sclerosis and Evans syndrome: A case report.
Mycobacterium avium complex infection in a patient with systemic sclerosis- associated interstitial lung disease: A case report.
High clinician- and patient-reported satisfaction with individualized onabotulinumtoxinA treatment for spasticity across several etiologies from the ASPIRE study.
Effectiveness of first-line treatment for relapsing-remitting multiple sclerosis in Brazil: A 16-year non-concurrent cohort study.
The PNPLA3 rs738409 variant can increase the risk of liver toxicity in multiple sclerosis patients treated with beta-interferon.
Using normalisation process theory to understand barriers and facilitators to implementing mindfulness-based stress reduction for people with multiple sclerosis.
FTY720 induces non-canonical phosphatidylserine externalization and cell death in acute myeloid leukemia.
The Association between Body Mass Index and Leisure-Time Physical Activity in Adults with Multiple Sclerosis.
Association Between System Usage Pattern and Impact of Web-Based Telerehabilitation in Patients with Multiple Sclerosis.
Health Behaviors, Wellness, and Multiple Sclerosis Amid COVID-19.
Effects of immunomodulatory drug Fingolimod (FTY720) on Chlamydia dissemination and pathogenesis.
Utilization of Visual Acuity Retroilluminated Charts for the Assessment of Afferent Visual System Dysfunction in a Pediatric Neuroimmunology Population.
Allergy and dimethyl fumarate treatment in a patient with multiple sclerosis.
The anticonvulsive Phenhydan® suppresses extrinsic cell death.
Decrease in Secondary Neck Vessels in Multiple Sclerosis: A 5-year Longitudinal Magnetic Resonance Angiography Study.
The Effect of a Series of Systemic Cryotherapy Treatments on the Functional State of Patients With Multiple Sclerosis
Are information provision interventions effective for people with multiple sclerosis? A Cochrane Review summary with commentary.
Sarm1 knockout protects against early but not late axonal degeneration in experimental allergic encephalomyelitis.
The use of Modified Rio score for determining treatment failure in patients with multiple sclerosis: retrospective descriptive case series study.
Intermittent catheterization and urinary tract infection in multiple sclerosis patients.
Changes in Th17 cells frequency and function after ozone therapy used to treat multiple sclerosis patients.
Reasons for switching to fingolimod in patients relapsing-remitting multiple sclerosis in France: the ESGILE study.
A case report with tuberculous meningitis during fingolimod treatment.
NFL and CXCL13 may reveal disease activity in clinically and radiologically stable MS.
The Energetic Origin of Neurodegeneration in MS
A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis.
Therapeutic potential of neuromodulation for demyelinating diseases.
Predictive factors and early biomarkers of response in multiple sclerosis patients treated with natalizumab.
The pharmacological effects of inhaled cannabis on pain in patients with multiple sclerosis: risks versus rewards.
Acquired factor VIII inhibitor in a patient with multiple sclerosis treated with interferon β-1a.
Mélange intéressante: COVID-19, autologous transplants and multiple sclerosis.
A comparative study of the effects of yoga and clinical Pilates training on walking, cognition, respiratory functions, and quality of life in persons with multiple sclerosis: A quasi-experimental study.
Self-diagnosed COVID-19 in people with multiple sclerosis: a community-based cohort of the UK MS Register.
Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms.
Systemic Mesenchymal Stem Cell Treatment Mitigates Structural and Functional Retinal Ganglion Cell Degeneration in a Mouse Model of Multiple Sclerosis.
Menopause and multiple sclerosis: Influence on prognosis and role of disease-modifying drugs and hormonal replacement therapy.
A multi-modal virtual reality treadmill intervention for enhancing mobility and cognitive function in people with multiple sclerosis: Protocol for a randomized controlled trial.
Lithium Use During Pregnancy in a Patient With Bipolar Disorder and Multiple Sclerosis.
Stem Cell-Derived Exosomes as Nanotherapeutics for Autoimmune and Neurodegenerative Disorders.
Are patients with multiple sclerosis (MS) at higher risk of COVID-19 infection?
A Systematic Review on the Role of Arachidonic Acid Pathway in Multiple Sclerosis.
[Radiologically isolated syndrome: prognosis and predictors of conversion to multiple sclerosis].
[Myelin oligodendrocyte glycoprotein immunoglobulin G-associated encephalomyelitis].
[Registry-based comparison of multiple sclerosis epidemiology trend data in 1999 and 2019: the case of Yaroslavl].
[The use of music therapy in the treatment of adverse effects in patients with multiple sclerosis treated with alemtuzumab].
[Experience in designing an electronic multiple sclerosis registry].
[Effect of different groups of first line DMT on endothelial damage in multiple sclerosis].
[Multifocal inflammatory levamisole-induced leukoencephalopathy].
Low-Dose Naltrexone for Chronic Pain: Update and Systemic Review.
FTY720 in CNS injuries: Molecular Mechanisms and Therapeutic Potential.
The effect of stem cell therapy and comprehensive physical therapy in motor and non-motor symptoms in patients with multiple sclerosis: A comparative study.
Persistence, adherence, healthcare resource utilisation and costs for interferon Beta in multiple sclerosis: a population-based study in the Campania region (southern Italy).
Relapsing Demyelinating Syndromes in Children: A Practical Review of Neuroradiological Mimics.
Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS).
Myasthenia Gravis and Physical Exercise: A Novel Paradigm.
Pregnancy Outcomes in Patients With Multiple Sclerosis Exposed to Natalizumab-A Retrospective Analysis From the Austrian Multiple Sclerosis Treatment Registry.
Clinical and Neurochemical Effects of Transcranial Magnetic Stimulation (TMS) in Multiple Sclerosis: A Study Protocol for a Randomized Clinical Trial.

Gonadal Steroids and Sperm Quality in a Cohort of Relapsing Remitting Multiple Sclerosis: A Case-Control Study.
Teriflunomide preserves peripheral nerve mitochondria from oxidative stress-mediated alterations.
Fatal COVID-19 in an MS patient on natalizumab: A case report.
Sensory-Neural Hearing Loss as an Early Rebound Relapse after Fingolimod Cessation in Multiple Sclerosis.
Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS)
The Effect of High Tone Power Therapy on Fatigue and Functional Outcomes in Multiple Sclerosis
Dendritic Cells Therapy Combined With Immunomodulatory Treatment in Multiple Sclerosis
Efficacy and Safety of 2 Fingolimod Doses vs Glatiramer Acetate for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial.
Would it be recommended treating multiple sclerosis relapses with high dose oral instead intravenous steroids during the COVID-19 pandemic? Yes.
Feasibility Study of Transcutaneous Tibial Nerve Stimulation for Urinary Symptoms in People With Multiple Sclerosis
Effect of CoDuSe Balance Training and Step Square Exercises on Risk of Fall in Multiple Sclerosis
Autologous hematopoietic stem cell transplantation following alemtuzumab therapy in aggressive multiple sclerosis: A report of three cases.
Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM).
Personalized Yoga Therapy for Multiple Sclerosis: Effect on Symptom Management and Quality of Life.
Biotransformation of cladribine by a nanostabilized extremophilic biocatalyst.
Multiple sclerosis in a young woman with sickle cell disease.
Predictive probability of success using surrogate endpoints.
Percutaneous Venous Angioplasty in Patients with Multiple Sclerosis and Chronic Cerebrospinal Venous Insufficiency.
Self-efficacy and walking performance across the lifespan among adults with multiple sclerosis.
Relationship Between Exercise Duration in Multimodal Telerehabilitation and Quality of Sleep in Patients with Multiple Sclerosis.
Effect of vitamin D supplementation on N-glycan branching and cellular immunophenotypes in MS.
Leptomeningeal Enhancement on 3D-FLAIR MRI in Multiple Sclerosis: Systematic Observations in Clinical Practice.
Reorganization of multiple sclerosis health care system in Clinical Centre of Montenegro during the COVID-19 pandemic.
Protection of Fecal Microbiota Transplantation in a Mouse Model of Multiple Sclerosis.
Functional electrical stimulation for foot drop in people with multiple sclerosis: The relevance and importance of addressing quality of movement.
Assessing the susceptibility to acute respiratory illness COVID-19-related in a cohort of multiple sclerosis patients.
COVID-19 in a multiple sclerosis (MS) patient treated with alemtuzumab: Insight to the immune response after COVID.
Treatment-Refractory Headache in the Setting of COVID-19 Pneumonia: Migraine or Meningoencephalitis? Case Report.
iTBS Study for Depression in Patients With Multiple Sclerosis
Impaired micronutrients and prealbumin in patients with established and very early systemic sclerosis.
CLINICAL course of acute disseminated encephalomyelitis in adults from Rio de Janeiro: Retrospective study of 23 cases and literature review.
Effect of Cladribine on Neuronal Apoptosis: New Insight of In Vitro Study in Multiple Sclerosis Therapy.
Metformin as a Potential Agent in the Treatment of Multiple Sclerosis.
The Use of Electrochemical Voltammetric Techniques and High-Pressure Liquid Chromatography to Evaluate Conjugation Efficiency of Multiple Sclerosis Peptide-Carrier Conjugates.
Molecular Biomarkers in Multiple Sclerosis and Its Related Disorders: A Critical Review.
Do modern therapies change natural history of Neuromyelitis optica?
Localised multiple sclerosis-like disease after irradiation of the cervicothoracic spinal cord.
High levels of circulating GM-CSF+CD4+ T cells are predictive of poor outcomes in sepsis patients: a prospective cohort study.
CD70 defines a subset of proinflammatory and CNS-pathogenic TH1/TH17 lymphocytes and is overexpressed in multiple sclerosis.
Self-Powered Direct Muscle Stimulation Using a Triboelectric Nanogenerator (TENG) Integrated with a Flexible Multiple-Channel Intramuscular Electrode.
Helicobacter pylori infection: Beyond gastric manifestations.
Protective Effects of Leukadherin1 in a Rat Model of Targeted Experimental Autoimmune Encephalomyelitis (EAE): Possible Role of P47phox and MDA Downregulation.
Mirabegron versus solifenacin in multiple sclerosis patients with overactive bladder symptoms: a prospective comparative non-randomized study.
Effects of dietary restriction on gut microbiota and CNS autoimmunity.
Multiple sclerosis in Pakistan: Current status and future perspective.
Instrumented Version of the Modified Dynamic Gait Index in Patients With Neurologic Disorders.
Patient and Plan Spending after State Specialty-Drug Out-of-Pocket Spending Caps.
Beyond barrier functions: Roles of pericytes in homeostasis and regulation of neuroinflammation.
Glomerulonephritis With Positive Anti-Glomerular Basement Membrane Antibodies Following Alemtuzumab Treatment.
Turning Toward Monitoring of Gaze Stability Exercises: The Utility of Wearable Sensors.
Long-term prognostic value of longitudinal measurements of blood neurofilament levels.
Accurate Diagnosis of Multiple Sclerosis Using Hybrid Positron Emission Tomography/Magnetic Resonance (PET/MR)
Physiotherapy assessment of individuals with multiple sclerosis prior to a group intervention – A qualitative observational and interview study.
Targeted delivery for neurodegenerative disorders using gene therapy vectors: Gen next therapeutic goals.
Rates, patterns, and correlates of fitness tracker use among older adults with multiple sclerosis.
Kombucha ameliorates experimental autoimmune encephalomyelitis through activation of Treg and Th2 cells.
The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis.
Dietary education programs for adults with neurological diseases: a scoping review protocol.
Internet-Delivered Lifestyle Physical Activity Intervention for Cognitive Processing Speed in Multiple Sclerosis
StatPearls
Newest evidence for tetrahydrocannabinol:cannabidiol oromucosal spray from postapproval pragmatic studies.
IL-23 and dendritic cells: What are the roles of their mutual attachment in immune response and immunotherapy?
Activin-A limits Th17 pathogenicity and autoimmune neuroinflammation via CD39 and CD73 ectonucleotidases and Hif1-α-dependent pathways.
A Systematic Review of Cerebral Functional Near-Infrared Spectroscopy in Chronic Neurological Diseases-Actual Applications and Future Perspectives.
Progressive patterns of neurological disability in multiple sclerosis and neuromyelitis optica spectrum disorders.
Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands.
Patient-reported financial toxicity in multiple sclerosis: Predictors and association with care non-adherence.
A comprehensive review on miR-146a molecular mechanisms in a wide spectrum of immune and non-immune inflammatory diseases.
Development of α4 integrin DNA aptamer as a potential therapeutic tool for multiple sclerosis.
Physical activity participation according to the pyramidal, sensory, and cerebellar functional systems in multiple sclerosis.
Multifocal Micronodular Pneumocyte Hyperplasia in Tuberous Sclerosis Complex: Resolution with Everolimus Treatment.
Effect of Eccentric Strength Training on Elbow Flexor Spasticity and Muscle Weakness in People With Multiple Sclerosis: Proof-of-Concept Single-System Case Series.
Trunk and foot acceleration variability during walking relates to fall history and clinical disability in persons with multiple sclerosis.
Aryl hydrocarbon receptor signaling activation in systemic sclerosis attenuates collagen production and is a potential antifibrotic target.
Secular trends in disease modifying treatment and expenditure in multiple sclerosis: A longitudinal population study in the north of Ireland.
[Variability of the Mitochondrial Genome and Development of the Primary Progressing form of Multiple Sclerosis].
Safety profile of ocrelizumab for the treatment of multiple sclerosis: a systematic review.
Current perspectives on co-morbid depression and multiple sclerosis.
Effect of genetic polymorphisms on therapeutic response in multiple sclerosis relapsing-remitting patients treated with interferon-beta.
Mesenchymal stromal cells (MSCs) for neurodegenerative disease: A promising frontier.
Erratum to “Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: Safety algorithm” [Neurologia. 2020;35(6):357-362].
The Role of TH17 Cells in Multiple Sclerosis: Therapeutic Implications.
Reelin depletion protects against autoimmune encephalomyelitis by decreasing vascular adhesion of leukocytes.
Lymphocyte recovery after fingolimod discontinuation in patients with MS.
REFRESH protocol: a non-inferiority randomised clinical trial comparing internet and teleconference to in-person ‘Managing Fatigue’ interventions on the impact of fatigue among persons with multiple sclerosis.
Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach.
An Overview on Probiotics as an Alternative Strategy for Prevention and Treatment of Human Diseases.
Olive Leaf Polyphenols Attenuate the Clinical Course of Experimental Autoimmune Encephalomyelitis and Provide Neuroprotection by Reducing Oxidative Stress, Regulating Microglia and SIRT1, and Preserving Myelin Integrity.
Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients.
Applications of Head-Mounted Displays for Virtual Reality in Adult Physical Rehabilitation: A Scoping Review.
Branch retinal vein occlusion associated with fingolimod treatment for multiple sclerosis.
Assessing upper limb function in Multiple Sclerosis by an engineered glove.
Preventing Job Loss Using Acceptance and Commitment Therapy in Vocational Rehabilitation
Opposing and potentially antagonistic effects of BMP and TGF-β in multiple sclerosis: The “Yin and Yang” of neuro-immune Signaling.
Biologic Therapy in Refractory Non-Multiple Sclerosis Optic Neuritis Isolated or Associated to Immune-Mediated Inflammatory Diseases. A Multicenter Study.
Focus on Data: Statistical Significance, Effect Size and the Accumulation of Evidence Achieved by Combining Study Results Through Meta-analysis.
Opicinumab: is it a potential treatment for multiple sclerosis?
Commentary on: “Calling Out MS Fatigue: Feasibility and Preliminary Effects of a Pilot Randomized Telephone-Delivered Exercise Intervention for Multiple Sclerosis Fatigue”.
Vaccines for measles, mumps, rubella, and varicella in children.
Systematic review of prediction models in relapsing remitting multiple sclerosis.

Lipid-specific IgMs induce antiviral responses in the CNS: implications for progressive multifocal leukoencephalopathy in multiple sclerosis.
Gsta4 controls apoptosis of differentiating adult oligodendrocytes during homeostasis and remyelination via the mitochondria-associated Fas-Casp8-Bid-axis.
Advanced MRI features in relapsing multiple sclerosis patients with and without CSF oligoclonal IgG bands.
Temelimab, an IgG4 Anti-Human Endogenous Retrovirus Monoclonal Antibody: An Early Development Safety Review.
Safety, Tolerability, and Pharmacodynamics of Intrathecal Injection of Recombinant Human HGF (KP-100) in Subjects With Amyotrophic Lateral Sclerosis: A Phase I Trial.
The nature of anger in people with multiple sclerosis: a qualitative study.
Upper limb motor evoked potentials as outcome measure in progressive multiple sclerosis.
Idebenone does not inhibit disability progression in primary progressive MS.
Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases.
Failed, Interrupted, or Inconclusive Trials on Immunomodulatory Treatment Strategies in Multiple Sclerosis: Update 2015-2020.
The effect of a telerehabilitation virtual reality intervention on functional upper limb activities in people with multiple sclerosis: a study protocol for the TEAMS pilot randomized controlled trial.
Timing of Communication Device Introduction Defined by ALSFRS-R Score in Patients with Amyotrophic Lateral Sclerosis.
Hyperglucosylated adhesin-derived peptides as antigenic probes in multiple sclerosis: Structure optimization and immunological evaluation.
Evaluation of serum human epididymis protein 4 in patients with relapsing-remitting multiple sclerosis.
Feasibility and acceptability of a single-session, videoconference-delivered group intervention for pain in multiple sclerosis.
Impact of obstructive sleep apnoea on cognitive function in multiple sclerosis: A longitudinal study.
Physical and functional aspects of persons with multiple sclerosis practicing Tai-Geiko: randomized trial.
Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection.
Potential anti-neuroinflammatory NF-кB inhibitors based on 3,4-dihydronaphthalen-1(2H)-one derivatives.
Treatment patterns and comorbid burden of patients newly diagnosed with multiple sclerosis in the United States.
9-month Study to Assess the Efficacy of Ofatumumab on Microglia in Patients With Relapsing Forms of Multiple Sclerosis
The cerebrospinal fluid CD4/CD8 ratio and interleukin-6 and -10 levels in neurosarcoidosis: a multicenter, pragmatic, comparative study.
Neuroinflammation at single cell level: What is new?
Maintenance Intravenous Immunoglobulin Treatment for Multiple Sclerosis Coexisting with Ehlers-Danlos Syndrome and Muir-Torre Syndrome: A Case Study.
Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination.
IFI35 as a biomolecular marker of neuroinflammation and treatment response in multiple sclerosis.
Serum neurofilament-light concentration and real-world outcome in MS.
Enhanced Recruitment During Executive Control Processing in Cognitively Preserved Patients With Pediatric-Onset MS.
IL-9 Controls Central Nervous System Autoimmunity by Suppressing GM-CSF Production.
Bcl6 modulates innate immunity by controlling macrophage activity and plays critical role in experimental autoimmune encephalomyelitis.
First-ever treatment in multiple sclerosis.
TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis.
Inhibition of Bruton´s tyrosine kinase as a novel therapeutic approach in multiple sclerosis.
Eculizumab in the treatment of neuromyelitis optica spectrum disorder.
Multiple sclerosis management during the COVID-19 pandemic.
Bu-Shen-Yi-Sui Capsule, an Herbal Medicine Formula, Promotes Remyelination by Modulating the Molecular Signals via Exosomes in Mice with Experimental Autoimmune Encephalomyelitis.
Effect of natalizumab treatment on metalloproteinases and their inhibitors in a mouse model of multiple sclerosis.
Varicella Zoster immunity loss in multiple sclerosis patient treated with ocrelizumab.
Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab.
Is there a correlation between dyslipidemia and cognitive impairment in patients with multiple sclerosis?
Neuroimmunologic disorders in pregnancy.
Methylprednisolone Concentrations in Breast Milk and Serum of Patients with Multiple Sclerosis Treated with IV Pulse Methylprednisolone.
Effects of MS disease-modifying therapies on responses to vaccinations: A review.
Distinctive sphingolipid patterns in chronic multiple sclerosis lesions.
Retinal and brain damage during multiple sclerosis course: inflammatory activity is a key factor in the first 5 years.
Network-based modeling of drug effects on disease module in systemic sclerosis.
COVID-19 pneumonia in a multiple sclerosis patient with severe lymphopenia due to recent cladribine treatment.
Efficacy and safety of fampridine for walking disability in multiple sclerosis.
Recovery from COVID-19 in a B-cell-depleted multiple sclerosis patient.
Risk attitude and personality in people with multiple sclerosis facing the choice of different disease-modifying therapy scenarios.
The multiple sclerosis (MS) drugs as a potential treatment of ARDS in COVID-19 patients.
Disability Improvement Is Associated with Less Brain Atrophy Development in Multiple Sclerosis.
Using Serum Metabolomics to Predict Development of Anti-drug Antibodies in Multiple Sclerosis Patients Treated With IFNβ.
Oxidative/Nitroxidative Stress and Multiple Sclerosis.
Serious safety events in rituximab-treated multiple sclerosis and related disorders.
Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment.
Conscientiousness and deterioration in employment status in multiple sclerosis over 3 years.
Is there a role for sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction?
Avoiding COVID-19 complications with diabetic patients could be achieved by multi-dose Bacillus Calmette-Guérin vaccine: a case study of beta cells regeneration.
Audiovestibular symptoms in patients with multiple sclerosis: A correlation between self-reported symptomatology and MRI findings to monitor disease progression.
Auricular acupuncture for the treatment of nonepileptic seizures: A pilot study.
A Case of Severe Multiple Sclerosis Manifesting upon GnRH Agonist Therapy for Uterine Fibroids.
Thalamic Atrophy Predicts 5-Year Disability Progression in Multiple Sclerosis.
Randomized feasibility trial to assess tolerance and clinical effects of lithium in progressive multiple sclerosis.
Age-Related Lymphocyte Output During Disease-Modifying Therapies for Multiple Sclerosis.
Inhibition of Bruton’s tyrosine kinase interferes with pathogenic B-cell development in inflammatory CNS demyelinating disease.
Lipoic acid modulates inflammatory responses of monocytes and monocyte-derived macrophages from healthy and relapsing-remitting multiple sclerosis subjects.
Accuracy of FRAX® in People With Multiple Sclerosis.
Immune checkpoint molecules. Possible future therapeutic implications in autoimmune diseases.
Dissecting task-specific plasticity capacity in patients with multiple sclerosis with transcranial magnetic stimulation.
MOG Antibody Associated Disease: How it Differs From and Resembles Other Neuroinflammatory Disorders.
Exploring the Use of Dimethyl Fumarate as Microglia Modulator for Neurodegenerative Diseases Treatment.
Sensorized Tip for Monitoring People with Multiple Sclerosis that Require Assistive Devices for Walking.
Biosynthesis and signalling functions of central and peripheral nervous system neurosteroids in health and disease.
Ofatumumab versus Teriflunomide in Multiple Sclerosis.
iPS-Derived Early Oligodendrocyte Progenitor Cells from SPMS Patients Reveal Deficient In Vitro Cell Migration Stimulation.
[Treatment and Management of Spasticity].
Real-World Treatment Patterns of Disease Modifying Therapy (DMT) for Patients with Relapse-Remitting Multiple Sclerosis and Patient Satisfaction with Therapy: Results of the Non-Interventional SKARLET Study in Slovakia.
Diagnosis of depression in multiple sclerosis is predicted by frontal-parietal white matter tract disruption.
Remyelination promoting therapies in multiple sclerosis animal models: a systematic review and meta-analysis.
Using Sigma-ligands as part of a multi-receptor approach to target diseases of the brain.
Critical factors influencing the decision to enroll in a physical activity intervention among a predominant group of adults with spinal cord injury: a grounded theory study.
Engineered immunological niches to monitor disease activity and treatment efficacy in relapsing multiple sclerosis.
Predictors of training-related improvement in visuomotor performance in patients with multiple sclerosis: A behavioural and MRI study.
Dendrosomal nanocurcumin promotes remyelination through induction of oligodendrogenesis in experimental demyelination animal model.
Application of stem cell transplantation in autoimmune diseases.
The impact of physical exercise on the fatigue symptoms in patients with multiple sclerosis: a systematic review and meta-analysis.
Three Decades of Interferon-β in Multiple Sclerosis: Can We Repurpose This Information for the Management of SARS-CoV2 Infection?
Effect of Donepezil on Cognitive Impairment, Quality of Life, and Depression in Multiple Sclerosis Patients: A Randomized Clinical Trial.
CXCR3+ T cells in multiple sclerosis correlate with reduced diversity of the gut microbiome.
Long-term drug treatment in multiple sclerosis: safety success and concerns.
Induction of a higher-ordered architecture in glatiramer acetate improves its biological efficiency in an animal model of multiple sclerosis.
Conventional Vestibular Training Versus Virtual Reality- Based Vestibular in Multiple Sclerosis
Reducing Symptoms of Multiple Sclerosis Using Non-invasive Neuromodulation
Imaging correlates of visual function in multiple sclerosis.
Effectiveness of Physical Therapy Interventions in Reducing Fear of Falling among Individuals with Neurological Diseases: A Systematic Review and Meta-analysis.
Conduction Delays in the Visual Pathways of Progressive Multiple Sclerosis Patients Covary with Brain Structure.
An immunological and transcriptomics approach on differential modulation of NK cells in multiple sclerosis patients under interferon-β1 and fingolimod therapy.
N-Glycan Branching Decouples B Cell Innate and Adaptive Immunity to Control Inflammatory Demyelination.
SPINCOMS Biomarker Study

Examining the Efficacy of Non-invasive Neuromodulation in Reducing Symptoms of Multiple Sclerosis – a Pilot Study
Examining the Neural Effects of a Behavioral Intervention for Physical Activity in Multiple Sclerosis
Sirt6 inhibition delays the onset of experimental autoimmune encephalomyelitis by reducing dendritic cell migration.
Epidemiology of neurologic disease in pregnancy.
Protein kinase inhibitors for Amyotrophic Lateral Sclerosis therapy.
Actigraph-Measured Movement Correlates of Attention-Deficit/Hyperactivity Disorder (ADHD) Symptoms in Young People with Tuberous Sclerosis Complex (TSC) with and without Intellectual Disability and Autism Spectrum Disorder (ASD).
Multifaceted Genes in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia.
Particles Containing Cells as a Strategy to Promote Remyelination in Patients With Multiple Sclerosis.
Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders.
Incidence of seroconversion and sero-reversion in patients with multiple sclerosis (MS) who had been treated with natalizumab: A systematic review and meta-analysis.
Enabling More Accessible MS Rehabilitation Training Using Virtual Reality.
The Effect of Coffee and Caffeine Consumption on Patients with Multiple Sclerosis-Related Fatigue.
The role of ADC values within the normal-appearing brain in the prognosis of multiple sclerosis activity during interferon-β therapy in the 3-year follow-up: a preliminary report.
Alterations in Circulating Fatty Acid Are Associated With Gut Microbiota Dysbiosis and Inflammation in Multiple Sclerosis.
Understanding Pediatric Neuroimmune Disorder Conflicts: A Neuroradiologic Approach in the Molecular Era.
Optimizing the noninvasive ventilation pathway for patients with amyotrophic lateral sclerosis/motor neuron disease: a systematic review.
Cognitive rehabilitation for attention and memory in people with multiple sclerosis: a randomized controlled trial (CRAMMS).
Effect of generic glatiramer acetate on spending and use of drugs for multiple sclerosis.
The Treatment of Cognitive, Behavioural and Motor Impairments from Brain Injury and Neurodegenerative Diseases through Cannabinoid System Modulation-Evidence from In Vivo Studies.
Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study.
Lipid Profile Alterations during Fingolimod Treatment in Multiple Sclerosis Patients.
Clinical assessment, management and rehabilitation of walking impairment in MS: An Expert Review.
Mitoxantrone, pixantrone and mitoxantrone (2-hydroxyethyl)piperazine are toll-like receptor 4 antagonists, inhibit NF-κB activation, and decrease TNF-alpha secretion in primary microglia.
Efficacy and safety of rituximab in relapsing-remitting multiple sclerosis: A systematic review and meta-analysis.
Health economics and patient outcomes of hematopoietic stem cell transplantation versus disease-modifying therapies for relapsing remitting multiple sclerosis in the United States of America.
Validation of the functional assessment of chronic illness therapy – General treatment satisfaction (FACIT-TS-G) in multiple sclerosis.
Long-term outcome in multiple sclerosis patients treated with fingolimod.
Does Siponimod Exert Direct Effects in the Central Nervous System?
Alterations of Gut Microbiota and the Brain-Immune-Intestine Axis in Patients With Relapsing-Remitting Multiple Sclerosis After Treatment With Oral Cladribine: Protocol for a Prospective Observational Study.
Expenditure, Utilization, and Cost of Specialty Drugs for Multiple Sclerosis in the US Medicaid Population, 2008-2018.
Recent trends in the development of peptide and protein-based hydrogel therapeutics for the healing of CNS injury.
Parity and disability progression in relapsing-remitting multiple sclerosis.
[Erratum to: Ocrelizumab for treatment of multiple sclerosis].
Sexual functioning in patients with multiple sclerosis and its association with social support and self-esteem.
Statins in COVID-19: is there any foundation?
Genetic Etiology Shared by Multiple Sclerosis and Ischemic Stroke.
Clinical effectiveness of reduced fingolimod dose in relapsing remitting multiple sclerosis-a Portuguese cohort.
A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications.
Effects of fingolimod treatments on alanine transaminase and aspartate transaminase levels in patients with multiple sclerosis.
Use of state sequence analysis for care pathway analysis: The example of multiple sclerosis.
Tyrosine Kinase Receptors Axl and MerTK Mediate the Beneficial Effect of Electroacupuncture in a Cuprizone-Induced Demyelinating Model.
Cathepsin E in neutrophils contributes to the generation of neuropathic pain in experimental autoimmune encephalomyelitis.
Transcranial Magnetic Stimulation as a Potential Biomarker in Multiple Sclerosis: A Systematic Review with Recommendations for Future Research.
Therapy-resistant dysphagia successfully treated using pharyngeal electrical stimulation in a patient with the pharyngeal-cervical-brachial variant of the Guillain-Barré syndrome.
Gestational vitamin D and offspring risk of multiple sclerosis: a systematic review and meta-analysis.
Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study.
Impact of cervical stenosis on multiple sclerosis lesion distribution in the spinal cord.
Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article.
Differential Effects of MS Therapeutics on B Cells-Implications for Their Use and Failure in AQP4-Positive NMOSD Patients.
The Role of MicroRNAs in Repair Processes in Multiple Sclerosis.
Gait asymmetry, and bilateral coordination of gait during a six-minute walk test in persons with multiple sclerosis.
The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history.
Lesion stage-dependent causes for impaired remyelination in MS.
Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study.
COVID-19 and multiple sclerosis: A description of two cases on alemtuzumab.
Multiple sclerosis and related disorders: Short report peripheral vascular events in a real-world cohort of multiple sclerosis patients using Fingolimod.
Effects of co-administration of rapamycin and evening primrose / hemp seed oil supplement on immunologic factors and cells membrane fatty acids of experimental autoimmune encephalomyelitis.
Training the brain: could it improve multiple sclerosis treatment?
Effects on Melanoma Cell Lines Suggest No Significant Risk of Melanoma Under Cladribine Treatment.
Bi-directional communication: Conversations between fibroblasts and immune cells in systemic sclerosis.
Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis.
The effect of novel simple saffron syrup on fatigue reduction in patients with multiple sclerosis.
Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab.
Incidence and prevalence of multiple sclerosis in Hungary based on record linkage of nationwide multiple healthcare administrative data.
Under and Over Rehabilitation Study
Switching to fingolimod in PREFERMS: Effect of treatment history and naïvety on clinical, MRI and treatment satisfaction outcomes✰.
Utilization of High-Cost Interventions for Targeted Clinical Conditions During the Early Stages of ACO Development in a Commercially Insured Population.
Recent advances of long noncoding RNAs involved in the development of multiple sclerosis.
B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran.
Treating patients with multiple sclerosis during the COVID-19 pandemic: Assessing the expert recommendations.
Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic.
Rehabilitation Recommendations for Multiple Sclerosis Patients during the COVID-19 Pandemic.
A case of lung injury resembling diffuse pulmonary hemorrhage after the first administration of alemtuzumab in a patient with multiple sclerosis. Role of the HRCT.
Computerized cognitive rehabilitation for treatment of cognitive impairment in multiple sclerosis: an explorative study.
Backward walking sensitively detects fallers in persons with multiple sclerosis.
Ocrelizumab exposure in the second trimester of pregnancy without neonatal B-cell depletion.
Transverse myelitis as a rare presentation of antiphospholipid-antibody-associated disorders.
A Single Arm Study Evaluating the Efficacy, Safety and Tolerability of Ofatumumab in Patients With Relapsing Multiple Sclerosis
Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients.
[Prevalence and impact of comorbidities in patients with multiple sclerosis].
US Spending Associated With Transition From Daily to 3-Times-Weekly Glatiramer Acetate.
Remyelination in multiple sclerosis: from basic science to clinical translation.
Psychological status of patients with relapsing-remitting multiple sclerosis during coronavirus disease-2019 outbreak.
Non-invasive Spinal Cord Stimulation for Spasticity Control and Augmentation of Voluntary Motor Control in Individuals With Multiple Sclerosis
Clinical and laboratory features distinguishing MOG antibody disease from multiple sclerosis and AQP4 antibody-positive neuromyelitis optica.
The effects of high-dose corticosteroids for multiple sclerosis relapse on blood pressure: A pilot study.
Dietary responses to a multiple sclerosis diagnosis: a qualitative study.
Myelin oligodendrocyte glycoprotein revisited-sensitive detection of MOG-specific T-cells in multiple sclerosis.
Dimethyl fumarate suppresses metastasis and growth of melanoma cells by inhibiting the nuclear translocation of NF-κB.
Dabigatran Suppresses PAR-1/SphK/S1P Activation of Astrocytes in Experimental Autoimmune Encephalomyelitis Model.
Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis.
The importance of physical activity to preserve hippocampal volume in people with multiple sclerosis: a structural MRI study.
Biomarkers as an opportunity to stratify for outcome in systemic sclerosis.
Dimethyl fumarate alters intracellular Ca2+ handling in immune cells by redox-mediated pleiotropic effects.
Evaluation of Myelin Radiotracers in the Lysolecithin Rat Model of Focal Demyelination: Beware of Pitfalls!
Five-years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extension.
Volumetric imaging of myelin in vivo using 3D inversion recovery-prepared ultrashort echo time cones magnetic resonance imaging.
The immunoregulatory and neuroprotective effects of human adipose derived stem cells overexpressing IL-11 and IL-13 in the experimental autoimmune encephalomyelitis mice.
Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis
Clinical Trial Assessing Temelimab Following Rituximab Treatment in Patients With Relapsing Forms of Multiple Sclerosis

Engineering biomaterial microenvironments to promote myelination in the central nervous system.
[Medical cannabinoids and their indications in chronic pain].
A neuropsychologically-based intervention with increased follow-up support for employed women with multiple sclerosis: a pilot randomized controlled trial.
Diroximel fumarate in the treatment of multiple sclerosis.
Multiple sclerosis and COVID-19.
Eriodictyol suppresses Th17 differentiation and the pathogenesis of experimental autoimmune encephalomyelitis.
Trends in hospital readmissions in Multiple Sclerosis patients between 2009 and 2015.
Treatment of Multiple Sclerosis: A Review.
Candidate Gene Association Analysis of Multiple Sclerosis in the Jordanian Arab Population: A Case-Control Study.
Effect of combined exercise training on pentraxins and pro- inflammatory cytokines in people with multiple sclerosis as a function of disability status.
Attitudes of patients with relapsing-remitting form of multiple sclerosis using disease-modifying drugs in Montenegro regarding COVID-19 pandemic.
Apolipoproteins AI and E are associated with neuroaxonal injury to gray matter in multiple sclerosis.
Immunologic Effects of Vitamin D on Human Health and Disease.
Cerebellar Intermittent Theta-Burst Stimulation Combined with Vestibular Rehabilitation Improves Gait and Balance in Patients with Multiple Sclerosis: a Preliminary Double-Blind Randomized Controlled Trial.
Chemical genetic analysis of FTY720- and Ca2+ -sensitive mutants reveals a functional connection between FTY720 and membrane trafficking.
A concerns report survey of physical activity support needs of people with moderate-to-severe MS disability and family caregivers.
Roles of chitinase 3-like 1 in the development of cancer, neurodegenerative diseases, and inflammatory diseases.
Long Noncoding RNAs and Circular RNAs in Autoimmune Diseases.
Gene therapy, a novel therapeutic tool for neurological disorders: Current progress, challenges and future prospective.
Serum neurofilament light as a biomarker in progressive multiple sclerosis.
Imaging in Pediatric Multiple Sclerosis : An Iconographic Review.
Endoplasmic reticulum stress in the dorsal root ganglia regulates large-conductance potassium channels and contributes to pain in a model of multiple sclerosis.
[Anti-NMDAR encephalitis associated with relapsing optic neuritis].
The role of the brain in the treatment of multiple sclerosis as a connectomopathy.
A Digital Patient Portal for Patients With Multiple Sclerosis.
Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide.
The “Treatise on the spleen and stomach” (Pí Wèi Lùn) as the first record of multiple sclerosis in the medical literature – A hypothesis based on the analysis of clinical presentation and herbal medicine.
Short-term lung function changes and predictors of progressive systemic sclerosis-related interstitial lung disease.
Real-world evidence on the safety and effectiveness of fingolimod in patients with multiple sclerosis from Taiwan.
High-dose vitamin B supplementation for persistent visual deficit in multiple sclerosis: a pilot study.
Use of a symptom-based questionnaire to screen for the presence of significant voiding dysfunction in patients with multiple sclerosis and lower urinary tract symptoms: a pilot study.
Acquisition of human immunodeficiency virus infection in a patient with multiple sclerosis: could these conditions positively influence each other’s course?
COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases.
What’s in a name? That which we call Multiple Sclerosis Fatigue.
Patient reported outcomes and performance metrics at diagnosis of secondary progressive multiple sclerosis.
Exploiting relationships between outcomes in Bayesian multivariate network meta-analysis with an application to relapsing-remitting multiple sclerosis.
Structural insights into the multiple binding modes of Dimethyl Fumarate (DMF) and its analogs to the Kelch domain of Keap1.
[COMPLEXITIES IN THE DIFFERENTIAL DIAGNOSIS OF MULTIPLE SCLEROSIS AND HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (CLINICAL CASE)].
Capitalising on the opinions of persons with multiple sclerosis to inform the main trial – participant opinions from participation in a feasibility study, a qualitative extension study.
Impact of intrathecal IgG synthesis on neurological disability in patients with multiple sclerosis.
Immunological effects of vitamin D and their relations to autoimmunity.
Whole-body reversible neuropathic pain associated with right parieto-temporal operculum single inflammatory lesion in a patient with multiple sclerosis: A case report.
Twin pregnancy outcome following teriflunomide treatment in a relapsing-remitting multiple sclerosis patient: A case report.
Upregulation of Tolerogenic Pathways by the Hydrogen Sulfide Donor GYY4137 and Impaired Expression of H2S-Producing Enzymes in Multiple Sclerosis.
Real-world adherence to, and persistence with, once- and twice-daily oral disease-modifying drugs in patients with multiple sclerosis: a systematic review and meta-analysis.
Current Perspectives on Exercise Training in the Management of Multiple Sclerosis.
Inhibition of RhoA/ROCK pathway in the early stage of hypoxia ameliorates depression in mice via protecting myelin sheath.
Development of autoimmune thyroid disease in multiple sclerosis patients post-alemtuzumab improves treatment response.
Sleep quality can influence the outcome of patients with multiple sclerosis.
Effects of virtual reality associated with serious games for upper limb rehabilitation inpatients with multiple sclerosis: randomized controlled trial.
Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study.
Platelet-Activating Factor Deteriorates Lysophosphatidylcholine-Induced Demyelination Via Its Receptor-Dependent and -Independent Effects.
Repetitive percutaneous radiofrequency thermocoagulation for persistent idiopathic facial pain and central neuropathic pain attributed to multiple sclerosis-a retrospective monocentric analysis.
Tumefactive multiple sclerosis in association with fingolimod initiation and discontinuation.
Long-term outcomes of intrathecal baclofen in ambulatory multiple sclerosis patients: A single-center experience.
COVID-19 in multiple sclerosis: The Dutch experience.
Oxysterols and apolipoproteins in multiple sclerosis: a 5 year follow-up study.
Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists.
Pathogenic T cell cytokines in multiple sclerosis.
Phosphodiesterase Type 4 Inhibition in CNS Diseases.
The change of PD1, PDL1 in experimental autoimmune encephalomyelitis treated by 1,25(OH)2D3.
Vitamin D3-mediated resistance to a multiple sclerosis model disease depends on myeloid cell 1,25-dihydroxyvitamin D3 synthesis and correlates with increased CD4+ T cell CTLA-4 expression.
Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group Recommendations.
Longitudinal Intravital Microscopy Reveals Axon Degeneration Concomitant With Inflammatory Cell Infiltration in an LPC Model of Demyelination.
Can We Improve the Monitoring of People With Multiple Sclerosis Using Simple Tools, Data Sharing, and Patient Engagement?
Sex effects across the lifespan in women with multiple sclerosis.
Short-term outcomes of pediatric multiple sclerosis patients treated with alemtuzumab at a Canadian University multiple sclerosis clinic.
Sphenopalatine Ganglion Block: Treatment of Migraine and Trigeminal Neuralgia Associated With Multiple Sclerosis.
Cannabidiol for Viral Diseases: Hype or Hope?
Monoclonal Antibody Therapies for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.
Medical cannabis: What practitioners need to know.
Ultra-high field 7 T imaging in multiple sclerosis.
Biotin Interference in Susceptible CanAg Ca242 Immunoassays and Elimination Method.
Long-term management of multiple sclerosis patients treated with cladribine tablets: an expert opinion.
Measurements of the corpus callosum index and fractional anisotropy of the corpus callosum and their cutoff values are useful to assess global brain volume loss in multiple sclerosis.
Posterior Reversible Encephalopathy Syndrome, Multiple Sclerosis and interferon therapy: Association, co-incidence or convoluted interplay?
The voltage-gated potassium channel KV1.3 as a therapeutic target for venom-derived peptides.
Acute pancreatitis after ocrelizumab treatment for relapsing remitting multiple sclerosis.
Management of Idiopathic CNS inflammatory diseases during the COVID-19 pandemic: Perspectives and strategies for continuity of care from a South East Asian Center with limited resources.
A randomized, placebo-controlled phase 2 trial of laquinimod in primary progressive multiple sclerosis.
GABAA receptor autoimmunity after alemtuzumab treatment for multiple sclerosis.
Physical and Cognitive Functions, Physical Activity, and Sedentary Behavior in Older Adults With Multiple Sclerosis.
Views of healthcare professionals on training for and delivery of a fatigue self-management program for persons with multiple sclerosis.
Barriers and solutions to participation in exercise for moderately disabled people with multiple sclerosis not currently exercising: a consensus development study using nominal group technique.
Psychometric properties of the Arabic Activities-specific Balance Confidence scale in people with multiple sclerosis: Reliability, validity, and minimal detectable change.
Atypical Multiple Sclerosis Lesions or Progressive Multifocal Leukoencephalopathy Lesions: That Is the Question.
Two susceptible HLA-DRB1 alleles for multiple sclerosis differentially regulate anti-JC virus antibody serostatus along with fingolimod.
COVID-19 outcomes in MS: Observational study of early experience from NYU Multiple Sclerosis Comprehensive Care Center.
Efficiency Model of Cladribine Tablets Versus Infusion-Based Disease-Modifying Drugs for Patients with Relapsing-Remitting Multiple Sclerosis.
Diroximel fumarate to treat multiple sclerosis.
Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy.
Multiple sclerosis and neuromyelitis optica after optic neuritis: A nationwide cohort study in Taiwan.
Targeting P2X4 and P2X7 receptors in multiple sclerosis.
Fingolimod downregulates brain sphingosine-1-phosphate receptor 1 levels but does not promote remyelination or neuroprotection in the cuprizone model.
Alterations in circulating T cell functional subpopulations in interferon-beta treated multiple sclerosis patients: A pilot study.
Comorbid disease drives short-term hospitalization outcomes in patients with multiple sclerosis.
Characterization of myelin oligodendrocyte glycoprotein (MOG)35-55-specific CD8+ T cells in experimental autoimmune encephalomyelitis.
StatPearls
Multiple sclerosis and COVID-19: A great opportunity for databases promoting research and collaboration.
StatPearls

A Comparison Study of Efficacy and Safety of a Biosimilar Form of Intramuscular Βeta-interferon I-a Versus the Reference Product: A Randomized Controlled Clinical Trial in Iran.
Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases.
Phase I trial of dimethyl fumarate, temozolomide, and radiation therapy in glioblastoma.
Occupational therapy interventions for multiple sclerosis: A scoping review.
Non-invasive Transcranial Electrical Stimulation in MS
AI in Radiology: Where are we today in Multiple Sclerosis Imaging?
Impact of Ocrelizumab on Cerebrospinal Fluid Biomarkers at Multiple Sclerosis Onset
Relapses in multiple sclerosis reported by patients versus physicians – Insights from a large observational study.
Clinical exacerbation of SARS-CoV2 infection after fingolimod withdrawal.
Effectiveness of blood flow-restricted slow walking on mobility in severe multiple sclerosis: a pilot randomized trial.
Dimethyl fumarate protects cardiomyocytes against oxygen-glucose deprivation/reperfusion (OGD/R)-induced inflammatory response and damages via inhibition of Egr-1.
The efficacy of anti- IL-1 treatment in three patients with coexisting familial Mediterranean fever and multiple sclerosis.
The ocrelizumab phase II extension trial suggests the potential to improve the risk: Benefit balance in multiple sclerosis.
Metabolic syndrome components and disease disability in egyptian multiple sclerosis patients.
Assessment of Language Disorders in Multiple Sclerosis Patients
Efficacy of daclizumab beta versus intramuscular interferon beta-1a on disability progression across patient demographic and disease activity subgroups in DECIDE.
Magnetic resonance imaging changes following natalizumab discontinuation in multiple sclerosis patients with progressive multifocal leukoencephalopathy.
Effects and mechanisms of differently cued and non-cued motor imagery in people with multiple sclerosis: A randomised controlled trial.
Can we trust self-reported walking distance when determining EDSS scores in patients with multiple sclerosis? The Danish MS hospitals rehabilitation study.
Tasks of activities of daily living (ADL) are more valuable than the classical neurological examination to assess upper extremity function and mobility in multiple sclerosis.
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System.
Rapamycin combined with MCC950 to treat multiple sclerosis in experimental autoimmune encephalomyelitis.
Development of the Arm Function in Multiple Sclerosis Questionnaire-Short Form (AMSQ-SF): A static 10-item version.
A proof-of-concept study of extracting patient histories for rare/intractable diseases from social media.
Intensive immunosuppression followed by autologous hematopoietic stem cell transplantation for the treatment of multiple sclerosis.
Increased mental health care use by mothers of children with multiple sclerosis.
Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study.
Expert opinion on the use of cladribine tablets in clinical practice.
A case of Disseminated Herpes Zoster in a patient with Multiple Sclerosis on Glatiramer acetate.
Impact of COVID-19 on U.S. and Canadian neurologists’ therapeutic approach to multiple sclerosis: a survey of knowledge, attitudes, and practices.
Neuroinflammatory Disease as an Isolated Manifestation of Hemophagocytic Lymphohistiocytosis.
Calorie restriction promotes remyelination in a Cuprizone-Induced demyelination mouse model of multiple sclerosis.
Prediction of on-treatment disability worsening in RRMS with the MAGNIMS score.
Signatures of cell stress and altered bioenergetics in skin fibroblasts from patients with multiple sclerosis.
The effect of ellagic acid on spinal cord and sciatica function in a mice model of multiple sclerosis.
Real-World Goal Setting and Use of Outcome Measures According to the International Classification of Functioning, Disability and Health: A European Survey of Physical Therapy Practice in Multiple Sclerosis.
Design, synthesis, and biological evaluation of spiroindolines as novel inducers of oligodendrocyte progenitor cell differentiation-Use of a conformation-based hypothesis to facilitate compound design.
Cannabinoids in multiple sclerosis: A neurophysiological analysis.
What does first-line therapy mean for paediatric multiple sclerosis in the current era?
Pilot randomized active-placebo-controlled trial of low-dose ketamine for the treatment of multiple sclerosis-related fatigue.
Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy in paediatric patients with multiple sclerosis: Results from the PARADIGMS study.
G-POEM may be an optional treatment for refractory gastroparesis in systemic sclerosis.
N-Acylethanolamine Acid Amidase contributes to disease progression in a mouse model of multiple sclerosis.
Long term results of augmentation cystoplasty and urinary diversion in multiple sclerosis.
Quantitative Synthesis of Timed 25-Foot Walk Performance in Multiple Sclerosis.
Motor Learning in People with Multiple Sclerosis: A Systematic Review and Meta-analysis.
Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation.
Visualizing the Central Nervous System: Imaging Tools for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders.
Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton’s Tyrosine Kinase (BTK) Inhibitor SAR442168 (PERSEUS)
Single-Center 8-Years Clinical Follow-Up of Cladribine-Treated Patients From Phase 2 and 3 Trials.
Co-treatments to Boost IDO Activity and Inhibit Production of Downstream Catabolites Induce Durable Suppression of Experimental Autoimmune Encephalomyelitis.
[Conotation of ancient “stroke” and Qianyin Yaofang Xiaoxuming Decoction treating cerebral infarction and cerebral hemorrhage].
[Experience of treating facial neuritis, unexplained limb weakness, cervical spondylosis, acute myelitis, acute radiculitis, Guillain Barre syndrome, multiple sclerosis, myasthenia gravis, motor neuron disease, dermatomyositis with Xiaoxuming Decoction].
Therapeutic status quo in patients with relapsing-remitting multiple sclerosis: A sign of poor self-perception of their clinical status?
MSCOVID19: Using social media to achieve rapid dissemination of health information.
Monomethyl fumarate has better gastrointestinal tolerability profile compared with dimethyl fumarate.
Dissolving microneedles for the delivery of peptides – towards tolerance-inducing vaccines.
A feasibility trial of an internet-delivered psychological intervention to manage mental health and functional outcomes in neurological disorders.
Multiple sclerosis with intractable vomiting and atypical area postrema lesion.
Neurogenic lower urinary tract dysfunction in multiple sclerosis, neuromyelitis optica, and related disorders.
Relapsing paralytic ileus in multiple sclerosis requiring surgery: a video case report.
FDA-approved drugs for multiple sclerosis have no efficacy or disability data in non-Caucasian patients.
A Randomized, Triple-blind Placebo-controlled Trial to Determine the Effect of Saffron on the Serum Levels of MMP-9 and TIMP-1 in Patients with Multiple Sclerosis.
Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity.
Re-Evaluating the Use of IFN-β and Relapsing Multiple Sclerosis: Safety, Efficacy and Place in Therapy.
Discontinuation of disease-modifying treatments for multiple sclerosis in patients aged over 50 with disease Inactivity.
Factors Associated With Medication Use Among Individuals Living With Multiple Sclerosis.
Knowledge regarding COVID-19 pandemic in patients with multiple sclerosis (MS): A report from Iran.
COVID-19 pandemic: The experience of a multiple sclerosis centre in Chile.
Changes in patient and physician attitudes resulting from COVID-19 in neuromyelitis optica spectrum disorder and multiple sclerosis.
CSF chitinase 3-like-1 association with disability of primary progressive MS.
Data Collection in Multiple Sclerosis: The MSDS Approach.
Recommendations of the Polish Medical Society of Radiology and the Polish Society of Neurology for the routinely used magnetic resonance imaging protocol in patients with multiple sclerosis.
Feasibility of a smartphone app to enhance physical activity in progressive MS: a pilot randomized controlled pilot trial over three months.
The influence of trait mindfulness on depression in multiple sclerosis: potential implications for treatment.
Mesenchymal Stem Cells Attenuated Blood-Brain Barrier Disruption via Downregulation of Aquaporin-4 Expression in EAE Mice.
Dysregulation of NF-κB-Associated lncRNAs in Multiple Sclerosis Patients.
Time matters: Early-phase multiple sclerosis is accompanied by considerable impairments across multiple domains.
Combination treatment with secukinumab and dimethyl fumarate in a patient with psoriasis and recent diagnosis of multiple sclerosis.
Epigenetic insights into multiple sclerosis disease progression.
Can t2 blackout effect be A marker of iron accumulation in brains of multiple sclerosis patients ?: A qualitative study.
Discovery and Function of B Cell IgD Low (BDL) B Cells in Immune Tolerance.
Optic neuropathy: A 15-year retrospective observational study.
Atypical MOG antibody disease presenting with typical multiple sclerosis lesions.
Immunoadsorption and Plasma Exchange in Seropositive and Seronegative Immune-Mediated Neuropathies.
Outcomes in a Modern Cohort of Treated Patients with Multiple Sclerosis from Diagnosis Up to 15 Years.
Test-Retest Reliability and Response Stability of Gaze Stabilization, Postural Sway, and Dynamic Balance Tests in Persons with Multiple Sclerosis and Controls.
Real-World Results of Ocrelizumab Treatment for Primary Progressive Multiple Sclerosis.
A Case of Drug-Induced Liver Injury Secondary to Natalizumab.
Vaccination-associated acute disseminated encephalomyelitis.
Neuropsychiatric and cognitive effects of the COVID-19 outbreak on multiple sclerosis patients.
Apigenin Modulates Dendritic Cell Activities and Curbs Inflammation Via RelB Inhibition in the Context of Neuroinflammatory Diseases.
Management of central nervous system demyelinating diseases during the coronavirus disease 2019 pandemic: a practical approach.
Secretion of proteins and antibody fragments from transiently transfected endothelial progenitor cells.
Older age, higher perceived disability and depressive symptoms predict the amount and severity of work-related difficulties in persons with multiple sclerosis.
Pediatric-onset multiple sclerosis is associated with reduced parental health-related quality of life and family functioning.
Burden for Parents of Patients With Schizophrenia-A Nationwide Comparative Study of Parents of Offspring With Rheumatoid Arthritis, Multiple Sclerosis, Epilepsy, and Healthy Controls.
Bone marrow vs Wharton’s jelly mesenchymal stem cells in experimental sepsis: a comparative study.
Challenges in systemic sclerosis trial design.
Exoskeleton-assisted Gait Training in Persons With Multiple Sclerosis: A Single-Group Pilot Study.

Effectiveness and Adverse Events of Use of Natalizumab in a Brazilian Cohort of Patients With Multiple Sclerosis.
Prevention of rebound effect after natalizumab withdrawal in multiple sclerosis. Study of two high-dose methylprednisolone schedules.
Functional recovery in multiple sclerosis patients undergoing rehabilitation programs is associated with plasma levels of hemostasis inhibitors.
Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report.
The Effect of Transcranial Direct Current Stimulation on Chronic Neuropathic Pain in Patients with Multiple Sclerosis: Randomized Controlled Trial.
Mesenchymal Stem Cells Ameliorate Cuprizone-Induced Demyelination by Targeting Oxidative Stress and Mitochondrial Dysfunction.
Primaquine elicits Foxp3+ regulatory T cells with a superior ability to limit CNS autoimmune inflammation.
Effects of Teriflunomide on B Cell Subsets in MuSK-Induced Experimental Autoimmune Myasthenia Gravis and Multiple Sclerosis.
Transplantation of Stem Cells as a Potential Therapeutic Strategy in Neurodegenerative Disorders.
Effects of EHP-101 on inflammation and remyelination in murine models of Multiple sclerosis.
Theta burst stimulation ameliorates symptoms of experimental autoimmune encephalomyelitis and attenuates reactive gliosis.
The pressing questions in multiple sclerosis Care in the era of COVID-19.
Mitoxantrone in relapsing-remitting and rapidly progressive multiple sclerosis: Ten-year clinical outcomes post-treatment with mitoxantrone.
Saliva immunoglobulin free light chain analysis for monitoring disease activity and response to treatment in multiple sclerosis.
The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trial.
Effects of Ten-Weeks Progressive Resistance Training on Neuromuscular Performance, Mobility, Heart Rate Variability and Sleep Quality in Persons With Multiple Sclerosis
Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: Safety algorithm.
Myelin Water Atlas: A Template for Myelin Distribution in the Brain.
Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis.
Long-term effectiveness in patients previously treated with cladribine tablets: a real-world analysis of the Italian multiple sclerosis registry (CLARINET-MS).
A Scoping Review on Clinical Trials of Pain Reduction With Cannabis Administration in Adults.
The Impact of Reproductive Issues on Preferences of Women with Relapsing Multiple Sclerosis for Disease-Modifying Treatments.
Prevalence of disability improvement as a potential outcome for multiple sclerosis trials.
Inner retinal layer thinning in radiologically isolated syndrome predicts conversion to multiple sclerosis.
Decision-making on management of ms and nmosd patients during the COVID-19 pandemic: A latin american survey.
Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation.
Pulmonary Hypertension Phenotypes in Systemic Sclerosis: The Right Diagnosis for the Right Treatment.
Disease-modifying therapy aids cognition in multiple sclerosis.
The Effectiveness of Occupational Therapy-Based Sleep Interventions on Quality of Life and Fatigue in Patients with Multiple Sclerosis: A Pilot Randomized Clinical Trial Study.
Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs.
Efficacy of the Whole-Body Cryotherapy as Add-on Therapy to Pharmacological Treatment of Depression-A Randomized Controlled Trial.
Absence of miRNA-146a Differentially Alters Microglia Function and Proteome.
B Lymphocytes as Targets of the Immunomodulatory Properties of Human Amniotic Mesenchymal Stromal Cells.
Analysis of MicroRNA-18a Expression in Multiple Sclerosis Patients.
Interleukin‑1β attenuates the proliferation and differentiation of oligodendrocyte precursor cells through regulation of the microRNA‑202‑3p/β‑catenin/Gli1 axis.
Immune-mediated hepatitis induced by therapy with Alemtuzumab in a patient with Multiple Sclerosis.
A novel in-home digital treatment to improve processing speed in people with multiple sclerosis: A pilot study.
A fully automated pipeline for brain structure segmentation in multiple sclerosis.
COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies.
Patients’ perspective and usability of innovation technology in a new rehabilitation pathway: An exploratory study in patients with multiple sclerosis.
Expression of platelet-derived growth factor receptor-α/ß, vascular endothelial growth factor receptor-2, c-Abl, and c-Kit in canine granulomatous meningoencephalitis and necrotizing encephalitis.
Thrombotic Microangiopathy in Interferon-beta-Treated Multiple Sclerosis Patient.
Feasibility of “Sit Less, Move More”: An intervention for reducing sedentary behavior Among African Americans with MS.
Brain Activity Changes Following Neuroproprioceptive Physiotherapy in Multiple Sclerosis
Severe B cell-mediated disease activation despite two cycles of alemtuzumab in a patient with multiple sclerosis.
Downregulation of Cancer-Associated lncRNAs in Peripheral Blood of Multiple Sclerosis Patients.
[Family planning in multiple sclerosis: conception, pregnancy, breastfeeding].
Real-world disability improvement in patients with relapsing-remitting multiple sclerosis treated with natalizumab in the Tysabri Observational Program.
A model of motivation for physical activity in individuals diagnosed with multiple sclerosis.
Isokinetic predictors of gait speed increase following high-intensity resistance training of the ankle dorsiflexors in people with multiple sclerosis: A pilot study.
Factors affecting the usability of an assistive soft robotic glove after stroke or multiple sclerosis.
Endeavor™ in Pediatric MS
Can optical flow perturbations detect walking balance impairment in people with multiple sclerosis?
ADAM12 is a costimulatory molecule that determines Th1 cell fate and mediates tissue inflammation.
Tolerogenic vaccines for the treatment of cardiovascular diseases.
Application of the 2017 McDonald diagnostic criteria for multiple sclerosis in Korean patients with clinically isolated syndrome.
Validation of the preference-based multiple sclerosis index.
Functional and structural plasticity following action observation training in multiple sclerosis.
Over three decades study populations in progressive multiple sclerosis have become older and more disabled, but have lower on-trial progression rates: A systematic review and meta-analysis of 43 randomised placebo-controlled trials.
Autologous hematopoietic stem cell transplantation improves fatigue in multiple sclerosis.
Month-of-birth-effect in multiple sclerosis in Austria.
Immunomodulatory properties of MSC-derived exosomes armed with high affinity aptamer toward mylein as a platform for reducing multiple sclerosis clinical score.
Sex-dependent factors encoded in the immune compartment dictate relapsing or progressive phenotype in demyelinating disease.
Fluoxetine in progressive multiple sclerosis: The FLUOX-PMS trial.
What Difference Does It Make? A Comparison of Health State Preferences Elicited From the General Population and From People With Multiple Sclerosis.
Apoptosis in Autoimmunological Diseases, with Particular Consideration of Molecular Aspects of Psoriasis.
Complementary and Alternative Medicine in Radiotherapy: A Comprehensive Review.
Can multiple sclerosis be cured? A case of highly active relapsing multiple sclerosis treated with autologous hematopoietic stem-cell transplantation 13 years ago.
Effects of a 10-week multimodal dance and art intervention program leading to a public performance in persons with multiple sclerosis – A controlled pilot-trial.
Conversion of clinically isolated syndrome to multiple sclerosis: a prospective study.
Highly sensitive quantification of optic neuritis intrathecal biomarker CXCL13.
A new paraplegin mutation in a patient with primary progressive multiple sclerosis.
Unilateral Optic Neuritis in Children: Experience of a Tertiary Centre.
Mobile Attentional Bias Modification Training in Pediatric MS
Maximizing placebo response in neurological clinical practice.
Coronavirus disease 2019: favorable outcome in an immunosuppressed patient with multiple sclerosis.
Disease-Modifying Drugs and Family Planning in People with Multiple Sclerosis: A Consensus Narrative Review from the Gulf Region.
HLA-DPB1*03 as Risk Allele and HLA-DPB1*04 as Protective Allele for Both Early- and Adult-Onset Multiple Sclerosis in a Hellenic Cohort.
Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement.
Use of Botulinum Toxin in the Genitourinary System.
Neurourological assessment in people with multiple sclerosis (MS): a new evaluated algorithm.
Incidence, prevalence and characteristics of MS in São Miguel, an island in the Atlantic.
Clinical and radiological profile of neuromyelitis optica spectrum disorders in an Ecuadorian cohort.
Real world application of ocrelizumab in multiple sclerosis: Single-center experience of 128 patients.
Psoriasiform eruption caused by teriflunomide in a patient with multiple sclerosis.
Acute disseminated encephalomyelitis in children and adults: A focused review emphasizing new developments.
microRNAs: key modulators of disease-modifying therapies in multiple sclerosis.
Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerations.
Potential COVID-19 infection in patients with severe multiple sclerosis treated with alemtuzumab.
The increasing economic burden of multiple sclerosis by disability severity in Australia in 2017: Results from updated and detailed data on types of costs.
Connection of miR-185 and miR-320a expression levels with response to interferon-beta in multiple sclerosis patients.
Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder.
Increased risk of cervical dysplasia in females with autoimmune conditions-Results from an Australia database linkage study.
Using amyloid PET imaging to diagnose Alzheimer’s disease in patients with multiple sclerosis.
Current application of cannabidiol (CBD) in the management and treatment of neurological disorders.
Relapses During High-Dose Biotin Treatment in Progressive Multiple Sclerosis: a Case-Crossover and Propensity Score-Adjusted Prospective Cohort.
[Data on multiple sclerosis in Germany and their representation in the ambulatory registry NeuroTransData (NTD) network].
Efficacy of levetiracetam on upper limb movement in multiple sclerosis patients with cerebellar signs: a multicenter double-blind, placebo-controlled, crossover study.
Medication adherence/persistence among patients with active multiple sclerosis in Finland.
Fampridine-induced changes in walking kinetics are associated with clinical improvements in patients with multiple sclerosis.

Beyond clinical changes: Rehabilitation-induced neuroplasticity in MS.
Beyond center-based testing: Understanding and improving functioning with wearable technology in MS.
Beyond cognitive dysfunction: Relevance of ecological validity of neuropsychological tests in multiple sclerosis.
Assessing disability and relapses in multiple sclerosis on tele-neurology.
The multiple sclerosis work difficulties questionnaire: translation and cross-cultural adaptation to Turkish and assessment of validity and reliability.
Nurses’ knowledge about perioperative care of patients with neurological diseases.
The protective effect of Helicobacter Pylori infection on the susceptibility of multiple sclerosis.
Role of Viruses in the Pathogenesis of Multiple Sclerosis.
Wisdom of the expert crowd prediction of response for 3 neurology randomized trials.
Health-Related Quality of Life and the Relationship to Treatment Satisfaction in Patients with Multiple Sclerosis: Insights from a Large Observational Study.
Interleukin 35-Producing Exosomes Suppress Neuroinflammation and Autoimmune Uveitis.
Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing-Remitting Multiple Sclerosis Patients.
MR findings of uterine PEComa in patients with tuberous sclerosis: report of two cases.
Discovery and Lead-Optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) Kinase.
Aging and Brain Atrophy in Multiple Sclerosis.
Safe and successful use of oocyte in-vitro maturation in two infertile women with multiple sclerosis.
Hookworm Treatment for Relapsing Multiple Sclerosis: A Randomized Double-Blinded Placebo-Controlled Trial.
Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis.
Cryptogenic cerebral venous thrombosis in a multiple-sclerosis-patient treated with Alemtuzumab.
A description of Covid-19 modifications to the TEAMS study protocol for remotely delivering teleassessment/teletraining of complementary alternative medicine among people with multiple sclerosis: protocol for a randomized controlled effectiveness trial.
An evaluation of dimethyl fumarate for the treatment of relapsing remitting multiple sclerosis.
Reliability in long-term clinical studies of disease-modifying therapies for relapsing-remitting multiple sclerosis: A systematic review.
Intervention for Young Adults With Multiple Sclerosis
Crocus Sativus (Saffron): An Immunoregulatory Factor in the Autoimmune and Non-autoimmune Diseases.
Mesenchymal stem cells in experimental autoimmune encephalomyelitis model of multiple sclerosis: A systematic review and meta-analysis.
Social cognitive theory as a guide for exercise engagement in persons with multiple sclerosis who use wheelchairs for mobility.
Aquatic Therapy in Contemporary Neurorehabilitation: An Update.
Juvenile xanthogranuloma as a new type of skin lesions in tuberous sclerosis complex.
The impact of regional astrocyte interferon-γ signaling during chronic autoimmunity: a novel role for the immunoproteasome.
Glatiramer acetate increases T- and B -regulatory cells and decreases granulocyte-macrophage colony-stimulating factor (GM-CSF) in an animal model of multiple sclerosis.
Identifying Incidence of and Risk Factors for Fluoroscopy-Guided Lumbar Puncture and Subsequent Persistent Low-Pressure Syndrome in Patients With Idiopathic Intracranial Hypertension.
A Highly Sensitive Sandwich ELISA to Detect CSF Progranulin: A Potential Biomarker for CNS Disorders.
Essential medicines for patients with multiple sclerosis.
Role of IRF8 in immune cells functions, protection against infections, and susceptibility to inflammatory diseases.
Delta-Globin Gene Expression Is Enhanced in vivo by Interferon Type I.
Real-world effectiveness of cladribine for Australian patients with multiple sclerosis: An MSBase registry substudy.
Aggressive multiple sclerosis (2): Treatment.
Aggressive multiple sclerosis (1): Towards a definition of the phenotype.
Acquired hemophilia A and other autoimmune diseases after alemtuzumab therapy for multiple sclerosis: A report of two cases.
Use of natural medicine and dietary supplements concomitant with conventional medicine among people with Multiple Sclerosis.
Covid-19 in a patient with multiple sclerosis treated with natalizumab: May the blockade of integrins have a protective role?
Switching from natalizumab to alemtuzumab in patients with relapsing multiple sclerosis.
Domperidone-induced elevation of serum prolactin levels and immune response in multiple sclerosis.
A High-dose Pharmacokinetic Study of a New IgG4 Monoclonal Antibody Temelimab/GNbAC1 Antagonist of an Endogenous Retroviral Protein pHERV-W Env.
Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic.
A Journey to the Conformational Analysis of T-Cell Epitope Peptides Involved in Multiple Sclerosis.
Severe paradoxical disease activation following alemtuzumab treatment for multiple sclerosis.
Waking Hypnosis in the Treatment of MS-related Fatigue
[Ocrelizumab for treatment of multiple sclerosis].
Long-term assessment of the cognitive effects of nabiximols in patients with multiple sclerosis: A pilot study.
Current and emerging therapeutics for neuromyelitis optica spectrum disorder: Relevance to the COVID-19 pandemic.
Reaching People With Disabilities in Underserved Areas Through Digital Interventions: Systematic Review.
An Italian programme for COVID-19 infection in multiple sclerosis.
Primary cutaneous cryptococcal infection due to fingolimod – Induced lymphopenia with literature review.
Prophylactic and therapeutic roles of oleanolic acid and its derivatives in several diseases.
Tuberous sclerosis complex presenting as primary intestinal lymphangiectasia: A case report.
Nano and Microparticle Emerging Strategies for Treatment of Autoimmune Diseases: Multiple Sclerosis and Type 1 Diabetes.
Impaired cognition is related to microstructural integrity in relapsing remitting multiple sclerosis.
Sleep in multiple sclerosis patients treated with interferon beta: an actigraphic study.
Pharmacological inhibition of carnitine palmitoyl transferase 1 inhibits and reverses experimental autoimmune encephalitis in rodents.
Pharmacotherapeutic considerations in women with multiple sclerosis.
Change in pregnancy-associated multiple sclerosis relapse rates over time: a meta-analysis.
COVID-19 Immunopathology and the Central Nervous System: Implication for Multiple Sclerosis and Other Autoimmune Diseases with Associated Demyelination.
Impaired local dynamic stability during treadmill walking predicts future falls in patients with multiple sclerosis: A prospective cohort study.
Effectiveness of the transcutaneous tibial nerve stimulation and pelvic floor muscle training with biofeedback in women with multiple sclerosis for the management of overactive bladder.
T Cell Delivery of Nanoparticles-Bound Anti-CD20 Monoclonal Antibody: Successful B Cell Depletion in the Spinal Cord during Experimental Autoimmune Encephalomyelitis.
Pedometers, the frustrating motivators: a qualitative investigation of users’ experiences of the Yamax SW-200 among people with multiple sclerosis.
Longitudinal biomarkers in amyotrophic lateral sclerosis.
An overview of lipidomic analysis in different human matrices of multiple sclerosis.
Pilates for rehabilitation in patients with multiple sclerosis: A systematic review of effects on cognition, health-related physical fitness, general symptoms and quality of life.
Assessment of a home-based standing frame programme in people with progressive multiple sclerosis (SUMS): a pragmatic, multi-centre, randomised, controlled trial and cost-effectiveness analysis.
Economic burden of multiple sclerosis in France estimated from a regional medical registry and national sick fund claims.
Self-regulation of brain activity and its effect on cognitive function in patients with multiple sclerosis – First insights from an interventional study using neurofeedback.
An overview of the current state of evidence for the role of specific diets in multiple sclerosis.
Role of B cells and antibodies in multiple sclerosis.
Evaluating the efficacy and safety of ZytuxTM (Rituximab, AryoGen pharmed) in Iranian multiple sclerosis patients: An observational study.
Randomized-controlled trial of a modified Mediterranean dietary program for multiple sclerosis: A pilot study.
Review of the anti-inflammatory effect of SIRT1 and SIRT2 modulators on neurodegenerative diseases.
Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression.
Immunologic characterization of a immunosuppressed multiple sclerosis patient that recovered from SARS-CoV-2 infection.
Arbutin Improves Functional Recovery and Attenuates Glial Activation in Lysolecethin-Induced Demyelination Model in Rat Optic Chiasm.
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis.
Breastfeeding and treatment of multiple sclerosis.
Cladribine transfer into human milk: A case report.
Gut commensals, dysbiosis, and immune response imbalance in the pathogenesis of multiple sclerosis.
Initial User Testing of Decision Aids for Multiple Sclerosis Disease-Modifying Therapies.
Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials.
High-dose biotin restores redox balance, energy and lipid homeostasis, and axonal health in a model of adrenoleukodystrophy.
Explanatory factors of balance confidence in persons with multiple sclerosis: Beyond the physical functions.
The Meaning of Immune Reconstitution after Alemtuzumab Therapy in Multiple Sclerosis.
Early diagnosis of secondary progressive multiple sclerosis: focus on fluid and neurophysiological biomarkers.
Standard Operating Procedure for the Good Manufacturing Practice-Compliant Production of Human Endometrial Stem Cells for Multiple Sclerosis.
Progress and Promise of Nur77-based Therapeutics for Central Nervous System Disorders.
Fibrinolysis induced clinical improvement in a patient with multiple sclerosis exacerbation.
Multiple sclerosis in 2018: new therapies and biomarkers.
Metabolic Control of Astrocyte Pathogenic Activity via cPLA2-MAVS.
Promising Nanotechnology Approaches in Treatment of Autoimmune Diseases of Central Nervous System.
Stress cardiomyopathy associated with the first manifestation of multiple sclerosis: a case report.
Study Protocol of AMASIA, a Non-Interventional Study to Gain First Insights on SPMS Patients Treated With Siponimod in Clinical Routine.
Onset of Marine-Lenhart syndrome and Graves’ ophthalmopathy in a female patient treated with alemtuzumab for multiple sclerosis.

A long-term follow-up study on biochemical and clinical biomarkers of response to interferon beta-1b treatment in relapsing-remitting multiple sclerosis.
Principal component analysis of blood microRNA datasets facilitates diagnosis of diverse diseases.
Quality of life among patients with multiple sclerosis and voiding dysfunction: a cross-sectional study.
Mild COVID-19 symptoms despite treatment with teriflunomide and high-dose methylprednisolone due to multiple sclerosis relapse.
COVID-19 in teriflunomide-treated patients with multiple sclerosis.
Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis.
[Multiple sclerosis : therapy update].
Clinical features and genetic risk of demyelination following anti-TNF treatment.
Gene expression of semaphorin-3A, semaphorin-7A, neuropilin-1, plexin-C1, and β1 integrin in treated-multiple sclerosis patients.
Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years.
Restless legs syndrome, sleep quality, and perceived cognitive impairment in adults with multiple sclerosis.
Stem cell transplantation and alemtuzumab – options for “early reprogramming” in multiple sclerosis?
Evaluation of NeuroPage as a memory aid for people with multiple sclerosis: A randomised controlled trial.
Progressive resistance exercise training and changes in resting-state functional connectivity of the caudate in persons with multiple sclerosis and severe fatigue: A proof-of-concept study.
Group-based, individualized, comprehensive core stability and balance intervention provides immediate and long-term improvements in walking in individuals with multiple sclerosis: A randomized controlled trial.
Spasticity, gait, and balance in patients with multiple sclerosis: A cross-sectional study.
Changes in standing stability with balance-based torso-weighting with cerebellar ataxia: A pilot study.
Recent Advances in Antigen-Specific Immunotherapies for the Treatment of Multiple Sclerosis.
Telerehabilitation vs Supervised Exercises in MS
Feasibility of a High-intensity Interval Training Program in Persons With Multiple Sclerosis Who Have Walking Disability
Listeria infection after treatment with alemtuzumab: a case report and literature review. Would antibiotic prophylaxis be considered?
Siponimod (Mayzent) Downregulates RhoA and Cell Surface Expression of the S1P1 and CX3CR1 Receptors in Mouse RAW 264.7 Macrophages.
Psycho-neuro-endocrino-immunologic issues in multiple sclerosis: a critical review of clinical and therapeutic implications.
Spiritual health in women with multiple sclerosis and its association with self-esteem.
Cladribine modifies functional properties of microglia.
Effects of aquatic exercises on postural control and hand function in Multiple Sclerosis: Halliwick versus Aquatic Plyometric Exercises: a randomised trial.
Swimming Exercise Ameliorates Symptoms of MOG-Induced Experimental Autoimmune Encephalomyelitis by Inhibiting Inflammation and Demyelination in Rats.
Perceptions, experiences, and understandings of cluster headache among GPs and neurologists: a qualitative study.
Comparing the Effectiveness of Computer-Based, Manual-based, and Combined Cognitive Rehabilitation on Cognitive Functions in Relapsing-Remitting Multiple Sclerosis Patients.
Clinical Data for the Use of Cannabis-Based Treatments: A Comprehensive Review of the Literature.
FTY720 reactivates cryptococcal granulomas in mice through S1P receptor 3 on macrophages.
Effect of hippotherapy on walking performance and gait parameters in people with multiple sclerosis.
Efficacy and safety of rituximab in multiple sclerosis: Experience from a developing country.
Emerging small-molecule treatments for multiple sclerosis: focus on B cells.
Gut dysbiosis and lack of short chain fatty acids in a Chinese cohort of patients with multiple sclerosis.
Bacterial transportable toxins of the nasopharyngeal microbiota in multiple sclerosis. Nose-to-brain direct.
Clinical Characteristics of Multiple Sclerosis in African-Americans.
Perivascular tissue resident memory T cells as therapeutic target in multiple sclerosis.
Ocrelizumab-induced alopecia areata-A series of five patients from Ontario, Canada: A case report.
Tolerizing Strategies for the Treatment of Autoimmune Diseases: From ex vivo to in vivo Strategies.
Implications of COVID-19 Outbreak on Immune Therapies in Multiple Sclerosis Patients-Lessons Learned From SARS and MERS.
Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton’s Tyrosine Kinase (BTK) Inhibitor SAR442168
DreaMS – Digital Biomarkers for Multiple Sclerosis
Umbilical cord-derived mesenchymal stem cells in neurodegenerative disorders: from literature to clinical practice.
Congenital lymphedema as a rare and first symptom of tuberous sclerosis complex.
Are type 1 interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19?
Neuropsychological assessments and psychotherapeutic services in Veterans with multiple sclerosis: Rates of utilization and their associations with socio-demographics and clinical characteristics using Veterans Health Administration-based data.
Evaluation of the Relationship Between ABCG2 Mutation and Teriflunomide Exposure and Safety in Chinese Relapsing Multiple Sclerosis Patients Treated With Teriflunomide 14 mg Once Daily for 24 Weeks
The MSReactor computerized cognitive battery correlates with the processing speed test in relapsing-remitting multiple sclerosis.
A novel bispecific antibody alleviates bleomycin-induced systemic sclerosis injury.
The 2013 clinical course descriptors for multiple sclerosis: A clarification.
Lipid Mediator Profiles Predict Response to Therapy with an Oral Frankincense Extract in Relapsing-Remitting Multiple Sclerosis.
Saccharomyces boulardii CNCM I-745: A Non-bacterial Microorganism Used as Probiotic Agent in Supporting Treatment of Selected Diseases.
Real-World Safety and Effectiveness of Dimethyl Fumarate in Hispanic or Latino Patients with Multiple Sclerosis: 3-Year Results from ESTEEM.
Real-World Safety and Effectiveness of Dimethyl Fumarate in Black or African American Patients with Multiple Sclerosis: 3-Year Results from ESTEEM.
Exercise improves neurotrophins in multiple sclerosis independent of disability status.
Plasma Exchange or Immunoadsorption in Demyelinating Diseases: A Meta-Analysis.
Anti-CD6 mAbs for the treatment of psoriasis.
[Development of an indicator set for the evaluation of the population-based integrated healthcare model ‘Gesundes Kinzigtal’ (Healthy Kinzigtal)].
Bioequivalence Study of 2 Capsule Formulations of Fingolimod 0.5 mg Assessing Both Parent Drug and Active Metabolite in New Zealand Healthy Subjects (Truncated Design).
EAN Guideline on Palliative Care of People with Severe, Progressive Multiple Sclerosis.
EAN guideline on palliative care of people with severe, progressive multiple sclerosis.
Late-onset neutropenia in a multiple sclerosis patient after first dose ocrelizumab switched from rituximab.
Teriflunomide vs injectable disease modifying therapies for relapsing forms of MS.
DCLK-1 LEVEL IN MULTIPLE SCLEROSIS PATIENTS AND ITS CORRELATION WITH CLINIC.
A prospective observational cohort study of posterior tibial nerve stimulation in patients with multiple sclerosis: design and methods.
Biomarkers in Multiple Sclerosis: a review of diagnostic and prognostic factors.
Remediation of Emotional Deficits in Multiple Sclerosis and Traumatic Brain Injury
Treatment of multiple sclerosis under the COVID-19 pandemic.
Disability progression in relapse-free multiple sclerosis patients on fingolimod versus interferon-beta/glatiramer acetate.
The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic.
Helminths products directly modulate T cells that mediate experimental autoimmune encephalomyelitis.
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis.
Spinal Cord Involvement in MS and Other Demyelinating Diseases.
Impact of communication on first treatment decisions in people with relapsing-remitting multiple sclerosis.
Inflammation-related plasma and CSF biomarkers for multiple sclerosis.
B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers.
Impact of Age on Multiple Sclerosis Disease Activity and Progression.
Antifungal itraconazole ameliorates experimental autoimmune encephalomyelitis through a novel mechanism of action.
[Relationship between parasitic infections and hygiene hypothesis: a review].
Frailty in ageing persons with multiple sclerosis.
Remyelination alters the pattern of myelin in the cerebral cortex.
Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study.
Amiloride, fluoxetine or riluzole to reduce brain volume loss in secondary progressive multiple sclerosis: the MS-SMART four-arm RCT
CD49d/CD29-integrin controls the accumulation of plasmacytoid dendritic cells into the CNS during neuroinflammation.
Self-reported changes in the expanded disability status scale score in patients with multiple sclerosis after autologous stem cell transplants: real-world data from a single center.
Hospitalization following influenza infection and pandemic vaccination in multiple sclerosis patients: a nationwide population-based registry study from Norway.
Long-term safety and efficacy of daclizumab beta in relapsing-remitting multiple sclerosis: 6-year results from the SELECTED open-label extension study.
Disease modifying therapies in multiple sclerosis: cost-effectiveness systematic review.
Reply to: Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary.
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary.
Machine Learning and Multiparametric Brain MRI to Differentiate Hereditary Diffuse Leukodystrophy with Spheroids from Multiple Sclerosis.
Effects of Constraint-Induced Movement Therapy on upper limb activity according to a bi-dimensional kinematic analysis in progressive multiple sclerosis patients: a randomized single-blind pilot study.
Severe skin reactions associated with cladribine in people with multiple sclerosis.
Phytotherapy as a Complementary Medicine for Multiple Sclerosis.
Inflammation and Oxidative Stress in Multiple Sclerosis: Consequences for Therapy Development.
Multimodal Image Analysis for Assessing Multiple Sclerosis and Future Prospects Powered by Artificial Intelligence.
Living Donor Preemptive Kidney Transplantation in Tuberous Sclerosis Complex Patient and the Role of Mammalian Target of Rapamycin Inhibitor: A Case Report.
Promises and Limitations of Neural Stem Cell Therapies for Progressive Multiple Sclerosis.
Construct validity of the Gait Assessment and Intervention Tool (GAIT) in people with Multiple Sclerosis.

BMI influences CD20 kinetics in multiple sclerosis patients treated with ocrelizumab.
Nabiximols plus robotic assisted gait training in improving motor performances in people with Multiple Sclerosis.
Targeting macrophages by an aza-anthrapyrazole to ameliorate experimental autoimmune encephalomyelitis.
Neurofilaments in progressive multiple sclerosis: a systematic review.
Exergames for balance dysfunction in neurological disability: a meta-analysis with meta-regression.
Efficacy and safety of alemtuzumab treatment in a real-world cohort of patients with multiple sclerosis.
Pregnancy Outcomes During the Clinical Development Program of Cladribine in Multiple Sclerosis: An Integrated Analysis of Safety.
Prevalence and Incidence of Multiple Sclerosis in Russian Federation: 30 Years of Studies.
Better Objective Sleep Was Associated with Better Subjective Sleep and Physical Activity; Results from an Exploratory Study under Naturalistic Conditions among Persons with Multiple Sclerosis.
Factors affecting outcome in frameless non-isocentric stereotactic radiosurgery for trigeminal neuralgia: a multicentric cohort study.
Study protocol: improving cognition in people with progressive multiple sclerosis: a multi-arm, randomized, blinded, sham-controlled trial of cognitive rehabilitation and aerobic exercise (COGEx).
A systematic review and meta-analyses of pregnancy and fetal outcomes in women with multiple sclerosis: a contribution from the IMI2 ConcePTION project.
Caregiver Burden in Multiple Sclerosis: Recent Trends and Future Directions.
Cognitive Dysfunction in the Early Stages of Multiple Sclerosis-How Much and How Important?
Epigenetics in Multiple Sclerosis.
Biocompatible nanovesicular drug delivery systems with targeting potential for autoimmune diseases.
A case of drug-induced bullous pemphigoid associated with teriflunomide: A patient with relapsing multiple sclerosis.
Alemtuzumab-induced simultaneous onset of autoimmune haemolytic anaemia, alveolar haemorrhage, nephropathy, and stroke: A case report.
Multiple Sclerosis Performance Test: Technical Development and Usability.
Participation in and outcomes from a 12-month tailored exercise programme for people with multiple sclerosis (MSTEP©): a randomized trial.
High-efficacy therapies for relapsing-remitting multiple sclerosis: implications for adherence. An expert opinion from the United Arab Emirates.
Highly active RRMS and ocrelizumab after failure of alemtuzumab therapy.
Stress cardiomyopathy associated with area postrema syndrome as a presentation of neuromyelitis optica: case report.
Laquinimod Protects Against TNF-α-Induced Attachment of Monocytes to Human Aortic Endothelial Cells (HAECs) by Increasing the Expression of KLF2.
Genus Boswellia as a new candidate for neurodegenerative disorders.
CBD Suppression of EAE Is Correlated with Early Inhibition of Splenic IFN-γ + CD8+ T Cells and Modest Inhibition of Neuroinflammation.
[Effects of rehabilitation on fatigue, disability and quality of life in people with multiple sclerosis: A systematic review].
Curcumin and neurological diseases.
Engagement of people with multiple sclerosis to enhance research into the physiological effect of hyperbaric oxygen therapy.
Consensus recommendations for family planning and pregnancy in multiple sclerosis in argentina.
Interferons in the Therapy of Severe Coronavirus Infections: A Critical Analysis and Recollection of a Forgotten Therapeutic Regimen with Interferon Beta.
A Brief Review of the Effects of Vitamin D on Multiple Sclerosis.
The protective effects of phoenixin-14 against lipopolysaccharide-induced inflammation and inflammasome activation in astrocytes.
Treatment Patterns Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy.
Structural changes in the brain of patients with relapsing-remitting multiple sclerosis compared to controls: a MRI-based stereological study.
Neuroplasticity and brain reorganization associated with positive outcomes of multidisciplinary rehabilitation in progressive multiple sclerosis: A fMRI study.
Dimethyl fumarate modulates the Treg:Th17 cell axis in psoriasis patients.
Molecular Interventions towards Multiple Sclerosis Treatment.
Investigating the Causal Effect of Brain Expression of CCL2, NFKB1, MAPK14, TNFRSF1A, CXCL10 Genes on Multiple Sclerosis: A Two-Sample Mendelian Randomization Approach.
Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility Study.
Regulatory B cells normalize CNS myeloid cell content in a mouse model of multiple sclerosis and promote oligodendrogenesis and remyelination.
Disease-modifying treatments and cognition in relapsing-remitting multiple sclerosis: A meta-analysis.
A Case of Multiple Sclerosis-Like Relapsing Remitting Encephalomyelitis Following Allogeneic Hematopoietic Stem Cell Transplantation and a Review of the Published Literature.
Anti-inflammatory Efficacy of Combined Natural Alkaloid Berberine and S1PR Modulator Fingolimod at Low Doses in Ulcerative Colitis Preclinical Models.
Ultrasonographic evaluation of the diaphragm thickness in patients with multiple sclerosis.
Predictors of people’s perceptions of second hand smoke exposure as a risk factor for multiple sclerosis.
Quality of life in patients with multiple sclerosis and its association with depressive symptoms and physical disability.
Compared to an active control condition, in persons with multiple sclerosis two different types of exercise training improved sleep and depression, but not fatigue, paresthesia, and intolerance of uncertainty.
Early initiation of fingolimod reduces the rate of severe relapses over the long term: Post hoc analysis from the FREEDOMS, FREEDOMS II, and TRANSFORMS studies.
Innate Immune System and Multiple Sclerosis. Granulocyte Numbers Are Reduced in Patients Affected by Relapsing-Remitting Multiple Sclerosis during the Remission Phase.
Desirability and acceptability of a treatment-sequencing model in relapsing-remitting multiple sclerosis: A health technology assessment perspective.
BetaEval Global: Prospective, Multinational, Observational Cohort Study of Patients Using BETACONNECT®.
Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis.
Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years’ follow-up of DEFINE, CONFIRM, and ENDORSE.
Are Type 1 Interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19?
Teriflunomide Does Not Change Dynamics of Nadph Oxidase Activation and Neuronal Dysfunction During Neuroinflammation.
Clinically reliable cognitive decline in relapsing remitting multiple sclerosis: Is it the tip of the iceberg?
Comparison of brain atrophy in multiple sclerosis patients treated with first generation disease modifying therapy without clinical relapse.
A possible case of serum sickness after ocrelizumab infusion.
Seasonal distribution of attacks in aquaporin-4 antibody disease and myelin-oligodendrocyte antibody disease.
Medication beliefs in first-line and second-line treated multiple sclerosis patients.
Aquatic exercising may improve sexual function in females with multiple sclerosis – an exploratory study.
Vidofludimus calcium, a next generation DHODH inhibitor for the Treatment of relapsing-remitting multiple sclerosis.
TAPAS: A Thresholding Approach for Probability Map Automatic Segmentation in Multiple Sclerosis.
Dietary interventions for multiple sclerosis-related outcomes.
An antimicrobial impregnated urinary catheter that reduces mineral encrustation and prevents colonisation by multi-drug resistant organisms for up to 12 weeks.
Exercise intensity-dependent immunomodulatory effects on encephalomyelitis.
Cerebellar White Matter Damage Is Associated With Postural Sway Deficits in People With Multiple Sclerosis.
Video-Based Pairwise Comparison: Enabling the Development of Automated Rating of Motor Dysfunction in Multiple Sclerosis.
Free Light Chains as a Novel Diagnostic Biomarker of Immune System Abnormalities in Multiple Sclerosis and HIV Infection.
The Combination Of Rtms And Pharmacotherapy On In Vitro Models: A Mini Review.
Orally Administered Alpha Lipoic Acid as a Treatment for Geographic Atrophy: A Randomized Clinical Trial.
Consensus Statement On Immune Modulation in Multiple Sclerosis and Related Disorders During the COVID-19 Pandemic: Expert Group on Behalf of the Indian Academy of Neurology.
Remission of early persistent cladribine-induced neutropenia after filgrastim therapy in a patient with Relapsing – Remitting Multiple Sclerosis.
Aggressive multiple sclerosis: a single center, real-world treatment experience: aematopoietic stem cell transplantation and alemtuzumab.
CD56bright Natural Killer Cells: A Possible Biomarker of Different Treatments in Multiple Sclerosis.
Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study.
A fine balance: Immunosuppression and immunotherapy in a patient with multiple sclerosis and COVID-19.
Gold nanoparticles and polyethylene glycol alleviate clinical symptoms and alter cytokine secretion in a mouse model of experimental autoimmune encephalomyelitis.
The modulatory effects of luteolin on cyclic AMP/Ciliary neurotrophic factor signaling pathway in experimentally induced autoimmune encephalomyelitis.
Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of the CARE-MS Studies.
Effect of Alemtuzumab Infusions on Vital Signs: A Prospective Observational Study in Patients with Relapsing-Remitting Multiple Sclerosis.
The Dilemma of When to Stop Disease-Modifying Therapy in Multiple Sclerosis: A Narrative Review and Canadian Regional Reimbursement Policies.
Lipid and Lipoprotein Metabolism in Microglia.
Expansion of Neutrophils and Classical and Nonclassical Monocytes as a Hallmark in Relapsing-Remitting Multiple Sclerosis.
The Successful Treatment of Severe Trigeminal Neuralgia by a Single Mandibular Nerve Block and Subsequent Natalizumab Administration in a Patient with Multiple Sclerosis.
Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study.
Sensory-motor network topology in multiple sclerosis: Structural connectivity analysis accounting for intrinsic density discrepancy.
Wearing-off at the end of natalizumab dosing interval and risk of MS disease activity: A prospective 1-year follow-up study.
Introduction to the Theme “New Therapeutic Targets”.
All-cause hospitalizations in multiple sclerosis patients.
Autoantibodies in Pandemrix®-induced narcolepsy: Nine candidate autoantigens fail the conformational autoantibody test.
Folate receptor-targeted positron emission tomography of experimental autoimmune encephalomyelitis in rats.
Multiple sclerosis in ophthalmology: beyond optic neuritis.
Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis.
Optical coherence tomography use in idiopathic intracranial hypertension.
Clinical outcomes in patients who discontinue natalizumab therapy after 2 years in the Tysabri® Observational Program (TOP).
Dietary factors in experimental autoimmune encephalomyelitis and multiple sclerosis: A comprehensive review.
Inadvertent Antegrade Urethral Placement of a Suprapubic Catheter.
Time Restricted Eating Outcomes in Multiple Sclerosis

Entire-body PET Scans for Multiple Sclerosis
Tonsillectomy in multiple sclerosis patients: Retrospective, case-controlled, exploratory study.
Cryptococcal meningitis in a patient with multiple sclerosis on dimethyl fumarate treatment: A case report.
Effectiveness and safety profile of anakinra in a HLA-B27 positive patient with multiple sclerosis-associated uveitis.
Severe COVID-19 infection in a patient with multiple sclerosis treated with fingolimod.
The Effect of Nurse Practitioner (NP-led) Care on Mood, Anxiety and Health Related Quality of Life in People With Multiple Sclerosis – A Randomized Trial
Effects of Ocrevus in Relapsing Multiple Sclerosis
Social Media Surveillance of Multiple Sclerosis Medications Used During Pregnancy and Breastfeeding: Content Analysis.
The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma.
High Dosage of Botulinum Toxin Type A in Adult Subjects with Spasticity Following Acquired Central Nervous System Damage: Where Are We at?
Treatment of neurogenic lower urinary tract symptoms: main contributions from 2018 and 2019.
An Expert Patient Program as a Tool to Empower People With Multiple Sclerosis.
The Main Determinants for Suicidal Ideation in a Romanian Cohort of Multiple Sclerosis Patients.
The contribution of enhancing lesions in monitoring multiple sclerosis treatment: is gadolinium always necessary?
The fiscal consequences of public health investments in disease-modifying therapies for the treatment of multiple sclerosis in Sweden.
Therapeutic effect of Omega-3 fatty acids on T cell-mediated autoimmune diseases.
Concerns about the safety of anti-TNF agents when treating rheumatic diseases.
Lung-Resident Mesenchymal Stromal Cells are Tissue-Specific Regulators of Lung Homeostasis.
Alemtuzumab and prescription medication use in the MS population.
Real-world incidence of fingolimod-associated macular oedema.
Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis.
Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis.
Medical Therapeutic Yoga for multiple sclerosis: examining self-efficacy for physical activity, motivation for physical activity, and quality of life outcomes.
Neuroprotective effects of exercise in people with progressive multiple sclerosis (Exercise PRO-MS): study protocol of a phase II trial.
Human equivalent dose of oral 4-aminopyridine differentiates nerve crush injury from transection injury and improves post-injury function in mice.
Pathogenicity of BK virus on the urinary system.
Neuroprotective natural products against experimental autoimmune encephalomyelitis: A review.
A systematic review of aerobic and resistance exercise and inflammatory markers in people with multiple sclerosis.
Differential Transcription of SOCS5 and SOCS7 in Multiple Sclerosis Patients Treated with Interferon Beta or Glatiramer Acetate.
The effect of tDCS on the fatigue in patients with multiple sclerosis: A systematic review of randomized controlled clinical trials.
[12th Post-ECTRIMS Meeting: review of the novelties from the 2019 ECTRIMS Congress (I)].
Exercise training and cognitive performance in persons with multiple sclerosis: A systematic review and multilevel meta-analysis of clinical trials.
Characterization of the Impact of Daclizumab Beta on Circulating Natural Killer Cells by Mass Cytometry.
Epidemiology of multiple sclerosis IN Santiago de Compostela (Spain).
Sex-Specific Differences in Life Span Brain Volumes in Multiple Sclerosis.
Influence of RehaCom Therapy on the Improvement of Manual Skills in Multiple Sclerosis Subjects.
Immuno-metabolic impact of the multiple sclerosis patients’ sera on endothelial cells of the blood-brain barrier.
Problems and Pitfalls of Identifying Remyelination in Multiple Sclerosis.
Optic nerve atrophy and whole and regional brain atrophy in Leber’s hereditary optic neuropathy with multiple sclerosis-like disease with m.11778G>A mutation.
Walking and cognitive performance in adults with multiple sclerosis: Do age and fatigability matter?
Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment.
Co-existence of multiple sclerosis and anti-NMDA receptor encephalitis: A case report and review of literature.
A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting.
Gadolinium enhancement on cranial MRI in multiple sclerosis is age dependent.
Symbol Digit Modalities Test: Greek Normative Data for the Oral and Written Version and Discriminative Validity in Patients with Multiple Sclerosis.
New approaches for testing non-inferiority for three-arm trials with Poisson distributed outcomes.
Ozanimod: First Approval.
Pharmacotherapeutic Options for Managing Pain in Multiple Sclerosis.
Early clinical markers of aggressive multiple sclerosis.
Personal Autonomy as Quality of Life Predictor for Multiple Sclerosis Patients.
Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot study.
Comparative analysis of affected and unaffected areas of systemic sclerosis skin biopsies by high-throughput proteomic approaches.
Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritis.
[Magnetic Resonance Imaging of Multiple Sclerosis].
[New Arrival of Disease Modifying Drugs Initiates New Era in Multiple Sclerosis Treatment in Japan].
Randomized comparison of functional electric stimulation in posturally corrected position and motor program activating therapy: treating foot drop in people with multiple sclerosis.
SARS-CoV-2 and Multiple Sclerosis: Not all immune depleting DMTs are equal or bad.
Lower urinary tract dysfunction in common neurological diseases.
Real-Word Effectiveness and Safety of Dimethyl Fumarate in a Multiple Sclerosis Portuguese Population.
Social value of a set of proposals for the ideal approach of multiple sclerosis within the Spanish National Health System: a social return on investment study.
COVID-19 infection in a patient with multiple sclerosis treated with fingolimod.
A new lower limb portable exoskeleton for gait assistance in neurological patients: a proof of concept study.
Choroid plexus and the blood-cerebrospinal fluid barrier in disease.
Arsenic trioxide ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice by inducing CD4+ T cell apoptosis.
Micro-percutaneous nephrolithotomy (Microperc) for renal stones, outcomes and learning curve.
Rapamycin and MCC950 modified gut microbiota in experimental autoimmune encephalomyelitis mouse by brain gut axis.
Sugammadex for Cesarean in a Patient with Multiple Sclerosis.
Mindfulness training for emotion dysregulation in multiple sclerosis: A pilot randomized controlled trial.
Association of Individual-Level Factors With Visual Outcomes in Optic Neuritis: Secondary Analysis of a Randomized Clinical Trial.
Measuring network disruption in neurodegenerative diseases: New approaches using signal analysis.
Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies in immune-mediated optic neuritis at long-term follow-up.
Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic.
Microglial and Astrocytic Function in Physiological and Pathological Conditions: Estrogenic Modulation.
Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis.
Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis.
Objective evaluation of Nintendo Wii Fit Plus balance program training on postural stability in Multiple Sclerosis patients: a pilot study.
Treatment and management of cognitive dysfunction in patients with multiple sclerosis.
Cognitive disturbances in the cuprizone model of multiple sclerosis.
The Effects of Evening Primrose/Hemp Seed Oil Compared to Rapamycin on the Gene Expression of Immunological Parameters in Experimental Autoimmune Encephalomyelitis Splenocytes.
Amelogenin Downregulates Interferon Gamma-Induced Major Histocompatibility Complex Class II Expression Through Suppression of Euchromatin Formation in the Class II Transactivator Promoter IV Region in Macrophages.
SUNLIGHT Study: Online Support Groups for MS to Address COVID-19
Physical Therapy and Neuroactive Steroids Therapy Does Not Modulate Serum Level of Neuroactive Steroids
Predicting the Disease Genes of Multiple Sclerosis Based on Network Representation Learning.
Difficult Discharges to Skilled Nursing Facilities Attributed to Multiple Sclerosis Medications: An Observational Study.
FCRL3 promotes IL-10 expression in B cells through the SHP-1 and p38 MAPK signalling pathways.
Prevention and management of adverse effects of disease modifying treatments in multiple sclerosis.
Neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease: current topics.
Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) Before and During Treatment With Ocrelizumab
The effect of retinyl-palmitate on the level of pro and anti-inflammatory cytokines in multiple sclerosis patients: A randomized double blind clinical trial.
DeepHarmony: A deep learning approach to contrast harmonization across scanner changes.
Computerized Cognitive Training in Multiple Sclerosis: A Systematic Review and Meta-analysis.
“Taming the Beast”: Exploring the Lived Experience of Relapsing Remitting Multiple Sclerosis Using a Life History Approach.
IC100: a novel anti-ASC monoclonal antibody improves functional outcomes in an animal model of multiple sclerosis.
[MS update: risk factors, diagnosis and treatment].
RehaCom rehabilitation training improves a wide-range of cognitive functions in multiple sclerosis patients.
Possible Influence of the Route of Treatment Administration on Treatment Adherence in Patients With Multiple Sclerosis.
Autologous hematopoietic stem cell transplantation for multiple sclerosis: A current perspective.
Highlights from the 2019 European Congress on Treatment and Research in Multiple Sclerosis (ECTRIMS 2019).
Evaluating the Risk of Macrovascular Events and Mortality Among People With Multiple Sclerosis in England.
A comprehensive review of non-coding RNAs functions in multiple sclerosis.

Alendronate alleviates the symptoms of experimental autoimmune encephalomyelitis.
Oral chitin treatment improved demyelination in murine autoimmune encephalomyelitis model by inhibition of inflammatory responses.
The IN-DEEP project “INtegrating and Deriving Evidence, Experiences, Preferences”: a web information model on magnetic resonance imaging for people with multiple sclerosis.
Cognitive Efficacy of Pharmacologic Treatments in Multiple Sclerosis: A Systematic Review.
Effects of 2-year treatment with dimethyl fumarate on cognition and functional impairment in patients with relapsing remitting multiple sclerosis.
Vitamin D as a Potential Therapy for Multiple Sclerosis: Where Are We?
Neurons promote encephalitogenic CD4+ lymphocyte infiltration in experimental autoimmune encephalomyelitis.
Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims data.
Mobility Disorders in Stroke, Parkinson Disease, and Multiple Sclerosis: A Multicenter Cross-Sectional Study.
Dimethyl itaconate, an itaconate derivative, exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis.
Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish population.
Neural mechanisms underlying state mental fatigue in multiple sclerosis: a pilot study.
Experience with rituximab therapy in a real-life sample of multiple sclerosis patients.
Role of long non-coding RNAs (LncRNAs) in multiple sclerosis: a brief review.
A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis.
Activated Protein C Attenuates Experimental Autoimmune Encephalomyelitis Progression by Enhancing Vascular Integrity and Suppressing Microglial Activation.
Exercise in the management of multiple sclerosis relapses: current evidence and future perspectives.
Effects of 4-week mindfulness training versus adaptive cognitive training on processing speed and working memory in multiple sclerosis.
MOSPD2 is a Therapeutic Target for the Treatment of CNS Inflammation.
Natural Product Piperine Alleviates Experimental Allergic Encephalomyelitis in Mice by Targeting Dihydroorotate Dehydrogenase.
Eligibility and implementation of disease-modifying therapy for primary progressive multiple sclerosis in a UK cohort.
Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study).
Short Arm Human Centrifuge Therapeutic Training and Rehabilitation (GRACER1)
Myotonometer Analyses of Muscles in Multiple Sclerosis Patients With Dysphagia
On the immunoregulatory role of statins in multiple sclerosis: the effects on Th17 cells.
Active Pulmonary Tuberculosis Triggered by Interferon Beta-1b Therapy of Multiple Sclerosis: Four Case Reports and a Literature Review.
A method to specifically activate the Klotho promoter by using zinc finger proteins constructed from modular building blocks and from naturally engineered Egr1 transcription factor backbone.
Emerging myelin repair agents in preclinical and early clinical development for the treatment of multiple sclerosis.
A Phase 1 Study of KHK4827 in Patients With Systemic Sclerosis
Sensor-based Technology for Upper Limb Rehabilitation
Internet-based Physical Activity Promotion and Exercise Prescription for People With Multiple Sclerosis
Walking to Music and Metronome at Various Tempi in Persons With Multiple Sclerosis: A Basis for Rehabilitation.
Finding a Way Out: S1P Signaling and Immune Cell Migration.
Cryptococcal meningoencephalitis in an IgG2-deficient patient with multiple sclerosis on fingolimod therapy for more than five years – case report.
The Multiple Sclerosis Surveillance Registry: A Novel Interactive Database Within the Veterans Health Administration.
Behavioral Interventions in Multiple Sclerosis.
Multiple Sclerosis Medications in the VHA: Delivering Specialty, High-Cost, Pharmacy Care in a National System.
The Future of Progressive Multiple Sclerosis Therapies.
β-Amyloid precursor protein (APP) and the human diseases.
Exercise and Multiple Sclerosis.
Design, Development, and Testing of an App for Dual-Task Assessment and Training Regarding Cognitive-Motor Interference (CMI-APP) in People With Multiple Sclerosis: Multicenter Pilot Study.
An update on the pharmacological management of pain in patients with multiple sclerosis.
Social participation of patients with multiple sclerosis.
Immediate and Sustained Effects of Interventions for Changing Physical Activity in People with Multiple Sclerosis: Meta-Analysis of Randomized Controlled Trials.
Neuropsychological management of multiple sclerosis: evaluation of a supervised and customized cognitive rehabilitation program for self-used at home (SEPIA): protocol for a randomized controlled trial.
A Neuropsychological Rehabilitation Program for Cognitive Impairment in Psychiatric and Neurological Conditions: A Review That Supports Its Efficacy.
Danish Physicians’ Views on the Appropriateness of the Involvement of Patients with Type 2 Diabetes in Regulatory Decision Making: A Qualitative Study.
Feasibility of remotely supervised transcranial direct current stimulation and cognitive remediation: A systematic review.
Exercise experiences among persons with multiple sclerosis living in the southeast of the United States.
Pseudotumoral calcinosis in systemic sclerosis: Data from systematic literature review and case series from two referral centres.
Real-world cost of treatment for multiple sclerosis patients initiating and receiving infused disease-modifying therapies per recommended label in the United States.
Successful disease control with alemtuzumab in MOG-IgG-associated demyelinating disease with MS-phenotype.
Piperine ameliorated memory impairment and myelin damage in lysolecethin induced hippocampal demyelination.
Safety and efficacy of memantine for multiple sclerosis-related fatigue: A pilot randomized, double-blind placebo-controlled trial.
Therapeutic effects of CO-releaser/Nrf2 activator hybrids (HYCOs) in the treatment of skin wound, psoriasis and multiple sclerosis.
Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study.
Multiple Sclerosis Treatment and Melanoma Development.
[Core aspects of a needs-conform care of patients with multiple sclerosis : Utilization of outpatient services and shared decision making].
Light therapy for multiple sclerosis-associated fatigue: a randomized, controlled phase II trial.
The Impact of Patient Support Programs on Adherence to Disease-Modifying Therapies of Patients with Relapsing-Remitting Multiple Sclerosis in Germany: A Non-Interventional, Prospective Study.
Effects of robot-assisted gait training combined with virtual reality on motor and cognitive functions in patients with multiple sclerosis: A pilot, single-blind, randomized controlled trial.
Clinical outcome measures in multiple sclerosis: A review.
TNFAIP3 Deficiency Affects Monocytes, Monocytes-Derived Cells and Microglia in Mice.
Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders.
Current state-of-art of the application of serum neurofilaments in multiple sclerosis diagnosis and monitoring.
Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder.
The TCR Repertoire Reconstitution in Multiple Sclerosis: Comparing One-Shot and Continuous Immunosuppressive Therapies.
Mendelian randomization study to evaluate the effects of interleukin-6 signaling on four neurodegenerative diseases.
Activity of Antioxidant Defense Enzymes in Rats with Experimental Allergic Encephalomyelitis.
[EMCAM (Multiple Sclerosis Autonomous Community of Madrid) document for the management of patients with multiple sclerosis during the SARS-CoV-2 pandemic].
Therapeutic effects of extracellular vesicles from human adipose-derived mesenchymal stem cells on chronic experimental autoimmune encephalomyelitis.
Multiple sclerosis relapse rates and healthcare costs of two versions of glatiramer acetate.
Fistulas healing. Stable gastric pentadecapeptide BPC 157 therapy.
Siponimod (BAF312) Activates Nrf2 While Hampering NFκB in Human Astrocytes, and Protects From Astrocyte-Induced Neurodegeneration.
Exercise and lifestyle physical activity recommendations for people with multiple sclerosis throughout the disease course.
Teriflunomide, a potential novel cause of chronic active colitis.
Risk Factors for Suicide in a National Sample of Veterans with Multiple Sclerosis.
Management of multiple sclerosis symptoms through reductions in sedentary behaviour: protocol for a feasibility study.
Functional Mobility and Basic Motor Skills in Patients with Multiple Sclerosis and Its Relation to the Anthropometrical Status and Body Composition Parameters.
Live birth in women with multiple sclerosis receiving assisted reproduction.
Matrix decomposition for modeling lesion development processes in multiple sclerosis.
Effectiveness of fingolimod in real-world relapsing-remitting multiple sclerosis Italian patients: the GENIUS study.
Determining the effectiveness of early intensive versus escalation approaches for the treatment of relapsing-remitting multiple sclerosis: The DELIVER-MS study protocol.
Effectiveness of mindfulness-integrated cognitive behavior therapy on anxiety, depression and hope in multiple sclerosis patients: a randomized clinical trial.
Training and Energy Management Education to Improve Quality of Life in Persons With Multiple Sclerosis
[The microbiota-gut-brain axis and its great projections].
Medically Refractory Multiple Sclerosis Is Successfully Treated with Plasmapheresis in a Super Morbidly Obese Pregnant Patient.
Spectrum of anti-myelin oligodendrocyte glycoprotein antibody (MOG-Ab)-associated diseases: an Indian perspective.
An observational study demonstrating the adherence and ease of use of the injector device, RebiSmart®.
COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
[New directions of immunocorrection in multiple sclerosis].
Identification of Concepts of Spiritual Care in Iranian Peoples with Multiple Sclerosis: A Qualitative Study.
Rapid evidence assessment of approaches to community neurological nursing care for people with neurological conditions post-discharge from acute care hospital.
Patient Attitudes to Routine Cognitive Testing in Multiple Sclerosis.
Neuromyelitis optica spectrum disorders.
A comprehensive analysis of antigen-specific autoimmune liver disease related autoantibodies in patients with multiple sclerosis.
Potential therapeutic applications of exosomes in different autoimmune diseases.
Moderator Effects in Intervention Studies.
From molecular mechanism to pre-clinical results: Anti-epileptic effects of Fingolimod.
From Charcot’s descriptions to the current understanding of neuropsychiatric symptoms in multiple sclerosis.

Critically appraised paper: Task-oriented gait training that focuses on the safe and correct use of a walking aid may reduce falls in people with multiple sclerosis [synopsis].
Neuroproprioceptive “Facilitation, Inhibition” and Brain Plasticity
Adherence to self-administering interferon-β1a using RebiSmart® device in Mexican patients with relapsing multiple sclerosis.
Critically appraised paper: Task-oriented gait training that focuses on the safe and correct use of a walking aid may reduce falls in people with multiple sclerosis [commentary].
Exercise Interventions for Improving Flexibility in People with Multiple Sclerosis: A Systematic Review and Meta-Analysis.
The effect of IFN-β 1a on expression of MDA5 and RIG-1 in Multiple Sclerosis patients.
MRI biomarkers of disease progression and conversion to secondary-progressive multiple sclerosis.
Modulating the immune response with the wake-promoting drug modafinil: a potential therapeutic approach for inflammatory disorders.
An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Dimethyl Fumarate or Fingolimod to Ofatumumab
Immunomodulation by dimethyl fumarate treatment improves mouse sciatic nerve regeneration.
Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver disease.
Sex-selective effects on behavior in a mouse model of Tuberous Sclerosis Complex.
Neurotoxicity after hematopoietic stem cell transplant in multiple sclerosis.
Advances in physical rehabilitation of multiple sclerosis.
Evaluation of cell transplant-mediated attenuation of diffuse injury in experimental autoimmune encephalomyelitis using onVDMP CEST MRI.
Acquired haemophilia A after alemtuzumab treatment of multiple sclerosis.
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of scleroderma spectrum.
NAD+ Attenuates Experimental Autoimmune Encephalomyelitis through Inducing of CD11b+ gr-1+ Myeloid-Derived Suppressor Cells.
Modified Delphi study of decision-making around treatment sequencing in relapsing-remitting multiple sclerosis.
Introduction to Purinergic Signaling.
Therapeutic effects of Crocin in autoimmune diseases: A review.
New targets and therapeutics for neuroprotection, remyelination and repair in multiple sclerosis.
Simultaneous quantification of natural and inducible regulatory T-cell subsets during interferon-β therapy of multiple sclerosis patients.
Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT.
An examination of the effects of a patient-designed-and-informed participant information sheet in comparison with a standard, researcher-designed information sheet on recruitment, retention and understanding: Protocol for a study-within-a-trial.
Benefits of Physical Activity for Depression and Fatigue in Multiple Sclerosis: A Longitudinal Analysis.
Prevalence of anxiety, depression, and stress in patients with multiple sclerosis in Kermanshah-Iran: a cross-sectional study.
Immune Reconstitution Therapy or Continuous Immunosuppression for the Management of Active Relapsing-Remitting Multiple Sclerosis Patients? A Narrative Review.
Adverse events related to biologicals used for patients with multiple sclerosis: a comparison between information originating from regulators and from the scientific community.
Ocular involvement in systemic sclerosis: A systematic literature review, it’s not all scleroderma that meets the eye.
Do Post-Translational Modifications Influence Protein Aggregation in Neurodegenerative Diseases: A Systematic Review.
Spousal support and self-determined physical activity in individuals with multiple sclerosis: A theory-informed qualitative exploration.
Oral Administration of miR-30d from Feces of MS Patients Suppresses MS-like Symptoms in Mice by Expanding Akkermansia muciniphila.
Is Initial Misdiagnosis Associated with Reaching Disability Milestones in Patients with Multiple Sclerosis?
Nimodipine reduces dysfunction and demyelination in models of multiple sclerosis.
Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosis.
Multiple Sclerosis in Children: Current and Emerging Concepts.
Evaluation of the Level of Anxiety among Iranian Multiple Sclerosis Fellowships During the Outbreak of COVID-19.
Pregnancy-related relapses and breastfeeding in a contemporary multiple sclerosis cohort.
The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis.
Smoking as a risk factor of onset and relapse of Multiple Sclerosis – a review.
Nocebo and its effects in dentistry and dental research.
Intrinsic and extrinsic mechanisms of thalamic pathology in multiple sclerosis.
Five- and seven-year prognostic value of new effectiveness measures (NEDA, MEDA and six-month delayed NEDA) in relapsing-remitting multiple sclerosis.
Discovery of a 2-pyridinyl urea-containing compound YD57 as a potent inhibitor of apoptosis signal-regulating kinase 1 (ASK1).
Matching and accepting assistive technology in multiple sclerosis: A focus group study with people with multiple sclerosis, carers and occupational therapists.
Patterns of gabapentin and pregabalin use and misuse: Results of a population-based cohort study in France.
HSV-2-encephalitis in a patient with multiple sclerosis treated with ocrelizumab.
Breastfeeding in the Multiple Sclerosis Patient.
Multiple sclerosis associated with pembrolizumab in a patient with non-small cell lung cancer.
Botulinum toxin for the management of spasticity in multiple sclerosis: the Italian botulinum toxin network study.
Healthy Gut, Healthy Brain: The Gut Microbiome in Neurodegenerative Disorders.
Validity and Reliability Study of the Turkish Version of Multiple Sclerosis Self-Management Scale.
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients.
A review of possible therapies for Parkinson’s disease.
Do disease-modifying drugs (DMD) have a positive impact on the occurrence of secondary progressive multiple sclerosis? Comment.
The immediate effect of stroboscopic visual training on information-processing time in people with multiple sclerosis: an exploratory study.
Anti-N-methyl-D-aspartate receptor encephalitis during treatment with adalimumab for psoriasis.
Glucocorticoid receptor mutations and clinical sensitivity to glucocorticoid in Chinese multiple sclerosis patients.
Cytokine profile during pregnancy predicts relapses during pregnancy and postpartum in multiple sclerosis.
Single-pulse transcranial magnetic stimulation in amyotrophic lateral sclerosis.
Assessing Pharmacists’ Preferences towards Efficacy Attributes of Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis.
Monitoring of radiologic disease activity by serum neurofilaments in MS.
[Intermediate Uveitis in Adults and Children – Update].
Comparison of prevalence rates of restless legs syndrome, self-assessed risks of obstructive sleep apnea, and daytime sleepiness among patients with multiple sclerosis (MS), clinically isolated syndrome (CIS) and Neuromyelitis Optica Spectrum Disorder (NMOSD).
Metformin-induced AMPK activation stimulates remyelination through induction of neurotrophic factors, downregulation of NogoA and recruitment of Olig2+ precursor cells in the cuprizone murine model of multiple sclerosis.
IMPDH inhibitors for antitumor therapy in tuberous sclerosis complex.
A resilience group training program for people with multiple sclerosis: Results of a pilot single-blind randomized controlled trial and nested qualitative study.
How and for whom does supportive adjustment to multiple sclerosis cognitive-behavioural therapy work? A mediated moderation analysis.
Pilot study of social cognitive theory variables as correlates of physical activity among adolescents with pediatric multiple sclerosis.
Proteomic changes during experimental de- and remyelination in the corpus callosum.
Role of Demographic and Clinical Factors in Cognitive Functioning of Persons with Relapsing-Remitting and Progressive Multiple Sclerosis.
Commentary: One Hundred Eleven Percutaneous Balloon Compressions for Trigeminal Neuralgia in a Cohort of 66 Patients with Multiple Sclerosis.
The Effectiveness of Percutaneous Balloon Compression, Thermocoagulation, and Glycerol Rhizolysis for Trigeminal Neuralgia in Multiple Sclerosis.
A Higher Mediterranean Diet Score, Including Unprocessed Red Meat, Is Associated with Reduced Risk of Central Nervous System Demyelination in a Case-Control Study of Australian Adults.
Migraine in 746 patients with multiple sclerosis.
UV light suppression of EAE (a mouse model of multiple sclerosis) is independent of vitamin D and its receptor.
Do disease-modifying drugs (DMD) have a positive impact on the occurrence of secondary progressive multiple sclerosis? Yes.
Rotating magnetic field ameliorates experimental autoimmune encephalomyelitis by promoting T cell peripheral accumulation and regulating the balance of Treg and Th1/Th17.
Microglia in Multiple Sclerosis: Friend or Foe?
Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders.
Fecal Microbiota Transplantation in Neurological Disorders.
Validity and Reliability of the World Health Organization Disability Assessment Schedule 2.0 36-Item Persian Version for Persons with Multiple Sclerosis.
Menopause in women with multiple sclerosis: A systematic review.
A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination.
Activated monocytes and markers of inflammation in newly diagnosed multiple sclerosis.
Neurofilament levels are associated with blood-brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis.
Study of Evobrutinib in Participants With Relapsing Multiple Sclerosis
Gray matter network reorganization in multiple sclerosis from 7-Tesla and 3-Tesla MRI data.
Effects of photobiomodulation on interleukin-10 and nitrites in individuals with relapsing-remitting multiple sclerosis – Randomized clinical trial.
The Broad Concept of “Spasticity-Plus Syndrome” in Multiple Sclerosis: A Possible New Concept in the Management of Multiple Sclerosis Symptoms.
Germline Genetic Risk Variants for Progressive Multifocal Leukoencephalopathy.
Cladribine Treatment Improved Homocysteine Metabolism and Increased Total Serum Antioxidant Activity in Secondary Progressive Multiple Sclerosis Patients.
Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options.
Measuring upper limb function in MS: Which existing patient reported outcomes are fit for purpose?
Remyelination Pharmacotherapy Investigations Highlight Diverse Mechanisms Underlying Multiple Sclerosis Progression.
Liver injury after methylprednisolone pulse therapy in multiple sclerosis is usually due to idiosyncratic drug-induced toxicity rather than autoimmune hepatitis.
Deubiquitinating enzymes (DUBs): DoUBle-edged swords in CNS autoimmunity.
Laquinimod inhibits MMP+ induced NLRP3 inflammasome activation in human neuronal cells.
Regulation of Stem Cell-Based Research in India in comparison with the US,EU other Asian countries: Current Issues and Future Perspectives.

Straighten your back! Self-correction posture and postural balance in “non rehabilitative instructed” multiple sclerosis patients.
An intensive task-oriented circuit training positively impacts gait biomechanics in MS patients.
The window of opportunity for treatment of progressive multiple sclerosis.
Contribution of cortical lesions to cognitive impairment in Japanese patients with multiple sclerosis.
The impact of vitamin D3 intake on inflammatory markers in multiple sclerosis patients and their first-degree relatives.
Intravesical Loss of OnabotulinumtoxinA During Endoscopic Intradetrusor Injection – A Multicenter Experience.
Possible therapies of Parkinson’s disease: A review.
Risk HLA-DRB1 alleles differentially influence brain and lesion volumes in Japanese patients with multiple sclerosis.
Plasma exchange in acute attacks of demyelinating diseases of the central nervous system: clinical outcomes and predictors of response.
Antiviral, Immunomodulatory and Antiproliferative Activities of Recombinant Soluble IFNAR2 without IFN-ß Mediation.
The Impact of Immunomodulatory Treatment on Kappa Free Light Chains as Biomarker in Neuroinflammation.
IL-2 and Mycobacterial Lipoarabinomannan as Targets of Immune Responses in Multiple Sclerosis Patients.
A Randomized Control Trial Study to Determine the Effect of Melatonin on Serum Levels of IL-1β and TNF-α in Patients with Multiple Sclerosis.
Oral therapies for treatment of relapsing-remitting multiple sclerosis in Austria: a 2-year comparison using an inverse probability weighting method.
Cell Type-Specific Intralocus Interactions Reveal Oligodendrocyte Mechanisms in MS.
Dimethyl fumarate promotes B cell-mediated anti-inflammatory cytokine profile in B and T cells, and inhibits immune cell migration in patients with MS.
Adaptation to repeated gait-slip perturbations among individuals with multiple sclerosis.
Construct validity and test-retest reliability of the Swedish version of the Acceptance of Chronic Health Conditions Scale.
The rate of neuropsychological assessments in multiple sclerosis has increased-A retrospective study in a Finnish Central Hospital.
The brain-heart connection: a multiple sclerosis relapse presenting as Takotsubo Syndrome. A case report and literature review.
Dense module searching for gene networks associated with multiple sclerosis.
Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence.
Facial pain – an interdisciplinary challenge
Number of MRI T1-hypointensity corrected by T2/FLAIR lesion volume indicates clinical severity in patients with multiple sclerosis.
Long-term MS secondary progression: Derivation and validation of a clinical risk score.
Deployment o the Multidisciplinary Prospective Cohort Imminent
Preventive action of benztropine on platinum-induced peripheral neuropathies and tumor growth.
Effects of Whole-Body Vibration on Motor Impairments in Patients With Neurological Disorders: A Systematic Review.
Safety outcomes of disease-modifying therapies for relapsing-remitting multiple sclerosis: A network meta-analysis.
Physical activity and walking performance across the lifespan among adults with multiple sclerosis.
Higher health care use before a clinically isolated syndrome with or without subsequent MS.
Accessing palliative care for multiple sclerosis: A qualitative study of a neglected neurological disease.
Continuous 12 min walking to music, metronomes and in silence: Auditory-motor coupling and its effects on perceived fatigue, motivation and gait in persons with multiple sclerosis.
Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP).
Histone Deacetylation Inhibitors as Modulators of Regulatory T Cells.
Induction Versus Escalation in Multiple Sclerosis: A 10-Year Real World Study.
Vocal wow in an adapted reflex resonance model.
The anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosis.
Spanish real-world experience with fingolimod in relapsing-remitting multiple sclerosis patients: MS NEXT study.
Informing MS patients on treatment options: a consensus on the process of consent taking.
Does disability level impact the relationship of muscle strength to walking performance in people with multiple sclerosis? a cross-sectional analysis.
On the path together: Experiences of partners of people with multiple sclerosis of the impact of lifestyle modification on their relationship.
Vigorous cool room treadmill training to improve walking ability in people with multiple sclerosis who use ambulatory assistive devices: a feasibility study.
Do subcortical gray matter volumes and aerobic capacity account for cognitive-motor coupling in multiple sclerosis?
Cryptosporidiosis after treatment with fingolimod: a case report and pharmacovigilance review.
Targeted immunomodulation of inflammatory monocytes across the blood-brain barrier by curcumin-loaded nanoparticles delays the progression of experimental autoimmune encephalomyelitis.
Current Advances in Pediatric Onset Multiple Sclerosis.
Distribution of Cortical Diffusion Tensor Imaging Changes in Multiple Sclerosis.
A Definition of “Multitargeticity”: Identifying Potential Multitarget and Selective Ligands Through a Vector Analysis.
Optimal Intereye Difference Thresholds in Retinal Nerve Fiber Layer Thickness for Predicting a Unilateral Optic Nerve Lesion in Multiple Sclerosis.
Calcitriol Prevents Neuroinflammation and Reduces Blood-Brain Barrier Disruption and Local Macrophage/Microglia Activation.
IL-17A is associated with the breakdown of the blood-brain barrier in relapsing-remitting multiple sclerosis.
pHERV-W envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosis.
Neuronal vulnerability and multilineage diversity in multiple sclerosis.
Bilateral paramedian pontine infarcts: a rare cause of bilateral horizontal gaze palsy.
Primary cutaneous Epstein-Barr virus-positive diffuse large B-cell lymphoma (DLBCL) in a patient taking fingolimod.
Matching-adjusted indirect treatment comparison of siponimod and other disease modifying treatments in secondary progressive multiple sclerosis.
Predictors of hospitalization in a Canadian MS population: A matched cohort study.
Changes in Anti-JCV Antibody Status in a Large Population of Multiple Sclerosis Patients Treated with Natalizumab.
The importance of considering differences in study and patient characteristics before undertaking indirect treatment comparisons: a case study of siponimod for secondary progressive multiple sclerosis.
Paraneoplastic tumefactive demyelination in a 47-year-old man with underlying seminoma.
CNS-localized myeloid cells capture living invading T cells during neuroinflammation.
Clinical and epidemiological characteristics of multiple sclerosis patients receiving disease-modifying treatment in Poland.
Daily Temporal Associations Between Physical Activity and Symptoms in Multiple Sclerosis.
Validity of sitting time scores from the International Physical Activity Questionnaire-Short Form in multiple sclerosis.
Severe cutaneous adverse event in a daclizumab-treated multiple sclerosis patient.
Optimization of tetrahydroindazoles as inhibitors of human dihydroorotate dehydrogenase and evaluation of their activity and in vitro metabolic stability.
“Ode to confidence”: Poetry groups for dysarthria in multiple sclerosis.
Rituximab Prevents the Development of Experimental Autoimmune Encephalomyelitis (EAE): Comparison with Prophylactic, Therapeutic or Combinational Regimens.
Patient and physician preferences for multiple sclerosis treatments in Germany: A discrete-choice experiment study.
Assessment of expression profile of microRNAs in multiple sclerosis patients treated with fingolimod.
The therapeutic potential of bilobalide on experimental autoimmune encephalomyelitis (EAE) mice.
Drug targeting strategies into the brain for treating neurological diseases.
A Controlled Clinical Trial on the Effects of Exercise on Lower Urinary Tract Symptoms in Women With Multiple Sclerosis.
Exercise Interventions for Individuals With Neurological Disorders: A Systematic Review of Systematic Reviews.
Opposing T cell responses in experimental autoimmune encephalomyelitis.
Kappa opioid receptor and oligodendrocyte remyelination.
[Non continent urinary diversion and other bladder managements in patients with multiple sclerosis].
Cerebrospinal fluid lactate in dogs with inflammatory central nervous system disorders.
Letter to the Editor Regarding “Possible Prognostic Role of Magnetic Resonance Imaging Findings in Patients with Trigeminal Neuralgia and Multiple Sclerosis who Underwent Percutaneous Balloon Compression: Report of Our Series and Literature Review”.
In Reply to the Letter to the Editor Regarding “Possible Prognostic Role of Magnetic Resonance Imaging Findings in Patients with Trigeminal Neuralgia and Multiple Sclerosis Who Underwent Percutaneous Balloon Compression: Report of Our Series and Literature Review”.
Device-Measured Physical Activity and Cognitive Processing Speed Impairment in a Large Sample of Persons with Multiple Sclerosis.
Environmental enrichment as a promising strategy for aiding multiple sclerosis treatment.
Effects of Transcranial Direct Current Stimulation on Hand Dexterity in Multiple Sclerosis: A Design for a Randomized Controlled Trial.
Interferon-Beta-Induced Headache in Patients with Multiple Sclerosis: Frequency and Characterization.
Unsupervised Domain Adaptation With Optimal Transport in Multi-Site Segmentation of Multiple Sclerosis Lesions From MRI Data.
Cognitive Impairment and Brain Reorganization in MS: Underlying Mechanisms and the Role of Neurorehabilitation.
Semaphorins in Angiogenesis and Autoimmune Diseases: Therapeutic Targets?
Feature selection based on differentially correlated gene pairs reveals the mechanism of IFN-β therapy for multiple sclerosis.
Randomized controlled trial of physical activity intervention effects on fatigue and depression in multiple sclerosis: Secondary analysis of data from persons with elevated symptom status.
Mental Practice and Manipulative Skills Training in Multiple Sclerosis
Multiple Doses of AT-1501-A201 in Adults With ALS
A new target for the treatment of inflammatory bowel disease: Interleukin-37.
First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study.
Drug reaction with eosinophilia and systemic symptoms after ocrelizumab therapy.
An exploratory analysis of the efficacy of ocrelizumab in patients with multiple sclerosis with increased disability.
Endogenous spinal cord stem cells in multiple sclerosis and its animal model.
Immunology of oligodendrocyte precursor cells in vivo and in vitro.
Natalizumab induced cutaneous sarcoidosis-like reaction.
Persistence of intrathecal oligoclonal B cells and IgG in multiple sclerosis.

Commentary: “Brave Dreams” Reanalysis Sheds New Light on Angioplasty for Venous Anomalies in Some Multiple Sclerosis Patients With Chronic Cerebrospinal Venous Insufficiency.
Is pulmonary arterial hypertension associated with interferon-β therapy for multiple sclerosis reversible? A case study to explore the complexity.
Maintenance of natalizumab during the first trimester of pregnancy in active multiple sclerosis.
Mature myelin maintenance requires Qki to coactivate PPARβ-RXRα-mediated lipid metabolism.
Long-term remission of tumefactive relapsing multiple sclerosis after alemtuzumab rescue treatment in an adolescent patient.
Comparison of the lower limb inter-segmental coordination during walking between healthy controls and people with multiple sclerosis with and without fall history.
A Self-management Program to Prevent Falls in People With Multiple Sclerosis
Machine learning analysis of motor evoked potential time series to predict disability progression in multiple sclerosis.
Trunk and pelvis movement compensation in people with multiple sclerosis: Relationships to muscle function and gait performance outcomes.
Efficacy of robot-assisted gait training in multiple sclerosis: A systematic review and meta-analysis.
Cross-sectional survey of complementary and alternative medicine used in Oregon and Southwest Washington to treat multiple sclerosis: A 17-Year update.
Application of the 2017 McDonald criteria for the diagnosis of multiple sclerosis after a first demyelinating event in patients from Argentina.
The S100B Inhibitor Pentamidine Ameliorates Clinical Score and Neuropathology of Relapsing-Remitting Multiple Sclerosis Mouse Model.
Correction to: Comparison of the effectiveness of a tailored cognitive behavioural therapy with a supportive listening intervention for depression in those newly diagnosed with multiple sclerosis (the ACTION-MS trial): protocol of an assessor-blinded, active comparator, randomised controlled trial.
Disease-Modifying Therapy Adherence and Associated Factors in a National Sample of Medicare Patients With Multiple Sclerosis.
Measuring Quality-Adjusted Life-Years When Health Fluctuates.
Neuroprotection Induced by Dexpramipexole Delays Disease Progression in a Mouse Model of Progressive Multiple Sclerosis.
Rethinking multiple sclerosis treatment strategies.
Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study.
miR-504 expression level is increased in multiple sclerosis patients responder to interferon-beta.
Design and characterization of a novel structural class of Kv1.3 inhibitors.
Nocturia and Nocturnal Polyuria in Neurological Patients: From Epidemiology to Treatment. A Systematic Review of the Literature.
The impact of multiple sclerosis relapses on worsening over the long term; insights in the treatment era.
Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS Population.
Neurologic Manifestations as Initial Clinical Presentation of Familial Hemophagocytic Lymphohistiocytosis Type2 Due to PRF1 Mutation in Chinese Pediatric Patients.
LRR domain of NLRX1 protein delivery by dNP2 inhibits T cell functions and alleviates autoimmune encephalomyelitis.
Considering patient clinical history impacts performance of machine learning models in predicting course of multiple sclerosis.
Epidemiology of multiple sclerosis in Central Europe, update from Hungary.
Longitudinal prevalence and determinants of pain in multiple sclerosis: results from the German National Multiple Sclerosis Cohort study.
The epidemiology of comorbidities among multiple sclerosis patients in northeastern Poland.
The role of chemokines and chemokine receptors in multiple sclerosis.
Peripheral nerve field stimulation in medically refractory trigeminal neuralgia attributed to multiple sclerosis.
A multicenter randomized controlled trial of two group education programs for fatigue in multiple sclerosis: Long-term (12-month) follow-up at one site.
Pure spinal multiple sclerosis: A possible novel entity within the multiple sclerosis disease spectrum.
A framework for measurement and harmonization of pediatric multiple sclerosis etiologic research studies: The Pediatric MS Tool-Kit.
Lifetime exposure to ultraviolet radiation and the risk of multiple sclerosis in the US radiologic technologists cohort study.
Five years before multiple sclerosis onset: Phenotyping the prodrome.
Drug-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients.
Impact of mindfulness-based stress reduction for people with multiple sclerosis at 8 weeks and 12 months: A randomized clinical trial.
Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade.
A randomised double-blind placebo-controlled feasibility trial of flavonoid-rich cocoa for fatigue in people with relapsing and remitting multiple sclerosis.
Immune profiling of a patient with alemtuzumab-associated progressive multifocal leukoencephalopathy.
The effectiveness of interferon beta versus glatiramer acetate and natalizumab versus fingolimod in a Polish real-world population.
Vitamin D Supplementation in Multiple Sclerosis: A Critical Analysis of Potentials and Threats.
The transcription factor Nurr1 is up-regulated in amyotrophic lateral sclerosis patients and SOD1-G93A mice.
Neurofilament Protein as a Potential Biomarker of Axonal Degeneration in Experimental Autoimmune Encephalomyelitis.
Fingolimod-associated macular edema controlled with nepafenac non-steroidal anti-inflammatory opthalmologic applications.
Myelin Protection by Ursolic Acid in Cuprizone-Induced Demyelination in Mice.
Oxygen Cost During Mobility Tasks and Its Relationship to Fatigue in Progressive Multiple Sclerosis.
Randomized Controlled Trial of a Telephone-Delivered Physical Activity and Fatigue Self-management Interventions in Adults With Multiple Sclerosis.
The GPR17 Receptor-A Promising Goal for Therapy and a Potential Marker of the Neurodegenerative Process in Multiple Sclerosis.
Evaluating the feasibility and preliminary efficacy of a Cognitive Occupation-Based programme for people with Multiple Sclerosis (COB-MS): protocol for a feasibility cluster-randomised controlled trial.
Protective effects of catalpol and rhein in murine experimental autoimmune encephalomyelitis via regulation of T helper (Th) 1, Th2, Th17, and regulatory T cell responses.
Effectiveness of Fingolimod versus Natalizumab as Second-Line Therapy for Relapsing-Remitting Multiple Sclerosis in Spain: Second-Line GATE Study.
Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies.
Rhythmic Auditory Stimulation & Gait Training
Data of safety in a single-center alemtuzumab treated population.
Gait Variability, Not Walking Speed, Is Related to Cognition in Adolescents With Multiple Sclerosis.
Soluble Antigen Arrays for Selective Desensitization of Insulin-Reactive B Cells.
Myristoylation Confers Oral Bioavailability and Improves the Bioactivity of c(MyD 4-4), a Cyclic Peptide Inhibitor of MyD88.
Effectiveness of rehabilitation interventions for people with multiple sclerosis – A Cochrane Review summary with commentary.
Accessible exercise equipment and individuals with multiple sclerosis: Aerobic demands and preferences.
Different roles of soluble CD40 ligand in central nervous system damage.
Workplace difficulties, health-related quality of life, and perception of stigma from the perspective of patients with Multiple Sclerosis.
Optic neuritis at disease onset predicts poor visual outcome in neuromyelitis optica spectrum disorders.
Comparison of rituximab originator (MabThera®) to biosimilar (Truxima®) in patients with multiple sclerosis.
Information Needs and Seeking Behavior of Italian Neurologists: Survey Describing Needs and Resources in Two Different Clinical Settings.
The Multiple Sclerosis Health Resource Utilization Survey (MS-HRS): Development and Validation Study.
Recombinant adenosine deaminase ameliorates inflammation, vascular disease and fibrosis in preclinical models of systemic sclerosis.
Leptomeningeal Contrast Enhancement Is Related to Focal Cortical Thinning in Relapsing-Remitting Multiple Sclerosis: A Cross-Sectional MRI Study.
Novel phloroglucinol derivative Compound 21 protects experimental autoimmune encephalomyelitis rats via inhibiting Th1/Th17 cell infiltration.
MAPK pathway and B cells overactivation in multiple sclerosis revealed by phosphoproteomics and genomic analysis.
Percutaneous Venous Angioplasty in Patients with Multiple Sclerosis and Chronic Cerebrospinal Venous Insufficiency: A Randomized Wait List Control Study.
Design of a non-interventional post-marketing study to assess the long-term safety and effectiveness of ocrelizumab in German real world multiple sclerosis cohorts – the CONFIDENCE study protocol.
The influence of vitamin D on neurodegeneration and neurological disorders: a rationale for its physio-pathological actions.
Transplantation of IFN-γ Primed hUCMSCs Significantly Improved Outcomes of Experimental Autoimmune Encephalomyelitis in a Mouse Model.
Gender identity and sexual orientation affect health care satisfaction, but not utilization, in persons with Multiple Sclerosis.
Physical activity interventions can improve emotion regulation and dimensions of empathy in persons with multiple sclerosis: An exploratory study.
Diagnostic profiles for precision medicine in systemic sclerosis; stepping forward from single biomarkers towards pathophysiological panels.
T-Cell Proapoptotic and Antifibrotic Activity Against Autologous Skin Fibroblasts in vitro Is Associated With IL-17A Axis Upregulation in Systemic Sclerosis.
An alternative to product-specific pregnancy registries? PRIM; PRegnancy outcomes Intensive Monitoring.
RNA-Binding Protein HuR Promotes Th17 Cell Differentiation and Can Be Targeted to Reduce Autoimmune Neuroinflammation.
Use of the Godin leisure-time exercise questionnaire in multiple sclerosis research: a comprehensive narrative review.
Food allergies are associated with increased disease activity in multiple sclerosis.
IL-17 and limits of success.
Minimally invasive asterional approach for microvascular decompression in trigeminal neuralgia.
Neuroinflammation: an overview of neurodegenerative and metabolic diseases and of biotechnological studies.
Targeted Kruppel-like factor 4 gene knockout in retinal ganglion cells improves visual function in multiple sclerosis mouse model.
Progression of Anterograde Trans-Synaptic Degeneration in the Human Retina Is Modulated by Axonal Convergence and Divergence.
A wearable sensor identifies alterations in community ambulation in multiple sclerosis: contributors to real-world gait quality and physical activity.
Treatment of Progressive Multifocal Leukoencephalopathy Using Immune Restoration.
Haematopoietic Stem Cell Transplantation for Multiple Sclerosis: Current Status.
Anti-oxidant and anti-inflammatory effects of auraptene on phytohemagglutinin (PHA)-induced inflammation in human lymphocytes.
Therapeutic intervention in relapsing autoimmune demyelinating disease through induction of myelin-specific regulatory CD8 T cell responses.
Exercise Training Guidelines for Multiple Sclerosis, Stroke, and Parkinson Disease: Rapid Review and Synthesis.
Stem Cells: A Review Encompassing the Literature with a Special Focus on the Side-Lined Miraculous Panacea; Pre-Morula Stem Cells.
Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors: a collaborative population-based cohort study from Denmark and Sweden.
Epidemiology, diagnosis and management of sexual dysfunction in multiple sclerosis.
Intrathecal IgM as a Prognostic Marker in Multiple Sclerosis.
Moving exercise research in multiple sclerosis forward (the MoXFo initiative): Developing consensus statements for research.

Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes.
Pregnancy and the Postpartum Period in Women With Relapsing-Remitting Multiple Sclerosis Treated With Old and New Disease-Modifying Treatments: A Real-World Multicenter Experience.
Vitamin D and Disease Severity in Multiple Sclerosis-Baseline Data From the Randomized Controlled Trial (EVIDIMS).
Successful Treatment of Pulmonary Arterial Hypertension in Systemic Sclerosis with Anticentriole Antibody.
A model of different cognitive processes during spontaneous and intentional coupling to music in multiple sclerosis.
Extra-Virgin Olive Oil Modifies the Changes Induced in Non-Nervous Organs and Tissues by Experimental Autoimmune Encephalomyelitis Models.
Therapeutic potential of enhancer of zeste homolog 2 in autoimmune diseases.
Interventions for preventing falls in people with multiple sclerosis.
Affective Disorder and Functional Status as well as Selected Sociodemographic Characteristics in Patients with Multiple Sclerosis, Parkinson’s Disease and History of Stroke.
Sexual Dysfunction and Depression in Patients with Multiple Sclerosis in Croatia.
Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism.
Exercise to Manage Fatigue in Progressive Multiple Sclerosis
Evaluation of emotional disorders before and during treatment with interferon beta in patients with multiple sclerosis.
Late-onset neutropenia after RITUXIMAB therapy for multiple sclerosis, neuromyelitis optica spectrum disorders and MOG-antibody-associated diseases.
Peripheral levels of selected adipokines in patients with newly diagnosed multiple sclerosis.
Localized sporotrichosis during natalizumab treatment in Multiple Sclerosis.
Motor Neurone Disease – Systematic Multi-Arm Adaptive Randomised Trial
Another brick in the wall: further evidence supporting the role of haematopoietic stem cell transplantation in treating multiple sclerosis.
Neuroprotective Benefits of Antidepressants in Multiple Sclerosis: Are We Missing the Mark?
Ecological validity of walking capacity tests following rehabilitation in people with multiple sclerosis.
Neurocognitive and emotional status after one-year of mindfulness-based intervention in patients with relapsing-remitting multiple sclerosis.
The Interactive Web-Based Program MSmonitor for Self-Management and Multidisciplinary Care in Persons With Multiple Sclerosis: Quasi-Experimental Study of Short-Term Effects on Patient Empowerment.
Angiopoietin-2 blockade ameliorates autoimmune neuroinflammation by inhibiting leukocyte recruitment into the CNS.
Coping and Adjusting to Living With Multiple Sclerosis
Characterizing vocal tremor in progressive neurological diseases via automated acoustic analyses.
Lichenoid rash: A new side effect of oral Cladribine.
The Role of Granulocyte-Macrophage Colony-Stimulating Factor in Murine Models of Multiple Sclerosis.
Perturbation of gut microbiota decreases susceptibility but does not modulate ongoing autoimmune neurological disease.
‘I can do this’: a qualitative exploration of acceptability and experiences of a physical activity behaviour change intervention in people with multiple sclerosis in the UK.
Self-help Acceptance and Commitment Therapy for Carers of People with Multiple Sclerosis: A Feasibility Randomised Controlled Trial.
Effect of Rituximab on Expanded Disability Status Scale and Relapse Rate in Multiple Sclerosis Patients.
Alemtuzumab for relapsing multiple sclerosis in clinical practice: A four-year retrospective one-center study.
Haptic vs sensorimotor training in the treatment of upper limb dysfunction in multiple sclerosis: A multi-center, randomised controlled trial.
Targeting toll-like receptor 4 to modulate neuroinflammation in central nervous system disorders.
Fatigue Profiles in Patients with Multiple Sclerosis are Based on Severity of Fatigue and not on Dimensions of Fatigue.
Psychosis in Parkinson’s disease and parkinsonism in antipsychotic-naive schizophrenia spectrum psychosis: clinical, nosological and pathobiological challenges.
Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-Review.
Vitamin D deficiency and its association with fatigue and quality of life in multiple sclerosis patients.
High-dose pharmaceutical grade biotin (MD1003) in amyotrophic lateral sclerosis: A pilot study.
Administration of subcutaneous interferon beta 1a in the evening: data from RELIEF study.
Adherence to laboratory monitoring among people taking oral drugs for multiple sclerosis: A Canadian population-based study.
Gene Therapy Approaches in an Autoimmune Demyelinating Disease: Multiple Sclerosis.
Perceived Treatment Satisfaction and Effectiveness Facilitators Among Patients With Chronic Health Conditions: A Self-Reported Survey.
[PROGNOSTIC VALUE OF BIOMARKERS OF MULTIPLE SCLEROSIS ACTIVITY].
Scope and Applications of Nanomedicines for the Management of Neuropathic Pain.
Socioeconomic status and disease-modifying therapy prescribing patterns in people with multiple sclerosis.
First approved treatment in children with multiple sclerosis slows brain atrophy.
Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIGMS study.
HLA-DRB1 allele impact on pediatric multiple sclerosis in a Hellenic cohort.
What role should spinal cord MRI take in the future of multiple sclerosis surveillance?
Healing hand ulcers caused by focal spasticity.
Non-compliance with disease modifying therapies in patients with Multiple Sclerosis: A qualitative analysis.
Dynamic expression of JC virus in urine and its relationship to serostatus.
Exposure to Ultraviolet Radiation in the Modulation of Human Diseases.
Siponimod to treat secondary progressive multiple sclerosis.
Fingolimod after a first unilateral episode of acute optic neuritis (MOVING) – preliminary results from a randomized, rater-blind, active-controlled, phase 2 trial.
Cannabinoids in Chronic Non-Cancer Pain: A Systematic Review and Meta-Analysis.
White matter lesion location correlates with disability in relapsing multiple sclerosis.
Pregnancy-related issues in women with multiple sclerosis: an evidence-based review with practical recommendations.
Tumefactive Acute Disseminated Encephalomyelitis.
Social Cognition Impairments in Patients with Multiple Sclerosis: Comparison with Grade of Disability.
Use of rituximab in adults with relapsing-remitting multiple sclerosis: a systematic literature review.
Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis.
Additional Effect of Intrapulmonary Percussive Ventilation (IPV) on Respiration in People With Multiple Sclerosis (MS).
Exercise Therapy in Multiple Sclerosis
The Potential of Computational Modeling to Predict Disease Course and Treatment Response in Patients with Relapsing Multiple Sclerosis.
DEL-1-Regulated Immune Plasticity and Inflammatory Disorders.
A pilot study on the efficacy of transcranial direct current stimulation applied to the pharyngeal motor cortex for dysphagia associated with brainstem involvement in multiple sclerosis.
[Causes and predictive factors of prolonged length of hospital stay after flexible ureteroscopy: Experience of a large volume institution].
Cognitive Behavioral Therapy for the Management of Multiple Sclerosis-Related Pain: A Randomized Clinical Trial.
Changes in Activity Participation After Multiple Sclerosis Diagnosis.
The Multiple Sclerosis Self-Management Scale-Revised (MSSM-R): Persian Version and Psychometric Analysis.
Perspectives of People with Multiple Sclerosis About Helminth Immunotherapy.
Predictors of Nabiximols (Sativex®) discontinuation over long-term follow-up: a real-life study.
Update on Pediatric Optic Neuritis.
Effects of Treating an Overactive Urinary Bladder in Patients with Multiple Sclerosis.
Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018.
Progressive multifocal leukoencephalopathy after CAR T therapy.
Deficit-specific Training in Spinal Disorders
Natural killer cells in multiple sclerosis: a review.
The effect of aquatic physical therapy on patients with multiple sclerosis: A systematic review and meta-analysis.
Is It Possible to Conduct a Multi-Arm Multi-Stage Platform Trial in Parkinson’s Disease: Lessons Learned from Other Neurodegenerative Disorders and Cancer.
Diseases of the Brain, Head and Neck, Spine 2020–2023: Diagnostic Imaging
The Irony of Humanization: Alemtuzumab, the First, But One of the Most Immunogenic, Humanized Monoclonal Antibodies.
StatPearls
Transcutaneous Electrical Spinal Cord Neuromodulator (TESCoN) Improves Symptoms of Overactive Bladder.
N-acetyl Cysteine Administration Is Associated With Increased Cerebral Glucose Metabolism in Patients With Multiple Sclerosis: An Exploratory Study.
Evaluation of glucose-6-phosphate dehydrogenase serum level in patients with multiple sclerosis and neuromyelitis optica.
Editorial: Multiple Sclerosis – From Bench to Bedside: Currents Insights Into Pathophysiological Concepts and Their Potential Impact on Patients.
Effectiveness and side effects of dimethyl fumarate in multiple sclerosis after 12 months of follow up: An Iranian clinical trial.
Identification of key genes associated with multiple sclerosis based on gene expression data from peripheral blood mononuclear cells.
Serotonin: A Potent Immune Cell Modulator in Autoimmune Diseases.
Psychological factors associated with self-management in multiple sclerosis.
Annualized hospitalization rate with natalizumab vs fingolimod in second-line treatment for RRMS in the public healthcare system in Brazil: A claim database approach.
Possible determinants of long-term adherence to physical activity in multiple sclerosis-theory-based development of a comprehensive questionnaire and results from a German survey study.
Rebound after discontinuation of teriflunomide in patients with multiple sclerosis: 2 case reports.
Phase I randomized trial of liothyronine for remyelination in multiple sclerosis: A dose-ranging study with assessment of reliability of visual outcomes.
Minocycline in MS: Confirmation of Benefit
Association of Multiple Sclerosis Phenotypes with Single Nucleotide Polymorphisms of IL7R, LAG3, and CD40 Genes in a Jordanian Population: A Genotype-Phenotype Study.
Two-year regional grey and white matter volume changes with natalizumab and fingolimod.

Copeptin – a new diagnostic and prognostic biomarker in neurological and cardiovascular diseases.
Progressive Multifocal Leukoencephalopathy associated to treatment with natalizumab in Mexican patient Multiple Sclerosis. Case report, analysis and update.
[Diagnostik Lumbar Puncture – Step by Step].
Axons Matter: The Promise of Treating Neurodegenerative Disorders by Targeting SARM1-Mediated Axonal Degeneration.
Location of first attack predicts the site of subsequent relapses in multiple sclerosis.
Psychometric properties of an Arabic translation of the modified fatigue impact scale in patients with multiple sclerosis.
Trends in FDA drug approvals over last 2 decades: An observational study.
Identification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics (RETIMUS)
Streptococcus thermophilus ST285 Alters Pro-Inflammatory to Anti-Inflammatory Cytokine Secretion against Multiple Sclerosis Peptide in Mice.
The Effectiveness and Value of Siponimod for Secondary Progressive Multiple Sclerosis.
Fingolimod for Relapsing-Remitting Multiple Sclerosis: The Experience From Saudi Arabia.
Transcutaneous Direct Current Stimulation of the Spinal Cord for Treatment of Spasticity in Multiple Sclerosis
When is a Ketogenic Diet Ketogenic? Comment on “Satiating Effect of a Ketogenic Diet and Its Impact on Muscle Improvement and Oxidation State in Multiple Sclerosis Patients, Nutrients 2019, 11, 1156”.
Reply to “When Is a Ketogenic Diet Ketogenic? Comment on Satiating Effect of a Ketogenic Diet and Its Impact on Muscle Improvement and Oxidation State in Multiple Sclerosis Patients. Nutrients 2019, 11, 1156”.
Changes in Cognitive Performance With Age in Adults With Multiple Sclerosis.
MiR-219a-5p Enriched Extracellular Vesicles Induce OPC Differentiation and EAE Improvement More Efficiently Than Liposomes and Polymeric Nanoparticles.
Multiple sclerosis and intracellular cobalamin defect (MMACHC/PRDX1) comorbidity in a young male.
[Surgical decompression of the peroneal nerve at the level of the fibular head].
Remyelination in multiple sclerosis: from concept to clinical trials.
Epstein-Barr virus and its association with disease – a review of relevance to general practice.
T Helper Cells: The Modulators of Inflammation in Multiple Sclerosis.
MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice.
Treatment of metastasized melanoma with combined checkpoint inhibition in a patient with highly active multiple sclerosis.
A cell-based assay for the detection of neutralizing antibodies against alemtuzumab.
NK cell-derived GM-CSF potentiates inflammatory arthritis and is negatively regulated by CIS.
The influence of age at disease onset on future relapses and disability progression in multiple sclerosis patients on immunomodulatory treatment.
Noninvasive spinal neuromodulation to map and augment lower urinary tract function in rhesus macaques.
Case 4: wounds associated with chronic progressive multiple sclerosis.
Influence of combined functional resistance and endurance exercise over 12 weeks on matrix metalloproteinase-2 serum concentration in persons with relapsing-remitting multiple sclerosis – a community-based randomized controlled trial.
Expert consensus from the Arabian Gulf on selecting disease-modifying treatment for people with multiple sclerosis according to disease activity.
Prognostic role of intrathecal IgM synthesis in multiple sclerosis: Results from a clinical series.
Optimization of spectral domain optical coherence tomography and visual evoked potentials to identify unilateral optic neuritis.
Socioeconomic status and race are correlated with affective symptoms in multiple sclerosis.
Early astragaloside IV administration attenuates experimental autoimmune encephalomyelitis in mice by suppressing the maturation and function of dendritic cells.
Neuroprotection by dihydrotestosterone in LPS-induced neuroinflammation.
MRI features associated with rapid disease activity in clinically isolated syndrome patients at high risk for multiple sclerosis.
Which is the best PML risk stratification strategy in natalizumab-treated patients affected by multiple sclerosis?
Benefits of curcumin in brain disorders.
Multiple Sclerosis: Clinical Updates in Women’s Health Care Primary and Preventive Care Review.
ANCA-associated life-threatening systemic vasculitis after alemtuzumab treatment for multiple sclerosis.
Alemtuzumab-related eosinophilic central nervous system vasculitis.
Real-state of autophagy signaling pathway in neurodegenerative disease; focus on multiple sclerosis.
Neuron-Specific Vitamin D Signaling Attenuates Microglia Activation and CNS Autoimmunity.
Event-Driven Immunoprofiling Predicts Return of Disease Activity in Alemtuzumab-Treated Multiple Sclerosis.
Recommendations for neurological, obstetrical and gynaecological care in women with multiple sclerosis: a statement by a working group convened by the Section of Multiple Sclerosis and Neuroimmunology of the Polish Neurological Society.
Clinical spectrum of central nervous system myelin oligodendrocyte glycoprotein autoimmunity in adults.
Lipid profile is associated with decreased fatigue in individuals with progressive multiple sclerosis following a diet-based intervention: Results from a pilot study.
Co-occurrence of multiple sclerosis and myasthenia gravis: A case report and review of immunological theories.
Descriptive analysis of free-text comments on healthcare priorities and experiences in a national sample of people with multiple sclerosis.
Pediatric acquired demyelinating syndrome (ADS) in inpatient hospital settings: The hospitalization rate, costs, and outcomes in the US.
Epigenetic aspects of multiple sclerosis and future therapeutic options.
ADAMTS13 ameliorates inflammatory responses in experimental autoimmune encephalomyelitis.
Elevated D-dimer as an immediate response to alemtuzumab treatment.
Changing therapeutic strategies and persistence to disease-modifying treatments in a population of multiple sclerosis patients from Veneto region, Italy.
Matching-adjusted comparisons demonstrate better clinical outcomes in patients with relapsing multiple sclerosis treated with peginterferon beta-1a than with teriflunomide.
Acute Intermittent Hypoxia in Persons With Multiple Sclerosis
MR-Guided Focused Ultrasound (MRgFUS) for the Management of Tremor in Patients With Multiple Sclerosis
BRCA1/BRCA2-containing complex subunit 3 controls oligodendrocyte differentiation by dynamically regulating lysine 63-linked ubiquitination.
New insights into the novel anti-inflammatory mode of action of glucocorticoids.
Oncostatin M-induced astrocytic tissue inhibitor of metalloproteinases-1 drives remyelination.
Transcutaneous Electrical Nerve Stimulation in Relieving Neuropathic Pain: Basic Mechanisms and Clinical Applications.
Effects of Ten-Weeks Resistance Training on Neuromuscular Performance and Mobility in Persons With Multiple Sclerosis
Validation and reliability study of the Turkish version of the Neuroquality of Life (Neuro-QoL)-Stigma Scale for neurological disorders
RebiQoL: A randomized trial of telemedicine patient support program for health-related quality of life and adherence in people with MS treated with Rebif.
Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD.
[Pathological and protective effects of tumor necrosis factor-alpha in multiple sclerosis].
[Results of a phase 1 clinical study of anti-CD20 monoclonal antibody (BCD-132): pharmacokinetics, pharmacodynamics and safety].
[The efficacy and safety of siponimod in the Russian population of patients with secondary progressive multiple sclerosis].
Phase 2 randomized placebo controlled double blind study to assess the efficacy and safety of tecfidera in patients with amyotrophic lateral sclerosis (TEALS Study): Study protocol clinical trial (SPIRIT Compliant).
Therapeutic effects of Tetanus neurotoxin in spinal cord injury: a case series on four dogs.
The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T’s come into focus.
Nursing Management of Gastrointestinal Adverse Events Associated With Delayed-Release Dimethyl Fumarate: A Global Delphi Approach.
Contraception in autoimmune diseases.
Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting.
Staphylococcal enterotoxin B increased severity of experimental model of multiple sclerosis.
Immunological consequences of “immune reconstitution therapy” in multiple sclerosis: A systematic review.
Reward presentation reduces on-task fatigue in traumatic brain injury.
Venous thromboembolism in multiple sclerosis: a report of two cases with pulmonary embolism on dimethyl fumarate and available data from adverse event reporting systems. Time to include disease modifying drugs in the equation?
Management of diabetes and hypertension in people with multiple sclerosis.
Effects of modified-release fampridine on upper limb impairment in patients with Multiple Sclerosis.
A tumefactive demyelinating lesion in a person with MS after five years of fingolimod.
The Effects of Carbenoxolone against Experimental Autoimmune Encephalomyelitis in a Mouse Model.
Diurnal Cortisol Secretion Is Not Related to Multiple Sclerosis-Related Fatigue.
Duration of natalizumab therapy and reasons for discontinuation in a multiple sclerosis population.
Tetrahydrocannabinol and cannabidiol oromucosal spray in resistant multiple sclerosis spasticity: consistency of response across subgroups from the SAVANT randomized clinical trial.
Summarizing Patient Preferences for the Competitive Landscape of Multiple Sclerosis Treatment Options.
Endocannabinoid receptors in the CNS: potential drug targets for the prevention and treatment of neurologic and psychiatric disorders.
Blinded sample size reestimation in event-driven clinical trials: Methods and an application in multiple sclerosis.
Endogenous opioid peptides and brain development: Endomorphin-1 and Nociceptin play a sex-specific role in the control of oligodendrocyte maturation and brain myelination.
The neuropsychological aspects of performance-based Internet navigation skills: A brief review of an emerging literature.
Rituximab in the treatment of multiple sclerosis in the Hospital District of Southwest Finland.
Therapeutic Plasmapheresis with Albumin Replacement in Alzheimer’s Disease and Chronic Progressive Multiple Sclerosis: A Review.
Advances in oral immunomodulating therapies in relapsing multiple sclerosis.
Correction to: Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing-Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMSII Trials.
Frontal brain activity and cognitive processing speed in multiple sclerosis: An exploration of EEG neurofeedback training.
Late onset absolute neutropenia associated with ocrelizumab treatment in multiple sclerosis: A case report and review of the literature.
Environmental risk factors for multiple sclerosis in Japanese people.
Longitudinal evaluation of demyelinated lesions in a multiple sclerosis model using ultrashort echo time magnetization transfer (UTE-MT) imaging.
Neuropsychiatric Symptoms of Multiple Sclerosis: State of the Art.
Eosinophilic Pneumonia Associated With Natalizumab In A Patient With Multiple Sclerosis: A Case Report And Literature Review.

Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
Multiple sclerosis drug FTY-720 toxicity is mediated by the heterotypic fusion of organelles in neuroendocrine cells.
Spinal parenchymal occupation by neural stem cells after subpial delivery in adult immunodeficient rats.
Fulminant MS Reactivation Following Combined Fingolimod Cessation and Yellow Fever Vaccination.
Cortical neurodynamics changes mediate the efficacy of a personalized neuromodulation against multiple sclerosis fatigue.
Folate receptor-targeted positron emission tomography of experimental autoimmune encephalomyelitis in rats.
Efficacy of the Spanish modified Story Memory Technique in Mexicans with multiple sclerosis: A pilot randomized controlled trial.
Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis – a pilot trial.
Evaluation of apamin effects on myelination process in C57BL/6 mice model of multiple sclerosis.
Mutually reinforcing effects of genetic variants and interferon-β 1a therapy for pulmonary arterial hypertension development in multiple sclerosis patients.
Four novel mutations in the mitochondrial ND4 gene of complex I in patients with multiple sclerosis.
In Clinic Physical Activity in Persons With Multiple Sclerosis
Unraveling the T-B tangle in anti-CD20 multiple sclerosis therapy.
Clinical predictors of Dimethyl Fumarate response in multiple sclerosis: a real life multicentre study.
FTY720 (Fingolimod) Ameliorates Brain Injury Through Multiple Mechanisms and is a Strong Candidate for Stroke Treatment.
Emerging Connections of S1P-Metabolizing Enzymes with Host Defense and Immunity During Virus Infections.
Effects of Treatment with the Hypomethylating Agent 5-aza-2′-deoxycytidine in Murine Type II Collagen-Induced Arthritis.
Dimethyl Fumarate: A Review in Relapsing-Remitting MS.
Comparison of Vigorous Versus Low Intensity Cool Room Treadmill Training in People With Multiple Sclerosis
Infusion-related reactions during Natalizumab treatment: Do we still need a post-infusion observation period?
Cognitive performance and cognitive workload in multiple sclerosis: Two different constructs of cognitive functioning?
Minocycline for Relapsing-Remitting Multiple Sclerosis and Clinically Isolated Syndrome: A Review of Clinical Effectiveness and Guidelines
Critically appraised paper: Task-oriented gait training that focuses on the safe and correct use of a walking aid may reduce falls in people with multiple sclerosis [commentary].
Idiopathic Thrombocytopenic Purpura: A Rare Syndrome with Alemtuzumab, Review of Monitoring Protocol.
7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions.
Immunoglobulin G index as a biomarker of relapse response to corticosteroids during early stages of multiple sclerosis.
Combination of Imipramine, a sphingomyelinase inhibitor, and β-caryophyllene improve their therapeutic effects on experimental autoimmune encephalomyelitis (EAE).
Health locus of control and mental health in patients with multiple sclerosis: Mediating effect of coping strategies.
Sphingosine-1-phosphate signaling: A novel target for simultaneous adjuvant treatment of triple negative breast cancer and chemotherapy-induced neuropathic pain.
Cognitive-motor Interference in Persons With MS: Dual Task Assessment and Training – A Multi-center Study
IL-10-producing regulatory B cells and plasmocytes: Molecular mechanisms and disease relevance.
Beyond the annualized relapse rate: Assessment of cognitive outcome after treatment in paediatric multiple sclerosis.
Sphingosine-1-Phosphate Receptor Modulator, FTY720, Improves Diastolic Dysfunction and Partially Reverses Atrial Remodeling in a Tm-E180G Mouse Model Linked to Hypertrophic Cardiomyopathy.
Time to treatment failure following initiation of fingolimod versus teriflunomide for multiple sclerosis: a retrospective U.S. claims study.
Intrathecal Baclofen Dosage for Long-Term Treatment of Patients With Spasticity Due to Traumatic Spinal Cord Injuries or Multiple Sclerosis.
Propranolol diminished severity of rat EAE by enhancing immunoregulatory/protective properties of spinal cord microglia.
Multiple Sclerosis: Melatonin, Orexin, and Ceramide Interact with Platelet Activation Coagulation Factors and Gut-Microbiome-Derived Butyrate in the Circadian Dysregulation of Mitochondria in Glia and Immune Cells.
Dietary phytol reduces clinical symptoms in experimental autoimmune encephalomyelitis (EAE) at least partially by modulating NOX2 expression.
Oxidative Stress and Inflammation Interdependence in Multiple Sclerosis.
Identifying potential targets for prevention and treatment of amyotrophic lateral sclerosis based on a screen of medicare prescription drugs.
Hochu-Ekki-To Improves Motor Function in an Amyotrophic Lateral Sclerosis Animal Model.
Developing a Model of Care for Home Infusions of Natalizumab for People With Multiple Sclerosis.
Non-Immersive Virtual Reality for Rehabilitation of the Older People: A Systematic Review into Efficacy and Effectiveness.
Genetic Interactions Affect Lung Function in Patients with Systemic Sclerosis.
Fingolimod Immune Effects Beyond Its Sequestration Ability.
Curcumin prevents experimental autoimmune encephalomyelitis by inhibiting proliferation and effector CD4+ T cell activation.
Is the walk ratio a window to the cerebellum in multiple sclerosis? A structural MRI study.
Arts & Health Education to Improve Health, Resilience, and Well-Being
Oxidized Lipids in Persistent Pain States.
The relationship between corticospinal tract integrity and lower-extremity strength is attenuated when controlling for age and sex in multiple sclerosis.
Neurofilament light levels are associated with long-term outcomes in multiple sclerosis.
Impact of FcγR variants on the response to alemtuzumab in multiple sclerosis.
Pill or needle? Determinants of the preference for long-acting injection over oral treatment in people facing chronic illness.
Efficacy of tocilizumab for fulminant multiple sclerosis with a tumefactive cervical lesion: A 12-year-old boy.
Biologic therapy in the idiopathic inflammatory myopathies.
Flare of hepatitis B virus after fingolimod treatment for relapsing and remitting multiple sclerosis.
Adoptive Transfer of Regulatory T Cells as a Promising Immunotherapy for the Treatment of Multiple Sclerosis.
Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study.
Efficient Distribution of a Novel Zirconium-89 Labeled Anti-cd20 Antibody Following Subcutaneous and Intravenous Administration in Control and Experimental Autoimmune Encephalomyelitis-Variant Mice.
Labeling of Disease-Modifying Therapies for Neurodegenerative Disorders.
Adaptive Features of Natural Killer Cells in Multiple Sclerosis.
Response to commentary of Shirani and Okuda regarding “Unilateral arm rehabilitation for persons with multiple sclerosis using serious games in a virtual reality approach: Bilateral treatment effect?”
Interrupting rituximab treatment in relapsing-remitting multiple sclerosis; no evidence of rebound disease activity.
CXCR2 antagonism promotes oligodendrocyte precursor cell differentiation and enhances remyelination in a mouse model of multiple sclerosis.
Autoimmune Encephalitis and CSF Anti-GluR3 Antibodies in an MS Patient after Alemtuzumab Treatment.
Exploring uncertainty measures in deep networks for Multiple sclerosis lesion detection and segmentation.
Fingolimod Rebound: A Review of the Clinical Experience and Management Considerations.
Ethyl pyruvate enhances spontaneous remyelination by targeting microglia phagocytosis.
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study.
FMT for MS Patients
Fampridine-SR and Optic Neuritis Recovery
Protective Effect of PBCA Nanoparticles Loaded with Thymulin Against the Relapsing-Remitting Form of Experimental Autoimmune Encephalomyelitis in Mice.
Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis.
Physical activity participation according to the pyramidal, sensory, and cerebellar functional systems in multiple sclerosis.
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients.
Dimethyl fumarate therapy reduces memory T cells and the CNS migration potential in patients with multiple sclerosis.
Small Molecule Antagonists of NAADP-Induced Ca2+ Release in T-Lymphocytes Suggest Potential Therapeutic Agents for Autoimmune Disease.
Analysis of clinical pharmacist interventions in the neurology unit of a Brazilian tertiary teaching hospital.
Efficacy of alemtuzumab over 6 years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies.
[Rapamycin in the treatment of renal diseases associated with tuberous sclerosis complex].
Differential diagnosis of multiple sclerosis and other inflammatory CNS diseases.
2D in-vivo L-COSY spectroscopy identifies neurometabolite alterations in treated multiple sclerosis.
Safety, feasibility, acceptability and effects of a behaviour-change intervention to change physical activity behaviour among people with multiple sclerosis: Results from the iStep-MS randomised controlled trial.
Artemisia dracunculus L. modulates the immune system in a multiple sclerosis mouse model.
Secukinumab for patients with plaque psoriasis affected by multiple sclerosis. A mini-review with a representative case report.
Quantitative Synthesis of Timed 25-Foot Walk Performance in Multiple Sclerosis.
Clinical and radiological findings of facial paralysis in multiple sclerosis.
Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelines.
Clinical characteristics and use of disease modifying therapy in the nationwide Danish cohort of paediatric onset multiple sclerosis.
HDL-cholesterol elevation associated with fingolimod and dimethyl fumarate therapies in multiple sclerosis.
Stem cell therapy for neurological disorders.
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
Magnetic resonance spectroscopy evidence for declining gliosis in MS patients treated with ocrelizumab versus interferon beta-1a.
Lymphocyte pharmacodynamics are not associated with autoimmunity or efficacy after alemtuzumab.
Natalizumab: Perspectives from the Bench to Bedside.
Role of Microglial Activation and Norepinephrine Transporter Abnormalities in Pathogenesis of MS-related Fatigue
Functional and self-care capacity of people with multiple sclerosis.
Elongated Flexuous Plant Virus-Derived Nanoparticles Functionalized for Autoantibody Detection.
Canadian Multiple Sclerosis Pregnancy Study (CANPREG-MS): Rationale and Methodology.

Management of antiphospholipid syndrome.
Retraining Reflexes: Clinical Translation of Spinal Reflex Operant Conditioning.
Walk With Me: a Mobile Application to Improve Walking in Persons With MS
Underlying Causes and Related Factors, and Rehabilitation Approaches
Physical activity, sedentary behavior, and restless legs syndrome in persons with multiple sclerosis.
Italian Consensus on treatment of spasticity in multiple sclerosis.
Expression of melanoma cell adhesion molecule-1 (MCAM-1) in natalizumab-treated multiple sclerosis.
The efficacy of interferon-beta therapy in multiple sclerosis patients: investigation of the RORA gene as a predictive biomarker.
Immune reconstitution therapies: concepts for durable remission in multiple sclerosis.
Retinal Degeneration After First-Ever Optic Neuritis Helps Differentiate Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.
Patterns of regional brain volume loss in multiple sclerosis: a cluster analysis.
Aspirin ameliorates experimental autoimmune encephalomyelitis through interleukin-11-mediated protection of regulatory T cells.
Do Antiretroviral Drugs Protect From Multiple Sclerosis by Inhibiting Expression of MS-Associated Retrovirus?
Interferon-β corrects massive gene dysregulation in multiple sclerosis: Short-term and long-term effects on immune regulation and neuroprotection.
Efficacy and Safety of Alemtuzumab in Patients of African Descent with Relapsing-Remitting Multiple Sclerosis: 8-Year Follow-up of CARE-MS I and II (TOPAZ Study).
Therapeutic plasma exchange in neurological disorders: Experience from a tertiary neuroscience centre.
Advancing Understanding of Transportation Options
Gaze Stability, Dynamic Balance and Participation Deficits in People with Multiple Sclerosis at Fall-Risk.
Introduction to Purinergic Signaling.
Immunomodulatory receptors are differentially expressed in B and T cell subsets relevant to autoimmune disease
Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063)
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
Brain activation patterns associated with paragraph learning in persons with multiple sclerosis: The MEMREHAB trial.
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
Multiple cardiac rhabdomyomas in tuberous sclerosis complex: case report and review of the literature.
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
Adherence to Treatment in Patients with Chronic Diseases: From Alertness to Persistence.
Medicinal Chemistry of Multiple Sclerosis: Focus on Cladribine.
Comparative discontinuation, effectiveness, and switching practices of dimethyl fumarate and fingolimod at 36-month follow-up.
[Multiple Sclerosis: Neurorehabilitation and Symptomatic Treatment].
Evaluation of multiple sclerosis disability outcome measures using pooled clinical trial data.
Demonstration of background rates of three conditions of interest for vaccine safety surveillance.
Using an interactive virtual environment to integrate a digital Action Research Arm Test, motor imagery and action observation to assess and improve upper limb motor function in patients with neuromuscular impairments: a usability and feasibility study protocol.
Cerebrospinal Fluid and Blood Cytokines as Biomarkers for Multiple Sclerosis: A Systematic Review and Meta-Analysis of 226 Studies With 13,526 Multiple Sclerosis Patients.
Altered motor plasticity in an acute relapse of multiple sclerosis.
Supra-Spinal Modulation Of Walking In Healthy Individuals And Persons With Multiple Sclerosis: A fNIRS Mobile Imaging Study.
Automated Integration of Multimodal MRI for the Probabilistic Detection of the Central Vein Sign in White Matter Lesions.
Palliative care interventions for people with multiple sclerosis.
TRPM2 Exacerbates Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis by Increasing Production of CXCL2 Chemokines.
The Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View.
Provisional best practices guidelines for the evaluation of bulbar dysfunction in amyotrophic lateral sclerosis.
Phloroglucinol derivative compound 21 attenuates cuprizone-induced multiple sclerosis mice through promoting remyelination and inhibiting neuroinflammation.
Setmelanotide, a Novel, Selective Melanocortin Receptor-4 Agonist Exerts Anti-inflammatory Actions in Astrocytes and Promotes an Anti-inflammatory Macrophage Phenotype.
MicroRNAs in blood and cerebrospinal fluid as diagnostic biomarkers of multiple sclerosis and to monitor disease progression.
Role of CD20+ T cells in multiple sclerosis: implications for treatment with ocrelizumab.
Joint application of magnetic resonance imaging and biochemical biomarkers in diagnosis of multiple sclerosis.
Reliability and minimal detectable change in the gait assessment and intervention tool in patients with multiple sclerosis.
Cognitive impairment in multiple sclerosis: An exploratory analysis of environmental and lifestyle risk factors.
Fasting as a Therapy in Neurological Disease.
Orthotic management of instability of the knee related to neuromuscular and central nervous system disorders: qualitative interview study of patient perspectives.
Simvastatin Therapy in Multiple Sclerosis Patients with Respect to Gut Microbiome-Friend or Foe?
JC virus antibodies in Portuguese multiple sclerosis patients: JUSTIFY study results.
[The pegylated form of interferon beta in the treatment of multiple sclerosis].
[The role of glutamate in the pathogenesis of multiple sclerosis].
Involvement of Heme Oxygenase-1 in Neuropsychiatric and Neurodegenerative Diseases.
[Tardue scales in the diagnostic of spasticity].
Supervised Perturbation Training Results in Changes in Balance and Falling in Patients With Multiple Sclerosis
The Role of Inflammation in Neurological Disorders.
Predictors of outcome in a large retrospective cohort of patients with transverse myelitis.
Use of Vitamins and Dietary Supplements by Patients With Multiple Sclerosis: A Review.
e-Health and multiple sclerosis: An update.
The Selective Oral Immunomodulator Vidofludimus in Patients with Active Rheumatoid Arthritis: Safety Results from the COMPONENT Study.
Tolerance regeneration by T regulatory cells in autologous haematopoietic stem cell transplantation for autoimmune diseases.
Participation in social/lifestyle activities in people with multiple sclerosis: Changes across 10 years and predictors of sustained participation.
Altered hypothalamic metabolism in early multiple sclerosis – MR spectroscopy study.
Anti-interferon-beta antibodies in Polish multiple sclerosis patients: prevalence and clinical significance in a long-term prospective study.
Teriflunomide Concentration in Serum and Cerebrospinal Fluid From Patients With Multiple Sclerosis
Electronic Pill Bottle Monitoring to Promote Medication Adherence for People With Multiple Sclerosis
Stroke and seizure continue to be the major brunt of in patient neurology care. An observation from teaching hospital.
Outcomes of patients with multiple sclerosis at a neurorehabilitation unit in Saudi Arabia.
Neurosteroidogenesis and progesterone anti-inflammatory/neuroprotective effects.
Quality of life assessment among multiple sclerosis patients in Saudi Arabia.
Multiple sclerosis and myasthenia gravis following severe weight loss.
Phase-III, randomized controlled trial of the behavioral intervention for increasing physical activity in multiple sclerosis: Project BIPAMS.
[Multiple sclerosis in central Hungary: experiences and future possibilities of developing a local database].
Informing the design of exercise programs for persons with multiple sclerosis who use wheelchairs: a qualitative inquiry of perceived components.
Screening for urinary tract colonisation prior to corticosteroid administration in acute multiple sclerosis relapses: Validation of an updated algorithm.
Focused ultrasound thalamotomy for multiple sclerosis-associated tremor.
Focal Thickness Reduction of the Ganglion Cell-Inner Plexiform Layer Best Discriminates Prior Optic Neuritis in Patients With Multiple Sclerosis.
StatPearls
Quantification characteristics of digital spiral analysis for understanding the relationship among tremor and clinical measures in persons with multiple sclerosis.
More than meets the eye: Point-of-care ultrasound diagnosis of acute optic neuritis in the emergency department.
Prospective study of clinical, neurophysiological and urodynamic findings in multiple sclerosis patients undergoing percutaneous transluminal venous angioplasty.
[Nutritional approach in systemic sclerosis: about a case].
Dimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment naïve relapsing MS patients.
The long-term outcomes of CIS patients in the Barcelona inception cohort: Looking back to recognize aggressive MS.
Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS.
Therapeutic Potential of ω-3 Polyunsaturated Fatty Acids in Human Autoimmune Diseases.
Necrostatin-1 ameliorates the pathogenesis of experimental autoimmune encephalomyelitis by suppressing apoptosis and necroptosis of oligodendrocyte precursor cells.
Effects of Fampridine in People with Multiple Sclerosis: A Systematic Review and Meta-analysis.
Letter to the Editor. Multiple sclerosis-related tremor and stereotactic radiosurgery.
Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosis.
Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis.